Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC
ENSG00000248429	GASK1B-AS1	-3.82316587602378	5.0226415165642e-29	LPS_vs_Control	HSALNG0038152	anti_sense,sense	Q50	hsa-miR-486-3p,hsa-miR-4466	Blood osmolality measurement,-	TMEM144
ENSG00000290525	GBP1P1	8.50157544270574	2.0002189394907798e-25	LPS_vs_Control	NA	NA	NA	NA	NA	GBP6
ENSG00000253891	ENSG00000253891	8.66994420590751	1.79050342279187e-24	LPS_vs_Control	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1
ENSG00000291077	ENSG00000291077	5.01843209666452	2.8075466378913197e-23	LPS_vs_Control	NA	NA	NA	NA	NA	ARHGEF19
ENSG00000274536	MIR223HG	-6.13062020242756	2.1301859757155e-22	LPS_vs_Control	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH
ENSG00000264456	ENSG00000264456	-2.67775295723202	7.95769576274704e-22	LPS_vs_Control	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089		RNF135
ENSG00000253838	ENSG00000253838	7.66618411136709	1.0735720065310301e-21	LPS_vs_Control	HSALNG0150187	sense	Q50		-	IDO1
ENSG00000238045	MVP-DT	5.70530970395056	3.74112885638988e-21	LPS_vs_Control	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p		CDIPT
ENSG00000266709	ENSG00000266709	4.43426669872331	1.71899281935537e-20	LPS_vs_Control	HSALNG0114719	intronic_sense	Q50			HS3ST3B1
ENSG00000230149	ENSG00000230149	4.62921739548055	3.2290454473577197e-20	LPS_vs_Control	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000288156	ENSG00000288156	-5.2978934748228	3.25529202057254e-19	LPS_vs_Control	HSALNG0123151	intronic_sense	Not conserved		-	NA
ENSG00000280798	LINC00294	-2.49807293452889	9.48306071471776e-19	LPS_vs_Control	HSALNG0083507	anti_sense,sense	Not conserved		-	TCP11L1
ENSG00000285744	ENSG00000285744	7.13571856475628	9.75890575769742e-18	LPS_vs_Control	HSALNG0066417	integenic	Not conserved			ZC2HC1A
ENSG00000259354	ENSG00000259354	4.12779589878746	1.5314549114903e-17	LPS_vs_Control	HSALNG0105653	intronic_antisense	Not conserved			C15orf48
ENSG00000287535	ENSG00000287535	7.18164876776309	1.71285369858401e-17	LPS_vs_Control	HSALNG0064835	integenic	Not conserved	hsa-miR-744-5p,hsa-miR-6089		GPAT4
ENSG00000272941	ENSG00000272941	3.2277940070275	2.38946640826163e-17	LPS_vs_Control	HSALNG0061535	anti_sense	Q50		-	TMEM140
ENSG00000232956	SNHG15	2.65710432889098	3.35988833666514e-17	LPS_vs_Control	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G
ENSG00000267199	ENSG00000267199	-4.54456238062214	4.51111784419473e-17	LPS_vs_Control	HSALNG0120110	anti_sense	Q75		-	PRELID3A
ENSG00000197536	IRF1-AS1	3.58002341006886	5.3838533818416503e-17	LPS_vs_Control	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA
ENSG00000266970	SOCS3-DT	6.63786963032092	8.64147135940177e-17	LPS_vs_Control	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1
ENSG00000180539	LINC02908	-3.9829190935644	1.3968343112245002e-16	LPS_vs_Control	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX
ENSG00000251230	MIR3945HG	6.51237281904751	4.62306147097472e-16	LPS_vs_Control	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1
ENSG00000268858	ENSG00000268858	-1.98434935694831	8.37620328018304e-16	LPS_vs_Control	HSALNG0131701	anti_sense	Q75	hsa-miR-1227-5p,hsa-miR-4281,hsa-miR-6791-5p,hsa-miR-6816-5p,hsa-miR-6852-5p	-	ZBTB46
ENSG00000273124	ENSG00000273124	5.77471178527775	1.79001164893245e-15	LPS_vs_Control	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1
ENSG00000256262	USP30-AS1	4.88996846887344	4.2172993177424105e-15	LPS_vs_Control	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP
ENSG00000278869	ENSG00000278869	4.1180435471178	5.24253604980049e-15	LPS_vs_Control	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12
ENSG00000239213	NCK1-DT	-3.20625358891314	7.441173480817201e-15	LPS_vs_Control	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000278330	ENSG00000278330	-4.36562381595722	9.927039034972342e-15	LPS_vs_Control	HSALNG0122607	anti_sense	Not conserved		-	GALR1
ENSG00000247556	OIP5-AS1	-1.65381710970099	1.45230820400963e-14	LPS_vs_Control	HSALNG0105345	anti_sense,sense	Not conserved			NUSAP1
ENSG00000250929	LINC01181	5.19306730672564	2.4956131290275902e-14	LPS_vs_Control	HSALNG0067501	integenic	Q50		Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC
ENSG00000231808	LINC01388	5.40046787644589	4.87808622653362e-14	LPS_vs_Control	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4
ENSG00000185433	LINC00158	5.59064607022361	5.2950219461938704e-14	LPS_vs_Control	HSALNG0132374	integenic	Not conserved			MRPL39
ENSG00000225450	ENSG00000225450	4.434906549156	7.36924645703145e-14	LPS_vs_Control	HSALNG0135443	anti_sense	Not conserved	hsa-miR-6779-5p		GTPBP1
ENSG00000178803	ADORA2A-AS1	5.10222324821698	1.5402909261192399e-13	LPS_vs_Control	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1
ENSG00000255197	ENSG00000255197	-1.94888977486791	2.65559897989765e-13	LPS_vs_Control	HSALNG0143174	anti_sense	Q90		Alcohol consumption measurement	SPI1
ENSG00000267737	ENSG00000267737	6.77457549184922	2.86745032720346e-13	LPS_vs_Control	HSALNG0119029	integenic	Not conserved			PGS1
ENSG00000224789	ENSG00000224789	6.73594262881735	3.4826843478743e-13	LPS_vs_Control	HSALNG0018360	anti_sense,sense	Q75		Serum albumin measurement,Glucuronate measurement,Glomerular filtration rate,-	TMEM185B
ENSG00000226004	LINC02528	4.91314456963024	3.61948623457347e-13	LPS_vs_Control	HSALNG0053802	integenic	Q50		Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP
ENSG00000286194	ENSG00000286194	-3.07541450693932	4.639382441139639e-13	LPS_vs_Control	HSALNG0145040	integenic	Not conserved	hsa-miR-4463		RNF135
ENSG00000253535	ADAM7-AS1	5.2034228578997	4.65163180740784e-13	LPS_vs_Control	HSALNG0064058	integenic	Not conserved			NEFL
ENSG00000231574	LINC02015	7.26024738082139	4.84705588524149e-13	LPS_vs_Control	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2
ENSG00000228526	MIR34AHG	-2.39766314761283	5.90347802959527e-13	LPS_vs_Control	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157
ENSG00000230647	ENSG00000230647	5.23469542004207	6.96835286200191e-13	LPS_vs_Control	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1
ENSG00000272669	ENSG00000272669	3.5229662077524	6.97239437965831e-13	LPS_vs_Control	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p		GTPBP1
ENSG00000255491	ENSG00000255491	-3.74088912745368	1.13036472354811e-12	LPS_vs_Control	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1
ENSG00000271795	ENSG00000271795	-4.17136029696531	1.61793640988479e-12	LPS_vs_Control	HSALNG0148747	anti_sense	Q90			SLC36A1
ENSG00000273033	LINC02035	-2.51832435098787	1.88908333354125e-12	LPS_vs_Control	HSALNG0028514	integenic	Q75		Protein measurement,-	SLC49A4
ENSG00000197989	SNHG12	-2.26719231069525	3.1937778533924996e-12	LPS_vs_Control	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12
ENSG00000282851	BISPR	1.95958062942868	6.18395117472284e-12	LPS_vs_Control	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A
ENSG00000261997	ENSG00000261997	-4.37041249561362	6.87361712035002e-12	LPS_vs_Control	NA	NA	NA	NA	NA	LPCAT2
ENSG00000204054	LINC00963	-2.18909764872779	1.2396471431105199e-11	LPS_vs_Control	HSALNG0074742	integenic	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-378g,hsa-miR-4686,hsa-miR-2467-5p,hsa-miR-5088-5p,hsa-miR-6089,hsa-miR-6742-5p,hsa-miR-6803-5p	Body height,-	NTMT1
ENSG00000226137	BAIAP2-DT	-3.58673804285031	1.43055494467288e-11	LPS_vs_Control	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK
ENSG00000176124	DLEU1	-2.76041860252782	1.44643610489396e-11	LPS_vs_Control	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	RNASEH2B
ENSG00000223768	LINC00205	-2.38673746829436	2.5899914621714e-11	LPS_vs_Control	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1
ENSG00000228436	RRAGC-DT	2.48524446151617	3.2076372566972003e-11	LPS_vs_Control	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1
ENSG00000291233	ENSG00000291233	2.33824775828244	3.58818935560245e-11	LPS_vs_Control	NA	NA	NA	NA	NA	NBPF9
ENSG00000235385	LINC02154	6.04380943811504	4.082828577901369e-11	LPS_vs_Control	HSALNG0136703	overlap_sense	Not conserved			ATXN3L
ENSG00000275210	ENSG00000275210	4.38875888704487	4.44894626512605e-11	LPS_vs_Control	NA	NA	NA	NA	NA	LILRA4
ENSG00000224307	LINC02975	-3.7547517922809	4.61758253428198e-11	LPS_vs_Control	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693		NA
ENSG00000249173	LINC01093	4.7410911873925	5.1250469918993295e-11	LPS_vs_Control	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p		ACSL1
ENSG00000258301	VASH1-AS1	-2.94492716204266	6.824120328281529e-11	LPS_vs_Control	HSALNG0102587	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4433a-3p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587,hsa-miR-4787-5p	-	ANGEL1
ENSG00000291174	ENSG00000291174	4.00515632792311	1.08418209803879e-10	LPS_vs_Control	NA	NA	NA	NA	NA	FRMD8
ENSG00000242125	SNHG3	-1.99347635046036	1.76734160873048e-10	LPS_vs_Control	HSALNG0002066	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-4492,hsa-miR-5787,hsa-miR-6890-5p	Systolic blood pressure,Nighttime rest measurement,-	RCC1
ENSG00000279762	ENSG00000279762	4.5088328814244	2.15792426172704e-10	LPS_vs_Control	HSALNG0115783	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-6089	Systolic blood pressure,-	MYO1D
ENSG00000273199	ENSG00000273199	3.49481326563164	2.22160267457609e-10	LPS_vs_Control	NA	NA	NA	NA	NA	CLDN14
ENSG00000276462	LINC03025	5.78992980260259	2.36860644978549e-10	LPS_vs_Control	HSALNG0071581	integenic	Not conserved			FOXD4L6
ENSG00000230438	SERPINB9P1	4.1382133567812	2.85041665264526e-10	LPS_vs_Control	HSALNG0047525	integenic	Not conserved			SERPINB9
ENSG00000289942	ENSG00000289942	6.55053004625862	2.92974211679274e-10	LPS_vs_Control	NA	NA	NA	NA	NA	TMPRSS11E
ENSG00000236682	MAP3K2-DT	-3.48330454652448	3.04560649026821e-10	LPS_vs_Control	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC
ENSG00000289365	ENSG00000289365	3.30391625128522	4.02381021425258e-10	LPS_vs_Control	HSALNG0139497	integenic	Q50			NXT2
ENSG00000221949	LINC01465	3.84712696990662	4.09582037978562e-10	LPS_vs_Control	HSALNG0143651	integenic	Q75	hsa-miR-4447	-	PPM1H
ENSG00000249249	TICAM2-AS1	4.22737805632875	4.21361574501024e-10	LPS_vs_Control	HSALNG0044270	anti_sense	Q90		-	AP3S1
ENSG00000270157	ENSG00000270157	-2.59170554482629	5.104955476589091e-10	LPS_vs_Control	HSALNG0061852	intronic_sense	Not conserved			DENND11
ENSG00000269970	ENSG00000269970	-4.55454366247302	5.54967174483057e-10	LPS_vs_Control	HSALNG0074238	sense	Not conserved			PTGS1
ENSG00000290427	ENSG00000290427	-3.58554439343559	5.87291622012062e-10	LPS_vs_Control	HSALNG0123614	integenic	Not conserved		Susceptibility to chronic sinus infection measurement	MBD3L2B
ENSG00000233834	MACC1-DT	3.3794517201029	6.255148531776601e-10	LPS_vs_Control	HSALNG0056475	anti_sense	Q50	hsa-miR-204-3p	Response to antineoplastic agent; Response to etoposide,-	ITGB8
ENSG00000225964	NRIR	4.38193874623123	7.33137865521631e-10	LPS_vs_Control	HSALNG0012717	integenic	Q75		Depressive symptom measurement,-	CMPK2
ENSG00000255355	PATL1-DT	5.44318392908073	7.72865266404835e-10	LPS_vs_Control	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p		STX3
ENSG00000232618	HIVEP2-DT	5.18848045441112	8.49517921672485e-10	LPS_vs_Control	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1
ENSG00000226239	ENSG00000226239	4.66860612236322	9.58234065186499e-10	LPS_vs_Control	HSALNG0129532	anti_sense	Q50		Cystatin c measurement,Cognitive decline measurement,-	PDRG1
ENSG00000262879	ENSG00000262879	-1.73629949275878	1.15143200274473e-9	LPS_vs_Control	HSALNG0116971	integenic	Not conserved			RPRML
ENSG00000267296	CEBPA-DT	-4.31459562172005	1.7543556077713602e-9	LPS_vs_Control	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG
ENSG00000258018	LINC02457	6.6085546513793	1.7619436858907401e-9	LPS_vs_Control	HSALNG0094325	integenic	Not conserved			MAP1LC3B2
ENSG00000226281	ENSG00000226281	-3.46366388092879	1.9690460668096e-9	LPS_vs_Control	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787		F13A1
ENSG00000230943	LINC02541	3.27960377108122	2.5472165184753904e-9	LPS_vs_Control	HSALNG0052910	integenic	Not conserved			HDAC2
ENSG00000287778	ENSG00000287778	-3.42822421463754	3.40945057149955e-9	LPS_vs_Control	HSALNG0032926	integenic	Not conserved			DRD5
ENSG00000234771	SLC25A25-AS1	-2.78356640372236	3.95572822442039e-9	LPS_vs_Control	HSALNG0074573	anti_sense	Q90	hsa-miR-328-5p,hsa-miR-1228-5p,hsa-miR-3714,hsa-miR-2392,hsa-miR-6803-5p	-	PTGES2
ENSG00000287188	ENSG00000287188	5.89425422003779	7.30216156417726e-9	LPS_vs_Control	HSALNG0038414	anti_sense	Q50		-	DDX60
ENSG00000233901	LINC01503	-1.90939792472995	9.47936683901326e-9	LPS_vs_Control	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA
ENSG00000222043	ENSG00000222043	4.12496403794042	1.25759679182534e-8	LPS_vs_Control	HSALNG0020654	anti_sense	Q75	hsa-miR-326,hsa-miR-1237-5p,hsa-miR-6889-5p	-	HNRNPA3
ENSG00000285103	ENSG00000285103	4.49700044061669	1.69869400244417e-8	LPS_vs_Control	HSALNG0070557	anti_sense	Q75	hsa-miR-874-3p	Sporadic amyotrophic lateral sclerosis,Heart failure,-	IFNK
ENSG00000242474	LINC03015	-3.46555067849146	1.80296109621014e-8	LPS_vs_Control	HSALNG0055495	integenic	Not conserved		-	PDGFA
ENSG00000260997	ENSG00000260997	2.76077578096465	2.08246393040234e-8	LPS_vs_Control	NA	NA	NA	NA	NA	MYO1G
ENSG00000234394	LINC03025	6.15373161080633	2.20321376871608e-8	LPS_vs_Control	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5
ENSG00000234148	LINC01961	6.12658671456357	2.31176781398464e-8	LPS_vs_Control	HSALNG0018065	integenic	Not conserved		-	FOXD4L1
ENSG00000228536	LYPLAL1-AS1	4.19957503681785	2.51845467199212e-8	LPS_vs_Control	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B
ENSG00000181577	LINC03040	3.56772020967336	2.70350090780175e-8	LPS_vs_Control	NA	NA	NA	NA	NA	TMEM63B
ENSG00000224945	ENSG00000224945	-6.22545116197826	2.92886800581354e-8	LPS_vs_Control	HSALNG0072581	sense	Not conserved			SHC3
ENSG00000248019	FAM13A-AS1	-2.18064268435211	3.19578125845181e-8	LPS_vs_Control	HSALNG0035768	anti_sense	Q75		Fev/fec ratio,-	HERC3
ENSG00000255717	SNHG1	-1.57870768651977	3.52321165938119e-8	LPS_vs_Control	HSALNG0084672	integenic	Q50		-	WDR74
ENSG00000287263	ENSG00000287263	1.84303545800042	3.58518400446139e-8	LPS_vs_Control	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R
ENSG00000266378	ENSG00000266378	4.76855733770314	3.64874838972518e-8	LPS_vs_Control	HSALNG0114722	intronic_sense	Q50			HS3ST3B1
ENSG00000267152	ENSG00000267152	-2.94577469545643	4.14081711653113e-8	LPS_vs_Control	HSALNG0145917	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089		ZNF573
ENSG00000177788	RAB4A-AS1	-3.88029441861848	4.83188440380781e-8	LPS_vs_Control	HSALNG0011302	anti_sense	Not conserved	hsa-miR-188-3p,hsa-miR-4281,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4733-3p,hsa-miR-2467-3p,hsa-miR-8485	Response to antidepressant,Mean arterial pressure; Alcohol drinking,Parental genotype effect measurement; Food allergy measurement,-	CCSAP
ENSG00000233975	LINC02574	4.43463801512134	5.33372058695576e-8	LPS_vs_Control	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6
ENSG00000291223	FAM86DP	-2.50287828170546	5.99368172654093e-8	LPS_vs_Control	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p		ZNF717
ENSG00000286674	ENSG00000286674	5.28003361604473	7.59077144918912e-8	LPS_vs_Control	HSALNG0055150	anti_sense,sense	Not conserved		Self reported educational attainment,Neuritic plaque measurement,Parental longevity,Response to alcohol,Urinary metabolite measurement,Serum metabolite measurement,Skin pigmentation measurement,Serum igg glycosylation measurement,Seasonal gut microbiome measurement,Cognitive function measurement,Uterine fibroid measurement,-	GPR31
ENSG00000289100	ENSG00000289100	-3.97894937632319	7.63839751291188e-8	LPS_vs_Control	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p		PFDN6
ENSG00000289589	ENSG00000289589	4.17359326423876	7.79228030070111e-8	LPS_vs_Control	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6
ENSG00000225138	SLC9A3-AS1	-2.63720356671857	8.13598670765766e-8	LPS_vs_Control	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3
ENSG00000262580	ENSG00000262580	-2.02805321385573	8.51957193660531e-8	LPS_vs_Control	HSALNG0119173	anti_sense	Q50		Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH
ENSG00000270607	NAV2-AS6	5.21024214103369	1.02305599542976e-7	LPS_vs_Control	HSALNG0083062	anti_sense	Q75		-	DBX1
ENSG00000225938	S1PR1-DT	5.0279460982931	1.05532019634203e-7	LPS_vs_Control	HSALNG0005575	integenic	Q50	hsa-miR-3194-3p,hsa-miR-4279,hsa-miR-6752-5p,hsa-miR-6845-3p	-	DPH5
ENSG00000233058	ATP13A3-DT	1.92811699930237	1.09347169468997e-7	LPS_vs_Control	HSALNG0031735	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4294	Lean mass-adjusted fat body mass; Femoral neck bone mineral density,3-hydroxypropylmercapturic acid measurement,-	FAM43A
ENSG00000274213	ENSG00000274213	3.61990684575379	1.14544066064447e-7	LPS_vs_Control	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE
ENSG00000289445	ENSG00000289445	4.9097284517383	1.39140336134546e-7	LPS_vs_Control	HSALNG0133098	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Heel bone mineral density,Body height,Bone fracture,Tpe interval measurement; Response to exercise,-	ETS2
ENSG00000273812	LINC02970	2.63348126318941	1.49636046909388e-7	LPS_vs_Control	HSALNG0131544	integenic	Q75	hsa-miR-1207-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3064-5p,hsa-miR-7160-3p	-	GATA5
ENSG00000289403	ENSG00000289403	5.95993649514497	1.5582827341651e-7	LPS_vs_Control	NA	NA	NA	NA	NA	INHBA
ENSG00000287091	ENSG00000287091	-2.96120400474501	1.59720664370086e-7	LPS_vs_Control	HSALNG0146641	sense	Q50	hsa-miR-1203		CD302
ENSG00000289198	ENSG00000289198	2.7801182361079	1.64684163421406e-7	LPS_vs_Control	HSALNG0052920	integenic	Q90		-	MARCKS
ENSG00000224078	SNHG14	-1.60472652515214	1.93574705858163e-7	LPS_vs_Control	HSALNG0104546	anti_sense,sense	Q75	hsa-miR-30b-3p,hsa-miR-188-3p,hsa-miR-370-3p,hsa-miR-574-5p,hsa-miR-619-5p,hsa-miR-3176,hsa-miR-4268,hsa-miR-4430,hsa-miR-4478,hsa-miR-4492,hsa-miR-3064-3p,hsa-miR-4755-3p,hsa-miR-5193,hsa-miR-5693,hsa-miR-6845-5p,hsa-miR-6858-5p,hsa-miR-7109-5p	Panic disorder,Blood osmolality measurement,Neuroticism measurement,Myopia,Bone density,Inflammatory biomarker measurement; Ykl40 measurement,-	SNRPN
ENSG00000260898	ADPGK-AS1	2.44026974182088	1.95656882304537e-7	LPS_vs_Control	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4
ENSG00000250742	LINC02381	7.4235829287394	2.1407999063847e-7	LPS_vs_Control	HSALNG0091335	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4667-3p,hsa-miR-4749-3p,hsa-miR-5001-3p,hsa-miR-6791-3p,hsa-miR-6803-5p,hsa-miR-6769b-3p	Coronary artery disease; Myocardial infarction,Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Adolescent idiopathic scoliosis,-	HOXC4
ENSG00000204261	PSMB8-AS1	1.52509865255595	2.94561850942821e-7	LPS_vs_Control	HSALNG0049455	anti_sense,sense	Q75		Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9
ENSG00000225519	ENSG00000225519	5.31884888236873	4.32579034961142e-7	LPS_vs_Control	HSALNG0079635	integenic	Q50	hsa-miR-30c-2-3p	Abnormality of refraction,Fibroblast growth factor basic measurement,-	RPP30
ENSG00000246273	SBF2-AS1	-2.23907093311208	4.73757022637321e-7	LPS_vs_Control	HSALNG0082633	integenic	Not conserved		Platelet count	SWAP70
ENSG00000277496	SLCO4A1-AS2	2.5436851934652	4.84363896015307e-7	LPS_vs_Control	HSALNG0131550	anti_sense	Not conserved	hsa-miR-940,hsa-miR-4492,hsa-miR-6752-3p,hsa-miR-6810-5p,hsa-miR-6810-3p,hsa-miR-7160-3p	Hemoglobin a1 measurement	GATA5
ENSG00000271270	TMCC1-DT	-2.72434972967931	5.35742755518807e-7	LPS_vs_Control	HSALNG0028917	integenic	Q75	hsa-miR-486-3p,hsa-miR-3162-5p	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	TRH
ENSG00000250274	ENSG00000250274	3.07188580658778	5.51068186476309e-7	LPS_vs_Control	NA	NA	NA	NA	NA	LCP2
ENSG00000178977	LINC00324	-2.67084285469687	5.79166410542565e-7	LPS_vs_Control	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1
ENSG00000257924	LINC02416	4.64505348511996	5.84474338561763e-7	LPS_vs_Control	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B
ENSG00000234869	LINC02925	-3.27279459491417	6.43611782537852e-7	LPS_vs_Control	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4
ENSG00000222041	CYTOR	1.72053343613378	6.65348850005848e-7	LPS_vs_Control	HSALNG0016642	integenic	Not conserved	hsa-miR-519d-5p,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6779-5p,hsa-miR-6800-3p,hsa-miR-6813-5p	Mitochondrial heteroplasmy measurement,-	PLGLB2
ENSG00000262223	LINC03048	3.39217703413755	6.78585055601515e-7	LPS_vs_Control	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10
ENSG00000286511	ENSG00000286511	4.60334686049813	7.37422863423861e-7	LPS_vs_Control	HSALNG0052591	integenic	Not conserved	hsa-miR-619-5p	Serum albumin measurement,Risk-taking behaviour,-	ARMC2
ENSG00000235513	L3MBTL2-AS1	3.79768919973057	7.96598100069798e-7	LPS_vs_Control	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL
ENSG00000288999	ENSG00000288999	2.49038815162107	8.0275803735495e-7	LPS_vs_Control	HSALNG0010910	integenic	Not conserved	hsa-miR-4467		CAPN2
ENSG00000226688	ENTPD1-AS1	-1.89032807135324	9.14003797163873e-7	LPS_vs_Control	HSALNG0079858	overlap_antisense,anti_sense	Not conserved		Diverticular disease,White matter hyperintensity measurement,Bmi-adjusted waist circumference,Total blood protein measurement,Age at menopause,Mean corpuscular volume,-	TCTN3
ENSG00000260804	LINC01963	-2.437779860253	9.18826860001631e-7	LPS_vs_Control	HSALNG0022112	integenic	Q50			XRCC5
ENSG00000272638	ENSG00000272638	3.24961809141128	9.39906699909545e-7	LPS_vs_Control	HSALNG0057001	anti_sense	Not conserved			NA
ENSG00000267002	ENSG00000267002	-2.05385385513103	1.08630681887959e-6	LPS_vs_Control	HSALNG0116617	anti_sense,sense	Q90	hsa-miR-30b-3p,hsa-miR-6782-5p,hsa-miR-6803-5p	-	BRCA1
ENSG00000291063	ENSG00000291063	-2.21929263682292	1.19061170198739e-6	LPS_vs_Control	HSALNG0145041	integenic	Not conserved			NF1
ENSG00000242258	LINC00996	3.39408781493423	1.20523059670604e-6	LPS_vs_Control	HSALNG0062275	sense	Not conserved		Electroencephalogram measurement	GIMAP8
ENSG00000236144	TMEM147-AS1	-2.04772939087432	1.24525673866085e-6	LPS_vs_Control	HSALNG0125628	anti_sense	Q75	hsa-miR-3155b,hsa-miR-6089,hsa-miR-6826-3p	Systolic blood pressure change measurement; Diastolic blood pressure change measurement,-	ATP4A
ENSG00000291144	ENSG00000291144	3.28897679232099	1.25128660514586e-6	LPS_vs_Control	HSALNG0082349	overlap_sense	Not conserved		Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1
ENSG00000289582	ENSG00000289582	4.2456594824877	1.30490841597875e-6	LPS_vs_Control	NA	NA	NA	NA	NA	GBP2
ENSG00000270055	ENSG00000270055	-2.71336678861637	1.32258242183126e-6	LPS_vs_Control	HSALNG0104765	integenic	Not conserved			GOLGA8Q
ENSG00000229664	ENSG00000229664	3.83007970275427	1.32986528752626e-6	LPS_vs_Control	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17
ENSG00000234717	TMEM212-AS1	6.02835217216166	1.36359982443313e-6	LPS_vs_Control	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1
ENSG00000260793	ENSG00000260793	-2.31606878513175	1.37032914725645e-6	LPS_vs_Control	HSALNG0116712	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4695-5p,hsa-miR-6085,hsa-miR-6090	Heel bone mineral density,Body weight; Body mass index,Visceral adipose tissue measurement,Reticulocyte count,Appendicular lean mass; Bone density,Cortical thickness,Uric acid measurement; Calcium measurement,Mean corpuscular hemoglobin concentration,Cortical surface area measurement,Self reported educational attainment,Body fat distribution,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	TMUB2
ENSG00000259380	LINC02895	4.60123777764941	1.43076354793907e-6	LPS_vs_Control	HSALNG0105106	integenic	Q75	hsa-miR-103a-1-5p,hsa-miR-4535	Lycopene measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone density,Body height,Tryptophan measurement,Self reported educational attainment; Mathematical ability,Chagas cardiomyopathy,Hypersomnia,Mathematical ability,Bipolar disorder,Lean body mass,Body weight,Fev/fec ratio; Response to bronchodilator,-	RASGRP1
ENSG00000229153	EPHA1-AS1	3.56222809339683	1.50152776433397e-6	LPS_vs_Control	HSALNG0061963	anti_sense,sense	Q50	hsa-miR-762,hsa-miR-3657,hsa-miR-1268b,hsa-miR-6089	Family history of alzheimerâ€™s disease,Protein measurement,-	TAS2R41
ENSG00000288792	ENSG00000288792	-2.94439585530356	1.59432183184371e-6	LPS_vs_Control	HSALNG0055740	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4701-5p		TTYH3
ENSG00000235888	LINC02940	3.41255430287441	1.59808887810411e-6	LPS_vs_Control	HSALNG0133099	integenic	Q50	hsa-miR-331-3p,hsa-miR-412-3p,hsa-miR-668-3p,hsa-miR-3189-5p,hsa-miR-4710,hsa-miR-5787,hsa-miR-6744-3p,hsa-miR-6748-3p,hsa-miR-6803-5p,hsa-miR-6780b-3p	Drugs affecting bone structure and mineralization use measurement; Osteoporosis; Heel bone mineral density,Bone density,Nicotine dependence,Covid-19,Nicotine dependence symptom count,Open-angle glaucoma,Female reproductive system disease,Colorectal cancer,Psoriasis; Neutrophil count; Mean corpuscular hemoglobin concentration; Platelet crit; Red blood cell distribution width; Ulcerative colitis; Ankylosing spondylitis; Mean corpuscular hemoglobin; Basophil count; Myeloid white cell count; Leukocyte count; Crohn's disease; Eosinophil count; Sclerosing cholangitis; Granulocyte count,Eye morphology measurement,C-reactive protein measurement; Inflammatory bowel disease; Alkaline phosphatase measurement; Ulcerative colitis; Crohn's disease; Triglyceride measurement,Ankylosing spondylitis; Takayasu arteritis,Ankylosing spondylitis,Inflammatory bowel disease; Ankylosing spondylitis; Takayasu arteritis; Hemoglobin measurement; Sclerosing cholangitis,Fibrinogen measurement,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Alkaline phosphatase measurement; C-reactive protein measurement; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Celiac disease; Autoimmune disease; Hemoglobin measurement; Juvenile idiopathic arthritis,Hemoglobin measurement; Takayasu arteritis,Neutrophil count; Granulocyte percentage of myeloid white cells; Leukocyte count; Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes,C-reactive protein measurement,Ulcerative colitis; Red blood cell distribution width,Alkaline phosphatase measurement; Mean corpuscular hemoglobin; Red blood cell distribution width,Red blood cell distribution width,Ulcerative colitis; Rheumatoid arthritis,C-reactive protein measurement; Takayasu arteritis,-	PSMG1
ENSG00000237181	PRKAR1B-AS1	2.18672617584871	1.62693730545698e-6	LPS_vs_Control	HSALNG0055551	anti_sense	Not conserved	hsa-miR-874-3p,hsa-miR-4667-3p,hsa-miR-6749-3p	Erythrocyte count,-	DNAAF5
ENSG00000271474	UNC5C-AS1	5.79072021838919	1.72654170359983e-6	LPS_vs_Control	HSALNG0035909	anti_sense	Q50		-	PDHA2
ENSG00000289530	ENSG00000289530	4.9025561319645	1.75590316253364e-6	LPS_vs_Control	HSALNG0035158	integenic	Q50		-	RASSF6
ENSG00000228863	ENSG00000228863	4.51112256334107	1.76399239103088e-6	LPS_vs_Control	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7
ENSG00000224934	GOT1-DT	-2.79897856138853	1.8684832490636e-6	LPS_vs_Control	HSALNG0080041	integenic	Q50	hsa-miR-659-5p,hsa-miR-4268,hsa-miR-4695-5p	-	CNNM1
ENSG00000273174	ENSG00000273174	2.91790758161086	1.92646563516374e-6	LPS_vs_Control	HSALNG0028857	anti_sense	Q50		-	GP9
ENSG00000240057	NEPRO-AS1	2.59916060212732	2.03468410723512e-6	LPS_vs_Control	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8
ENSG00000261468	ENSG00000261468	-5.52548722593819	2.07356121944508e-6	LPS_vs_Control	HSALNG0024922	integenic	Not conserved	hsa-miR-6165		TGFBR2
ENSG00000260231	KDM7A-DT	2.88445821058162	2.22243303654812e-6	LPS_vs_Control	HSALNG0061777	anti_sense	Q90			TBXAS1
ENSG00000234608	MAPKAPK5-AS1	-1.64155004644343	2.33227504772326e-6	LPS_vs_Control	HSALNG0094063	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-3197,hsa-miR-3960,hsa-miR-7974	-	TMEM116
ENSG00000267121	FMNL1-DT	-1.56317341521491	2.36300736841668e-6	LPS_vs_Control	HSALNG0116830	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-185-3p,hsa-miR-619-5p,hsa-miR-675-5p,hsa-miR-5589-5p,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-7108-3p,hsa-miR-8485	Body fat distribution,White matter microstructure measurement,Body height,Thyroid stimulating hormone measurement,Bmi-adjusted hip circumference,-	SPATA32
ENSG00000257433	RPAP3-DT	2.28592535191017	2.54684849943169e-6	LPS_vs_Control	HSALNG0090786	anti_sense	Q90	hsa-miR-4478,hsa-miR-4505,hsa-miR-1587,hsa-miR-4717-5p,hsa-miR-6744-3p,hsa-miR-6763-5p,hsa-miR-6855-5p,hsa-miR-8485	Cup-to-disc ratio measurement,Periodontitis,Blood protein measurement,-	SLC48A1
ENSG00000287733	ENSG00000287733	2.52338528210762	2.62717030195205e-6	LPS_vs_Control	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140
ENSG00000272463	ENSG00000272463	3.21415146888138	2.69785605550153e-6	LPS_vs_Control	HSALNG0047304	integenic	Q50		-	EXOC2
ENSG00000285967	NIPBL-DT	-1.68346009324444	2.95629856984681e-6	LPS_vs_Control	HSALNG0041218	integenic	Q50	hsa-miR-1268b	-	CPLANE1
ENSG00000272512	ENSG00000272512	5.15526242889386	2.96865187531119e-6	LPS_vs_Control	HSALNG0000065	integenic	Not conserved		Apolipoprotein a 1 measurement,Parental longevity,-	HES4
ENSG00000289293	ENSG00000289293	1.72548312454345	3.27762996475486e-6	LPS_vs_Control	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960		MED13
ENSG00000260360	ENSG00000260360	2.46841884539688	3.30036682781041e-6	LPS_vs_Control	HSALNG0008786	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-10392-3p	Prostate carcinoma,-	TOR1AIP2
ENSG00000259972	ENSG00000259972	-1.80631554032887	3.48779755041149e-6	LPS_vs_Control	HSALNG0112676	integenic	Not conserved	hsa-miR-7703		CLEC18B
ENSG00000267712	LINC01539	6.01240218232619	3.49663357054459e-6	LPS_vs_Control	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4
ENSG00000235852	ENSG00000235852	3.99442936485772	3.63338276602321e-6	LPS_vs_Control	HSALNG0021130	anti_sense	Q50	hsa-miR-6514-3p,hsa-miR-6894-3p	Bmi-adjusted waist-hip ratio,-	STAT1
ENSG00000212694	LINC01089	-1.73591420158741	3.64913874817288e-6	LPS_vs_Control	HSALNG0094605	anti_sense,sense	Q90	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-762,hsa-miR-3692-5p,hsa-miR-4433a-3p,hsa-miR-4472,hsa-miR-3155b,hsa-miR-4787-5p,hsa-miR-5581-5p,hsa-miR-5787,hsa-miR-6763-5p,hsa-miR-6803-5p,hsa-miR-4433b-3p	Leukocyte count; Neutrophil count; Myeloid white cell count; Platelet crit,Mean platelet volume,Eosinophil count,-	RHOF
ENSG00000268069	ENSG00000268069	-3.87207952116316	3.77067607436189e-6	LPS_vs_Control	HSALNG0090794	anti_sense	Q75		-	SLC48A1
ENSG00000259721	GREM1-AS1	3.515090219004	3.97621970146843e-6	LPS_vs_Control	HSALNG0144495	anti_sense	Q50	hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-3195,hsa-miR-7843-5p,hsa-miR-9899	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,-	FMN1
ENSG00000280007	ENSG00000280007	5.3598141605661	4.06022005253577e-6	LPS_vs_Control	HSALNG0133953	anti_sense	Not conserved	hsa-miR-619-5p	Atrial fibrillation,T-tau measurement,Carotid plaque build,-,Mean platelet volume	MICAL3
ENSG00000277511	ENSG00000277511	2.49202191236937	4.0703925806105e-6	LPS_vs_Control	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1
ENSG00000231177	LINC00852	-2.61865590513279	4.14629311790805e-6	LPS_vs_Control	HSALNG0024099	anti_sense,sense	Q90	hsa-miR-4650-5p	Self reported educational attainment,Ghrelin measurement,-	NA
ENSG00000289353	ENSG00000289353	-3.52587965898284	4.29519405036934e-6	LPS_vs_Control	NA	NA	NA	NA	NA	CMTM1
ENSG00000281005	LINC00921	-2.58014968745368	4.4058001679411e-6	LPS_vs_Control	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p		NA
ENSG00000228315	GUSBP11	-1.61972870508188	4.60147051505814e-6	LPS_vs_Control	HSALNG0134423	integenic	Not conserved		Adolescent idiopathic scoliosis	DRICH1
ENSG00000267123	SCAT1	-3.00118788400931	4.62893118855024e-6	LPS_vs_Control	HSALNG0119047	integenic	Not conserved	hsa-miR-4433a-3p,hsa-miR-4505,hsa-miR-4436b-3p,hsa-miR-7108-5p	Bilirubin measurement	DNAH17
ENSG00000183154	ENSG00000183154	-3.24493569974209	4.73849405756672e-6	LPS_vs_Control	HSALNG0150383	anti_sense	Q75		-	BRF2
ENSG00000260256	ENSG00000260256	3.68272814835775	4.77377070544743e-6	LPS_vs_Control	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410
ENSG00000223387	LINC02068	5.50952525349904	5.16225037625294e-6	LPS_vs_Control	HSALNG0030744	integenic	Q75	hsa-miR-619-5p,hsa-miR-7150	Breast carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Hemoglobin measurement; Platelet crit; Monocyte percentage of leukocytes; Protein measurement; Tnf-related apoptosis-inducing ligand measurement; Serum gamma-glutamyl transferase measurement; Aspartate aminotransferase to alanine aminotransferase ratio; Platelet count; Triglyceride measurement; Hematocrit; Mean corpuscular volume; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Serum albumin measurement,Sex hormone-binding globulin measurement; Renal cell carcinoma	NCEH1
ENSG00000244879	GABPB1-AS1	-2.50523952745289	5.33497819819894e-6	LPS_vs_Control	HSALNG0105872	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-4505	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,-	USP8
ENSG00000288754	ENSG00000288754	-2.27396816439705	5.6196633134967e-6	LPS_vs_Control	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4
ENSG00000225177	NHSL1-AS1	-2.33864974274794	5.64324687722793e-6	LPS_vs_Control	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A
ENSG00000203804	ADAMTSL4-AS1	2.93113620531117	5.94807488782544e-6	LPS_vs_Control	HSALNG0007053	anti_sense,sense	Q50	hsa-miR-30b-3p,hsa-miR-3196,hsa-miR-4508,hsa-miR-7160-3p	Aspartate aminotransferase measurement,Pulse pressure measurement,Eosinophil count; Eosinophil percentage of leukocytes,Basophil count,Total blood protein measurement; Neutrophil percentage of leukocytes; Blood protein measurement,Oral ulcer,Coronary artery disease,-	MCL1
ENSG00000233038	PTPRN2-AS1	-3.53914519956747	5.98204181986521e-6	LPS_vs_Control	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6
ENSG00000231721	LINC-PINT	2.51829684994207	6.55508346005957e-6	LPS_vs_Control	HSALNG0150064	integenic	Q50			KLF14
ENSG00000254416	LINC02732	3.99436411926621	6.68376740969447e-6	LPS_vs_Control	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1
ENSG00000257718	CPNE8-AS1	5.71659218914907	7.0912393941352e-6	LPS_vs_Control	HSALNG0090432	anti_sense	Q50	hsa-miR-6763-3p,hsa-miR-6878-3p		ALG10B
ENSG00000231249	ITPR1-DT	-3.09190773629206	8.19883428405954e-6	LPS_vs_Control	HSALNG0023876	integenic	Q75	hsa-miR-6090,hsa-miR-6763-3p		SUMF1
ENSG00000177369	FLJ40194	-3.40501177811526	8.41828797249516e-6	LPS_vs_Control	HSALNG0117173	integenic	Not conserved	hsa-miR-6089	Testosterone measurement	ABI3
ENSG00000234912	SNHG20	-2.32235903571644	9.09668858796899e-6	LPS_vs_Control	HSALNG0118895	sense	Q50	hsa-miR-619-5p,hsa-miR-762,hsa-miR-4449,hsa-miR-6069,hsa-miR-6089,hsa-miR-6777-3p	Heel bone mineral density,-	SEC14L1
ENSG00000242048	PRKAG2-AS2	3.18155089776337	1.08165766811816e-5	LPS_vs_Control	HSALNG0149841	anti_sense	Not conserved			GALNTL5
ENSG00000289977	ENSG00000289977	-4.87796988518866	1.1021255420243e-5	LPS_vs_Control	HSALNG0114255	integenic	Not conserved			ACADVL
ENSG00000291066	ENSG00000291066	-2.13307927908282	1.16231859980667e-5	LPS_vs_Control	HSALNG0110139	integenic	Not conserved	hsa-miR-619-5p	-	NPIPB4
ENSG00000289161	ENSG00000289161	2.35210544366063	1.16416338275812e-5	LPS_vs_Control	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6
ENSG00000271009	ENSG00000271009	-3.41290489701549	1.2458036247806e-5	LPS_vs_Control	HSALNG0112602	anti_sense	Q90		Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Body weight; Aspartate aminotransferase measurement,-	DHX38
ENSG00000261504	LINC01686	5.6685561469891	1.24843293994585e-5	LPS_vs_Control	HSALNG0141969	integenic	Not conserved	hsa-miR-194-3p		RGSL1
ENSG00000274818	ENSG00000274818	3.01076238410259	1.24843293994585e-5	LPS_vs_Control	HSALNG0102246	integenic	Q75			MAP3K9
ENSG00000270049	ATP6V0D1-DT	-2.74832031373557	1.24926245948045e-5	LPS_vs_Control	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1
ENSG00000291151	NSUN5P1	-2.60189672559521	1.26408653348584e-5	LPS_vs_Control	HSALNG0149717	anti_sense,sense	Not conserved	hsa-miR-619-5p	Body mass index,Uric acid measurement,Energy intake,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Parental longevity; Body mass index,Body weight,Serum gamma-glutamyl transferase measurement,Systemic lupus erythematosus,Visceral adipose tissue measurement,Systolic blood pressure,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure,Self reported educational attainment; Pulse pressure measurement; Diastolic blood pressure; Body mass index; Physical activity measurement; Mathematical ability; Systolic blood pressure; Body height; Smoking behavior,C-reactive protein measurement,Ankle injury,Mathematical ability; Fasting blood insulin measurement,Large artery stroke,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Basophil count,Ccl24 measurement,Dna methylation,Cognitive behavioural therapy,Essential tremor,Colorectal cancer,Covid-19,Carotid plaque build,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Sarcoidosis,Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-,Age-related nuclear cataract,Age at first sexual intercourse measurement; Health study participation; Cognitive function measurement,Age at menarche	TRIM73
ENSG00000240288	GHRLOS	-2.31946175939281	1.28815549214234e-5	LPS_vs_Control	HSALNG0024099	anti_sense,sense	Q90	hsa-miR-4650-5p	Self reported educational attainment,Ghrelin measurement,-	NA
ENSG00000278768	BACE1-AS	-1.75647922419609	1.28956024419974e-5	LPS_vs_Control	HSALNG0087449	anti_sense	Q90	hsa-miR-6089	Apolipoprotein a 1 measurement,-	RNF214
ENSG00000225733	FGD5-AS1	-1.13481052506922	1.36996427517912e-5	LPS_vs_Control	HSALNG0024363	anti_sense	Q75	hsa-miR-6748-3p		MRPS25
ENSG00000274461	LINC02930	-3.46417279365571	1.56485339879534e-5	LPS_vs_Control	HSALNG0081109	integenic	Not conserved		Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4
ENSG00000224875	EML4-AS1	3.76658030724568	1.64437151429223e-5	LPS_vs_Control	HSALNG0014464	anti_sense	Q75		C-reactive protein measurement,-	COX7A2L
ENSG00000272666	KLHDC7B-DT	4.16287126694281	1.77802221068406e-5	LPS_vs_Control	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3
ENSG00000239911	PRKAG2-AS1	-2.82222526870162	1.83322252933906e-5	LPS_vs_Control	HSALNG0062390	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6791-5p	-	GALNTL5
ENSG00000223960	CHROMR	1.20578973617855	1.97821723271771e-5	LPS_vs_Control	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6
ENSG00000177406	NINJ2-AS1	-1.86883986487272	2.09109063725649e-5	LPS_vs_Control	HSALNG0088498	anti_sense	Q50	hsa-miR-6809-3p	Platelet component distribution width,Mean platelet volume; Lymphocyte count; Platelet crit; Neutrophil percentage of leukocytes; Platelet count; Monocyte count,Soluble triggering receptor expressed on myeloid cells 2 measurement,Monocyte percentage of leukocytes,Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,-	B4GALNT3
ENSG00000226445	THBS2-AS1	-2.80549542908685	2.14358492868697e-5	LPS_vs_Control	HSALNG0055336	anti_sense	Not conserved			C6orf120
ENSG00000259291	ZNF710-AS1	-1.91887907186889	2.20818479268292e-5	LPS_vs_Control	HSALNG0108098	anti_sense	Q90		Body height,Comparative body size at age 10, self-reported,-	IDH2
ENSG00000288046	ENSG00000288046	-5.03468743612246	2.30056208520013e-5	LPS_vs_Control	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86
ENSG00000283849	ENSG00000283849	3.3853290007453	2.36985750497024e-5	LPS_vs_Control	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A
ENSG00000253982	CLN8-AS1	-1.41943420768239	2.46804065933022e-5	LPS_vs_Control	HSALNG0062950	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1225-3p,hsa-miR-6165,hsa-miR-6727-3p		ERICH1
ENSG00000253320	MAILR	2.47143140599414	2.50340252939731e-5	LPS_vs_Control	HSALNG0067488	integenic	Q50			ATP6V1C1
ENSG00000245694	CRNDE	-2.03495653121284	2.52736299156548e-5	LPS_vs_Control	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3
ENSG00000289425	ENSG00000289425	3.18720948080733	2.63176090689443e-5	LPS_vs_Control	NA	NA	NA	NA	NA	RABGAP1L
ENSG00000266469	ENSG00000266469	-5.19891143906268	2.65255901979752e-5	LPS_vs_Control	HSALNG0116238	anti_sense	Q90	hsa-miR-4443	High density lipoprotein cholesterol measurement,Mathematical ability,-	CDK12
ENSG00000254966	IGSF22-AS1	-5.18723329557891	2.72920416108533e-5	LPS_vs_Control	HSALNG0083030	anti_sense	Q75	hsa-miR-6086	-	TMEM86A
ENSG00000251364	SYT9-AS1	-3.07116289296691	2.78403319721656e-5	LPS_vs_Control	HSALNG0082493	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6895-5p	Serum igg glycosylation measurement,Stroke outcome severity measurement,-	CYB5R2
ENSG00000248371	LINC02056	4.49901034007026	2.85646386723059e-5	LPS_vs_Control	HSALNG0042592	integenic	Not conserved			ZNF366
ENSG00000260005	ENSG00000260005	-2.90058282552413	2.86871756386597e-5	LPS_vs_Control	HSALNG0145178	anti_sense	Q50	hsa-miR-6862-5p	Blood protein measurement,-	NDUFAF8
ENSG00000245937	SLC12A2-DT	-1.46076219957027	3.24759820305577e-5	LPS_vs_Control	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2
ENSG00000224116	INHBA-AS1	5.00906813699559	3.55640277753957e-5	LPS_vs_Control	HSALNG0057482	integenic	Not conserved	hsa-miR-6124		SUGCT
ENSG00000289972	ENSG00000289972	3.7070323828729	3.60346194060357e-5	LPS_vs_Control	HSALNG0080384	anti_sense	Q90	hsa-miR-4327	Self reported educational attainment,White matter hyperintensity measurement,White matter microstructure measurement,-	NEURL1
ENSG00000263718	SEPTIN9-DT	3.92402011580128	3.60961581513855e-5	LPS_vs_Control	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2
ENSG00000218510	LINC00339	-2.13848304992853	3.81093614026222e-5	LPS_vs_Control	HSALNG0001554	sense	Q90	hsa-miR-25-5p,hsa-miR-765,hsa-miR-4448,hsa-miR-4733-3p,hsa-miR-6088	Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil count,Neutrophil percentage of leukocytes,Alkaline phosphatase measurement,Body height; Bmi-adjusted hip circumference,Age at first birth measurement,Bmi-adjusted hip circumference,Systolic blood pressure; Body mass index,-	NA
ENSG00000267764	ENSG00000267764	-3.16569438721906	3.86787159426808e-5	LPS_vs_Control	HSALNG0121453	anti_sense	Q90	hsa-miR-6089,hsa-miR-6892-3p	Balding measurement,-	SMAD7
ENSG00000291015	ENSG00000291015	-2.5493005988146	3.89772225783415e-5	LPS_vs_Control	HSALNG0135407	sense	Not conserved			TPTEP2-CSNK1E
ENSG00000287306	ENSG00000287306	-3.80517106377811	3.99968375142861e-5	LPS_vs_Control	HSALNG0078581	integenic	Q50	hsa-miR-762,hsa-miR-8485	Body height,Hba1c measurement,-	TSPAN15
ENSG00000270426	ENSG00000270426	2.65272381157784	4.07861935169509e-5	LPS_vs_Control	HSALNG0039018	sense	Q90			IRF2
ENSG00000229484	LINC02766	-4.94030403118405	4.13722761409875e-5	LPS_vs_Control	HSALNG0000944	integenic	Not conserved		-	VPS13D
ENSG00000280303	ERICD	3.70567112334643	4.38963150734944e-5	LPS_vs_Control	HSALNG0069026	anti_sense	Q50	hsa-miR-4526,hsa-miR-4656,hsa-miR-4749-3p,hsa-miR-6749-3p,hsa-miR-8072	Age-related hearing impairment	CHRAC1
ENSG00000244701	ENSG00000244701	-2.72379011318356	4.62312562119724e-5	LPS_vs_Control	HSALNG0061850	anti_sense,sense	Q75		-	DENND11
ENSG00000270605	ENSG00000270605	-3.57516375589533	4.76016227825442e-5	LPS_vs_Control	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8
ENSG00000162888	C1orf147	4.11601953134281	4.76016227825442e-5	LPS_vs_Control	NA	NA	NA	NA	NA	EIF2D
ENSG00000272182	ENSG00000272182	-3.35798543543753	4.78278262491087e-5	LPS_vs_Control	HSALNG0026429	anti_sense	Q90		-	PXK
ENSG00000233237	LINC00472	3.35617166465249	5.05338259682089e-5	LPS_vs_Control	HSALNG0051173	integenic	Q50			B3GAT2
ENSG00000213963	ENSG00000213963	-1.64935635906943	5.56774992985118e-5	LPS_vs_Control	HSALNG0020668	sense	Not conserved			NFE2L2
ENSG00000270177	PPP2CA-DT	3.00567670405719	5.65970356576064e-5	LPS_vs_Control	HSALNG0044954	integenic	Q50	hsa-miR-432-3p,hsa-miR-4257		TCF7
ENSG00000273486	ENSG00000273486	-2.47583710748704	5.69478608253674e-5	LPS_vs_Control	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000281398	SNHG4	-1.83353286928678	5.8197145352452e-5	LPS_vs_Control	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3
ENSG00000235366	LINC01055	5.82383027232366	5.93163979727184e-5	LPS_vs_Control	HSALNG0096844	integenic	Not conserved		-	ERICH6B
ENSG00000233785	ENSG00000233785	3.19220643715236	6.11905867388612e-5	LPS_vs_Control	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9
ENSG00000289504	ENSG00000289504	-2.30890343890831	6.16963913403808e-5	LPS_vs_Control	NA	NA	NA	NA	NA	MAPKAPK3
ENSG00000234263	MAP3K5-AS1	5.14638784981256	6.19448236402712e-5	LPS_vs_Control	HSALNG0053716	anti_sense	Q75		Unipolar depression	PEX7
ENSG00000256633	PDE2A-AS2	-4.03085882416794	6.31464276909134e-5	LPS_vs_Control	HSALNG0143016	anti_sense	Q90	hsa-miR-6749-5p,hsa-miR-6763-5p	-	ATG16L2
ENSG00000225465	RFPL1S	-2.52211310850618	6.41511076346997e-5	LPS_vs_Control	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5
ENSG00000236120	ENSG00000236120	-1.69261295885084	6.45561490605771e-5	LPS_vs_Control	HSALNG0136490	integenic	Not conserved		Facial morphology measurement	NLGN4X
ENSG00000272668	ENSG00000272668	-5.19005372151407	6.59524856383273e-5	LPS_vs_Control	HSALNG0007790	anti_sense	Q90	hsa-miR-574-5p,hsa-miR-5586-5p,hsa-miR-6878-3p	Red blood cell density measurement,C-reactive protein measurement,Bilirubin measurement,-	SLAMF8
ENSG00000226125	LINC01907	-5.03014403523787	6.71712180683719e-5	LPS_vs_Control	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55
ENSG00000283839	ENSG00000283839	-1.59667702424944	7.60041551523981e-5	LPS_vs_Control	HSALNG0020893	anti_sense	Q50		Anxiety measurement; Depressive symptom measurement; Serum gamma-glutamyl transferase measurement; Wellbeing measurement; Bipolar disorder; Neuroticism measurement; Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Neuroticism measurement; Feeling emotionally hurt measurement,-	NCKAP1
ENSG00000254554	ADM-DT	2.99494088774957	7.90721353926389e-5	LPS_vs_Control	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2
ENSG00000175147	TMEM51-AS1	-1.87726562686252	8.11599040863115e-5	LPS_vs_Control	HSALNG0001056	anti_sense	Q50	hsa-miR-25-5p,hsa-miR-1203,hsa-miR-4492,hsa-miR-2467-3p	-	CASP9
ENSG00000250303	LINC02762	-2.46632935360866	8.29583331104073e-5	LPS_vs_Control	HSALNG0087198	integenic	Not conserved			PTS
ENSG00000237927	ENSG00000237927	4.03570226084267	9.12233522586311e-5	LPS_vs_Control	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2
ENSG00000245112	SMARCA5-AS1	2.97143382345292	9.12543327137526e-5	LPS_vs_Control	HSALNG0148463	anti_sense	Q90	hsa-miR-1247-5p	-	FREM3
ENSG00000274605	PCCA-DT	-3.13865029929008	9.35483984406477e-5	LPS_vs_Control	HSALNG0098967	integenic	Q50			ZIC5
ENSG00000177340	FLJ13224	3.4014588403398	9.44306656962706e-5	LPS_vs_Control	NA	NA	NA	NA	NA	DDX11
ENSG00000261618	LINC02605	4.84040146251299	9.51352272611313e-5	LPS_vs_Control	HSALNG0150243	integenic	Not conserved		Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A
ENSG00000234883	MIR155HG	3.0847628868662	1.013537176587e-4	LPS_vs_Control	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2
ENSG00000281404	LINC01176	1.763310249495	1.0551648061272e-4	LPS_vs_Control	HSALNG0149630	sense	Not conserved			NA
ENSG00000286989	ENSG00000286989	-3.13466055239087	1.0576630810602e-4	LPS_vs_Control	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2
ENSG00000223834	ENSG00000223834	-4.95036247531492	1.0734586056151e-4	LPS_vs_Control	HSALNG0077094	integenic	Q50		-	ZEB1
ENSG00000232442	MHENCR	-1.55922470789451	1.0813572477834e-4	LPS_vs_Control	HSALNG0131657	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6786-5p	-	RTEL1
ENSG00000257621	PSMA3-AS1	-1.20105912795908	1.1027578960675e-4	LPS_vs_Control	HSALNG0101614	overlap_antisense,anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-5047,hsa-miR-6769b-5p,hsa-miR-8485	Smoking status measurement,Non-melanoma skin carcinoma,Triglyceride measurement,Red blood cell distribution width,Reticulocyte measurement,Mean corpuscular volume,Erythrocyte count,Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin,Red blood cell density measurement,Bitter alcoholic beverage consumption measurement; Alcohol use disorder measurement; Alcohol consumption measurement,Venous thromboembolism,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Myocardial infarction,Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Ovarian carcinoma; Progression free survival,-,Alcohol consumption measurement,Mean corpuscular volume; Mean corpuscular hemoglobin	ARMH4
ENSG00000264269	DYM-AS1	5.2607699657174	1.1198976721042e-4	LPS_vs_Control	HSALNG0121468	anti_sense	Q50	hsa-miR-7107-5p,hsa-miR-7703	Apolipoprotein a 1 measurement,Bmi-adjusted hip circumference,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement; Total cholesterol measurement,Waist-hip ratio,-	CTIF
ENSG00000261644	CYLD-AS1	1.73161870582748	1.1211751533648e-4	LPS_vs_Control	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20
ENSG00000205444	KU-MEL-3	5.36965682646092	1.1399840754952e-4	LPS_vs_Control	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL
ENSG00000267904	ENSG00000267904	-2.00136770833064	1.1502948483859e-4	LPS_vs_Control	HSALNG0124459	sense	Not conserved	hsa-miR-7113-3p		SMIM7
ENSG00000288767	ENSG00000288767	2.9386617435157	1.1795878176602e-4	LPS_vs_Control	HSALNG0096284	integenic	Not conserved			RFC3
ENSG00000289634	ENSG00000289634	3.59245950258152	1.2492669436579e-4	LPS_vs_Control	NA	NA	NA	NA	NA	SLCO4A1
ENSG00000286369	ENSG00000286369	3.31901484979856	1.2673389290072e-4	LPS_vs_Control	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5
ENSG00000228223	HCG11	-1.53153289851834	1.2730475862773e-4	LPS_vs_Control	HSALNG0048782	integenic	Not conserved		-	HMGN4
ENSG00000231233	CFAP58-DT	2.16701209584294	1.3286932049618e-4	LPS_vs_Control	HSALNG0080427	integenic	Q50			ITPRIP
ENSG00000261795	ENSG00000261795	-6.66241740824107	1.3893834553003e-4	LPS_vs_Control	HSALNG0055499	integenic	Not conserved			PDGFA
ENSG00000226149	ENSG00000226149	-2.5921072781519	1.4645185859209e-4	LPS_vs_Control	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18
ENSG00000290600	ENSG00000290600	-2.83487158224713	1.4971544432884e-4	LPS_vs_Control	HSALNG0062142	sense	Not conserved	hsa-miR-331-3p,hsa-miR-4323,hsa-miR-6090		ZNF783
ENSG00000267100	ILF3-DT	-1.45442402291224	1.6621276594862e-4	LPS_vs_Control	HSALNG0123950	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4784		AP1M2
ENSG00000232110	ENSG00000232110	4.79810182377345	1.7128638268035e-4	LPS_vs_Control	HSALNG0079566	overlap_antisense,anti_sense,sense	Q75	hsa-miR-149-3p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-5589-5p	Total blood protein measurement; Blood protein measurement,Protein measurement; Parental longevity,Heart failure,C-reactive protein measurement,C-reactive protein measurement; Neutrophil count; Myeloid white cell count; Myocardial infarction; Coronary artery disease,Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count; Myocardial infarction; Leukocyte count; Abdominal aortic aneurysm; Neutrophil percentage of leukocytes; Coronary artery disease,Aspartate aminotransferase to alanine aminotransferase ratio; Myocardial infarction,Myocardial infarction,Fibrinogen measurement; Coronary artery disease,Red blood cell distribution width,Neutrophil count,Leukocyte count,Eosinophil count; Neutrophil count,Coronary artery disease,-	IFIT2
ENSG00000257906	LINC02156	6.14919644156348	1.7348422923716e-4	LPS_vs_Control	HSALNG0090758	integenic	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-8485	5-hiaa measurement; Hva measurement,-	PCED1B
ENSG00000231346	LINC01160	-2.41290126059103	1.7677164366913e-4	LPS_vs_Control	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3
ENSG00000256706	ENSG00000256706	-4.71145048659446	1.9299706408868e-4	LPS_vs_Control	HSALNG0088571	anti_sense	Not conserved		-	CACNA1C
ENSG00000289102	ENSG00000289102	-1.54837784143489	1.9571410273464e-4	LPS_vs_Control	HSALNG0145787	overlap_sense,sense	Not conserved		Vitamin d measurement,Colorectal cancer; Breast carcinoma,Longitudinal alcohol consumption measurement,-	ZNF701
ENSG00000247572	CKMT2-AS1	-2.02454476177511	2.003337760206e-4	LPS_vs_Control	HSALNG0043022	overlap_antisense,sense	Not conserved		Empathy measurement,-	ACOT12
ENSG00000259285	ALDH1A2-AS1	5.65130418700637	2.1855675045978e-4	LPS_vs_Control	HSALNG0106208	anti_sense	Q90	hsa-miR-4733-3p	Esophageal adenocarcinoma; Barrett's esophagus,-	AQP9
ENSG00000225975	ZNF567-DT	-2.38845415869474	2.2008261997369e-4	LPS_vs_Control	HSALNG0125780	anti_sense	Not conserved	hsa-miR-4463,hsa-miR-6869-3p,hsa-miR-1273h-5p		ZNF461
ENSG00000224666	ETV7-AS1	4.79991021459608	2.2287291977409e-4	LPS_vs_Control	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20
ENSG00000233016	SNHG7	-1.68825037582302	2.2592636328707e-4	LPS_vs_Control	HSALNG0075291	anti_sense	Q90	hsa-miR-6089,hsa-miR-6829-3p	Body height,-	NA
ENSG00000244491	ENSG00000244491	3.12283921470223	2.3108514675699e-4	LPS_vs_Control	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000251442	LINC01094	-1.23808243452678	2.3606400800249e-4	LPS_vs_Control	HSALNG0035402	integenic	Q50	hsa-miR-7150	Mean platelet volume,Total blood protein measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Monocyte count,Creatine kinase measurement; Serum non-albumin protein measurement,Protein measurement,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,-	ANXA3
ENSG00000254837	LIPT2-AS1	-3.29467443669782	2.369861184806e-4	LPS_vs_Control	HSALNG0143021	sense	Not conserved			POLD3
ENSG00000291043	GLUD1P3	-1.63114521463332	2.4107075784632e-4	LPS_vs_Control	HSALNG0078866	integenic	Not conserved		-	SEC24C
ENSG00000225855	RUSC1-AS1	1.81773649608172	2.4703613691884e-4	LPS_vs_Control	HSALNG0007497	anti_sense	Q90	hsa-miR-6891-5p	Vitamin d measurement,-	ASH1L
ENSG00000234741	GAS5	-1.29818252572243	2.4780045326997e-4	LPS_vs_Control	HSALNG0008545	anti_sense	Q50	hsa-miR-4292	Intelligence,Body height,Erythrocyte count,Hematocrit; Hemoglobin measurement,-,Red blood cell density measurement; Erythrocyte count	CENPL
ENSG00000215533	LINC00189	3.70194132018156	2.5094946395285e-4	LPS_vs_Control	HSALNG0132537	sense	Not conserved	hsa-miR-4772-3p	Myocardial infarction,Serum alanine aminotransferase measurement,Response to mtor inhibitor,Qt interval,Serum gamma-glutamyl transferase measurement,Hemorrhoid,High density lipoprotein cholesterol measurement,-	BACH1
ENSG00000271913	TAGAP-AS1	-2.30763781678705	2.5329676530254e-4	LPS_vs_Control	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1
ENSG00000283648	ENSG00000283648	5.00632697992008	2.5475964064462e-4	LPS_vs_Control	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2
ENSG00000247982	LINC00926	-2.49973877402979	2.5963829242858e-4	LPS_vs_Control	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12
ENSG00000225062	CATIP-AS1	-2.34850636802167	2.6294141093626e-4	LPS_vs_Control	HSALNG0022253	anti_sense	Q50	hsa-miR-4772-3p	-	TMBIM1
ENSG00000228192	ZNF691-DT	-2.03234684227509	2.6847853751261e-4	LPS_vs_Control	HSALNG0003039	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-5693	Red blood cell distribution width,-	SVBP
ENSG00000250777	ENSG00000250777	-2.25951880302135	2.7389605432203e-4	LPS_vs_Control	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18
ENSG00000228784	LINC00954	-2.83457800302424	2.8224441441344e-4	LPS_vs_Control	HSALNG0013382	integenic	Not conserved	hsa-miR-4433a-3p	Creatinine measurement,-	RHOB
ENSG00000260805	ENSG00000260805	2.62824284585345	2.8685824581926e-4	LPS_vs_Control	HSALNG0010371	integenic	Q50	hsa-miR-6090,hsa-miR-10392-3p	-	BATF3
ENSG00000258777	HIF1A-AS1	3.23174835419032	2.8700343086308e-4	LPS_vs_Control	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B
ENSG00000237797	MACORIS	-2.91892441472718	2.9027639751289e-4	LPS_vs_Control	HSALNG0077098	integenic	Q50		Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12
ENSG00000289880	ENSG00000289880	3.09687516484328	2.9282988815465e-4	LPS_vs_Control	NA	NA	NA	NA	NA	FAM177B
ENSG00000231131	LNCAROD	1.4520567758045	3.0391147732968e-4	LPS_vs_Control	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopfâ€related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopfâ€related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2
ENSG00000288755	ENSG00000288755	4.56613570893333	3.1247227701733e-4	LPS_vs_Control	HSALNG0142490	integenic	Q75			PFKP
ENSG00000291080	ZNF252P	-1.39202464550559	3.1289291708891e-4	LPS_vs_Control	NA	NA	NA	NA	NA	ZNF16
ENSG00000272902	TBC1D8-AS1	-3.87231581608362	3.2387888685987e-4	LPS_vs_Control	HSALNG0017347	anti_sense	Q50		Reticulocyte count	CNOT11
ENSG00000287104	ENSG00000287104	-3.37257471660897	3.3382662196681e-4	LPS_vs_Control	HSALNG0032665	anti_sense	Not conserved			CCDC96
ENSG00000255446	ENSG00000255446	-2.75847009335693	3.3509798527575e-4	LPS_vs_Control	HSALNG0084600	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6879-5p	Bmi-adjusted waist-hip ratio,Waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte count,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Chronic obstructive pulmonary disease; Cc16 measurement,-	AHNAK
ENSG00000250802	ZBED3-AS1	-2.28779393039418	3.3599489738464e-4	LPS_vs_Control	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA
ENSG00000273314	ENSG00000273314	2.18714208554862	3.4772103324441e-4	LPS_vs_Control	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p		EZH2
ENSG00000290838	NCF1B	3.09004119758921	3.4944904342808e-4	LPS_vs_Control	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p		FKBP6
ENSG00000262097	LINC02185	-3.10743941808329	3.4972703071338e-4	LPS_vs_Control	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN
ENSG00000281501	SEPSECS-AS1	-2.24312393720424	3.5072418493732e-4	LPS_vs_Control	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B
ENSG00000228800	ENSG00000228800	4.54904852676926	3.5170711000689e-4	LPS_vs_Control	HSALNG0077038	integenic	Not conserved		-	LYZL2
ENSG00000291122	CASTOR3P	-2.35670392612352	3.6263002544667e-4	LPS_vs_Control	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p		GPC2
ENSG00000287644	ENSG00000287644	-4.40094502015241	3.6333333206462e-4	LPS_vs_Control	HSALNG0145286	anti_sense	Q90	hsa-miR-34b-5p,hsa-miR-4492,hsa-miR-6783-3p	-	GJD3
ENSG00000255857	PXN-AS1	-1.97640157835627	3.7055889107321e-4	LPS_vs_Control	HSALNG0094500	anti_sense	Q90	hsa-miR-3183,hsa-miR-3925-3p,hsa-miR-4497,hsa-miR-6089,hsa-miR-6769a-3p,hsa-miR-7843-5p,hsa-miR-10392-3p	C-reactive protein measurement,-	SIRT4
ENSG00000286558	ENSG00000286558	-4.98828898536081	3.741859495271e-4	LPS_vs_Control	HSALNG0148220	integenic	Not conserved		-	TMEM144
ENSG00000224660	SH3BP5-AS1	-1.28008964603748	3.7492593329043e-4	LPS_vs_Control	HSALNG0024394	anti_sense	Q90		-	CAPN7
ENSG00000291091	SDHAP4	-1.45196928387369	3.8164281962879e-4	LPS_vs_Control	HSALNG0032044	integenic	Not conserved	hsa-miR-4281		BDH1
ENSG00000277782	ENSG00000277782	2.32370113574206	3.9374777149769e-4	LPS_vs_Control	HSALNG0107630	anti_sense	Q90	hsa-miR-5787	-	MESD
ENSG00000233695	GAS6-AS1	-2.07085299546269	4.0873908250041e-4	LPS_vs_Control	HSALNG0099627	anti_sense	Not conserved	hsa-miR-6721-5p		TMEM255B
ENSG00000273143	DUSP5-DT	4.11877798881193	4.0975873342878e-4	LPS_vs_Control	HSALNG0080582	integenic	Q50		Heel bone mineral density,Bone density,-	SMNDC1
ENSG00000233559	LINC00513	3.44901122382938	4.1236380004719e-4	LPS_vs_Control	HSALNG0061393	integenic	Not conserved		Parental genotype effect measurement; Vitamin d measurement	MKLN1
ENSG00000230631	ENSG00000230631	4.15738300533048	4.1281883349773e-4	LPS_vs_Control	HSALNG0048221	integenic	Not conserved	hsa-miR-920	Cytokine measurement,-	MCUR1
ENSG00000246859	STARD4-AS1	3.66941989316767	4.1281883349773e-4	LPS_vs_Control	HSALNG0044138	integenic	Not conserved			CAMK4
ENSG00000272734	ADIRF-AS1	-1.40446424049316	4.176066887817e-4	LPS_vs_Control	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2
ENSG00000250548	LINC01303	2.2517801416167	4.176066887817e-4	LPS_vs_Control	HSALNG0101771	anti_sense	Q75		Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B
ENSG00000229619	MBNL1-AS1	1.47548950666955	4.181728832626e-4	LPS_vs_Control	HSALNG0029874	anti_sense	Q50	hsa-miR-4492,hsa-miR-5587-3p	Body height,Balding measurement,Colorectal cancer,Pulse pressure measurement,Hematocrit; Hemoglobin measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Neutrophil count,Myeloid white cell count,-	IGSF10
ENSG00000254635	WAC-AS1	-1.38431712091352	4.3671187308767e-4	LPS_vs_Control	HSALNG0076905	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4492	Empathy measurement,Granulocyte percentage of myeloid white cells,Neutrophil percentage of leukocytes,-	MPP7
ENSG00000231711	LINC00899	-1.93906134479561	4.5539804666e-4	LPS_vs_Control	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B
ENSG00000253123	ENSG00000253123	2.82279492420871	4.5712064030061e-4	LPS_vs_Control	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2
ENSG00000231113	LINC02976	-1.7971665083468	5.0560950087644e-4	LPS_vs_Control	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3
ENSG00000224195	CAMK2G-AS1	4.07029216582633	5.0875429057825e-4	LPS_vs_Control	HSALNG0078882	anti_sense	Q90	hsa-miR-4755-3p	Self reported educational attainment; Vital capacity,-	ZSWIM8
ENSG00000273805	ENSG00000273805	4.11800278070429	5.0875429057825e-4	LPS_vs_Control	HSALNG0091671	integenic	Q50	hsa-miR-619-5p	Trochanter size,Hematocrit,Bmi-adjusted waist circumference; Body height,Platelet component distribution width,Body mass index,Intelligence,Self reported educational attainment,Body height; Cognitive function measurement,-	ATP23
ENSG00000235437	LINC01278	-1.04708453532962	5.10765289027e-4	LPS_vs_Control	HSALNG0138225	sense	Not conserved	hsa-miR-4328,hsa-miR-4447	Periodontitis,Balding measurement	SPIN4
ENSG00000276116	FUT8-AS1	-4.51663563696869	5.144600899842e-4	LPS_vs_Control	HSALNG0144243	anti_sense	Q75		Serum igg glycosylation measurement,-	MAX
ENSG00000283213	ENSG00000283213	-3.24707745143849	5.5238173682852e-4	LPS_vs_Control	HSALNG0110217	anti_sense	Q90		-	USP31
ENSG00000289526	ENSG00000289526	2.61896213504372	5.5583825625573e-4	LPS_vs_Control	HSALNG0083600	anti_sense	Q50		Covid-19,Uterine fibroid,Heel bone mineral density,Systemic lupus erythematosus,Systemic lupus erythematosus; Heel bone mineral density,Uterine fibroid; Bone density,Hip bone mineral density,Sex hormone-binding globulin measurement,Triglyceride measurement; Response to hydrochlorothiazide,-	APIP
ENSG00000274383	ENSG00000274383	-1.8379990758436	5.559093760874e-4	LPS_vs_Control	HSALNG0144546	anti_sense	Q50			SPG21
ENSG00000277895	ENSG00000277895	2.43386582743932	5.685656762102e-4	LPS_vs_Control	HSALNG0091934	anti_sense	Q75			C12orf56
ENSG00000231365	WARS2-AS1	-1.51233901354019	5.8193201234942e-4	LPS_vs_Control	HSALNG0006479	integenic	Not conserved			HAO2
ENSG00000272986	ENSG00000272986	2.52021277065722	5.9191829284929e-4	LPS_vs_Control	HSALNG0035038	anti_sense	Q50			JCHAIN
ENSG00000247828	TMEM161B-DT	-1.24430827891065	6.1834949104808e-4	LPS_vs_Control	HSALNG0043363	integenic	Q90	hsa-miR-4438		RASA1
ENSG00000251323	LINC02728	3.37723422923366	6.3124727901487e-4	LPS_vs_Control	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2
ENSG00000258860	ENSG00000258860	4.86592304610724	6.4861737807953e-4	LPS_vs_Control	HSALNG0144215	integenic	Not conserved	hsa-miR-4302,hsa-miR-4531,hsa-miR-6089	Psoriasis,Bmi-adjusted hip circumference	NFKBIA
ENSG00000249096	LINC02362	2.88108183171386	6.6323517594026e-4	LPS_vs_Control	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129		IRF2
ENSG00000260565	ERVK13-1	-1.00736888319485	6.7129638285254e-4	LPS_vs_Control	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27
ENSG00000250362	ENSG00000250362	5.49822673398886	6.7663165446708e-4	LPS_vs_Control	HSALNG0043626	integenic	Q50		Blood protein measurement; Serum non-albumin protein measurement,-	RHOBTB3
ENSG00000265458	NARF-AS2	1.32521232306648	6.7900919434106e-4	LPS_vs_Control	HSALNG0119438	anti_sense	Not conserved	hsa-miR-3192-5p,hsa-miR-6089,hsa-miR-6871-5p	Forced expiratory volume,-	CYBC1
ENSG00000229127	KANSL1L-AS1	-2.48372684440543	6.807147063967e-4	LPS_vs_Control	HSALNG0021947	anti_sense,sense	Q90		Neuroblastoma,-	RPE
ENSG00000232679	LINC01705	3.42193584985892	6.8341152451365e-4	LPS_vs_Control	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10
ENSG00000286435	ENSG00000286435	3.9120257442727	6.8952995137848e-4	LPS_vs_Control	HSALNG0117824	integenic	Not conserved			CA4
ENSG00000234072	GTF3C2-AS2	-1.57357155639122	6.9103085834304e-4	LPS_vs_Control	HSALNG0013804	anti_sense	Q90	hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-7155-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Testosterone measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Urinary albumin to creatinine ratio,Lactate measurement; Alpha-hydroxybutyric acid measurement,Triglyceride measurement,Sleep duration; Triglyceride measurement,Serum igg glycosylation measurement,-	SNX17
ENSG00000231811	ENSG00000231811	2.90799864060986	6.960466470568e-4	LPS_vs_Control	HSALNG0047724	integenic	Not conserved	hsa-miR-4447		ECI2
ENSG00000231535	LINC00278	6.85615246137203	7.0241801095386e-4	LPS_vs_Control	HSALNG0140973	integenic	Not conserved			ZFY
ENSG00000277232	GTSE1-DT	-4.49920594014569	7.2030355949191e-4	LPS_vs_Control	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ
ENSG00000290993	ENSG00000290993	-1.21660188428645	7.297425821211e-4	LPS_vs_Control	HSALNG0028889	integenic	Not conserved	hsa-miR-6871-5p		EFCAB12
ENSG00000231074	HCG18	-1.02836793858217	7.3946278094106e-4	LPS_vs_Control	HSALNG0049135	integenic	Not conserved		Psoriatic arthritis,Systemic lupus erythematosus	TRIM26
ENSG00000261087	ZNNT1	-2.82632431531104	7.5061680696853e-4	LPS_vs_Control	HSALNG0067345	integenic	Not conserved			ZNF706
ENSG00000222042	ENSG00000222042	4.86741440429547	7.5378175192351e-4	LPS_vs_Control	HSALNG0132366	integenic	Not conserved			MRPL39
ENSG00000224376	ENSG00000224376	-2.82866807795239	7.8190970425604e-4	LPS_vs_Control	HSALNG0022936	integenic	Not conserved	hsa-miR-4481,hsa-miR-4726-5p	Electrocardiography; Monocyte percentage of leukocytes,Monocyte count	B3GNT7
ENSG00000277566	ENSG00000277566	-3.04303254921303	8.0555249330083e-4	LPS_vs_Control	HSALNG0094145	sense	Not conserved			TPCN1
ENSG00000290082	ENSG00000290082	-1.92984865563719	8.1138191809513e-4	LPS_vs_Control	HSALNG0115585	anti_sense	Not conserved			ABHD15
ENSG00000287823	ENSG00000287823	-3.43256254823896	8.1176770335627e-4	LPS_vs_Control	NA	NA	NA	NA	NA	FAM120B
ENSG00000270194	GOLGA4-AS1	1.53766602028816	8.2039708960957e-4	LPS_vs_Control	HSALNG0025176	anti_sense	Q90		-	LRRFIP2
ENSG00000285693	ENSG00000285693	-2.25468593392	8.4110280149229e-4	LPS_vs_Control	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10
ENSG00000281162	LINC01127	-3.69797833359434	8.4651881335024e-4	LPS_vs_Control	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2
ENSG00000226419	SLC16A1-AS1	-1.56695072538057	8.5085880942957e-4	LPS_vs_Control	HSALNG0006160	integenic	Not conserved			LRIG2
ENSG00000263731	ENSG00000263731	-1.59627749633159	8.6424328474341e-4	LPS_vs_Control	HSALNG0119325	integenic	Not conserved			ALYREF
ENSG00000196810	CTBP1-DT	-1.53969217800568	8.8038782717939e-4	LPS_vs_Control	HSALNG0032263	anti_sense	Not conserved	hsa-miR-505-5p	Pulse pressure measurement,-	MAEA
ENSG00000256576	LINC02361	-2.02306146322383	8.9283501721776e-4	LPS_vs_Control	HSALNG0095275	integenic	Q50	hsa-miR-1237-5p,hsa-miR-4685-3p	-	GALNT9
ENSG00000260302	LINC01882	4.3436557165523	8.9368247900529e-4	LPS_vs_Control	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2
ENSG00000232098	ZNF584-DT	-1.43674879057965	9.313226337133e-4	LPS_vs_Control	HSALNG0127962	anti_sense	Not conserved		Mean platelet volume,-	ZNF837
ENSG00000291033	TXLNGY	7.17156291473038	9.5430998175569e-4	LPS_vs_Control	HSALNG0141378	integenic	Not conserved	hsa-miR-363-5p		EIF1AY
ENSG00000186235	LINC02610	-2.76217093973166	9.5523914749646e-4	LPS_vs_Control	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6
ENSG00000256546	LINC02985	-2.34699620807264	9.572158337369e-4	LPS_vs_Control	HSALNG0094625	integenic	Q75		Serum alanine aminotransferase measurement,Uric acid measurement; Body weight	BCL7A
ENSG00000255031	ENSG00000255031	-1.52923769688078	9.7344128465484e-4	LPS_vs_Control	HSALNG0085213	anti_sense,sense	Q75	hsa-miR-1249-5p	-	TCIRG1
ENSG00000291086	LGALS17A	5.06596007700186	9.8345958904398e-4	LPS_vs_Control	HSALNG0126029	integenic	Not conserved			LGALS14
ENSG00000226950	DANCR	-1.34506529660482	9.9459176858714e-4	LPS_vs_Control	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B
ENSG00000255921	ENSG00000255921	3.25444210398719	0.00100104715146666	LPS_vs_Control	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2
ENSG00000288736	ENSG00000288736	4.51239534242785	0.0010022745467675	LPS_vs_Control	HSALNG0005330	integenic	Q50	hsa-miR-5703,hsa-miR-6753-5p,hsa-miR-6893-5p		ABCD3
ENSG00000203446	SUGCT-AS1	2.11596796005751	0.00100440318394686	LPS_vs_Control	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP
ENSG00000230387	ENSG00000230387	-4.92475511486306	0.00101082488857412	LPS_vs_Control	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4
ENSG00000250519	ENSG00000250519	1.59427169679881	0.00102614237736217	LPS_vs_Control	HSALNG0086510	integenic	Q50		Serum alanine aminotransferase measurement,-	PANX1
ENSG00000289003	ENSG00000289003	-3.08266210446085	0.00104712213367368	LPS_vs_Control	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A
ENSG00000239445	ST3GAL6-AS1	-1.7445401693996	0.00106248684711084	LPS_vs_Control	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2
ENSG00000290418	TPTEP1	-2.16307574797817	0.00106258927920167	LPS_vs_Control	HSALNG0133819	integenic	Not conserved		-	IL17RA
ENSG00000267321	SNHG30	-1.77232651950555	0.0010667010631119	LPS_vs_Control	HSALNG0115960	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-7107-5p	Mean platelet volume; Platelet component distribution width; Platelet count,-	AP2B1
ENSG00000233672	RNASEH2B-AS1	-3.1227921778529	0.00109897693957557	LPS_vs_Control	HSALNG0097134	anti_sense	Q75		Hemorrhoid,Prostate specific antigen measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Mean corpuscular volume,Benign prostatic hyperplasia; Lower urinary tract symptom,-	DLEU7
ENSG00000259583	ALDH1A3-AS1	-2.73033154898603	0.00111575800966086	LPS_vs_Control	HSALNG0108607	anti_sense	Q90		-	CHSY1
ENSG00000228427	ENSG00000228427	-2.10521452145314	0.00111834493971622	LPS_vs_Control	HSALNG0138463	integenic	Q75	hsa-miR-30b-3p,hsa-miR-6089	Prostate carcinoma	ZMYM3
ENSG00000253557	ENSG00000253557	2.15858005346198	0.00112496811609955	LPS_vs_Control	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3
ENSG00000237980	LINC02773	3.22597968506725	0.00116334407386936	LPS_vs_Control	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3
ENSG00000227199	ST7-AS1	2.02713918712335	0.00118027564666301	LPS_vs_Control	HSALNG0060774	anti_sense	Q75	hsa-miR-1249-3p,hsa-miR-4313,hsa-miR-4488,hsa-miR-4508,hsa-miR-4787-5p	Blood protein measurement,-	WNT2
ENSG00000273373	SLC16A4-AS1	-2.14111241935409	0.00120180851798178	LPS_vs_Control	HSALNG0005977	anti_sense	Q75		-	RBM15
ENSG00000289047	ENSG00000289047	-1.3754684598504	0.00121502301557434	LPS_vs_Control	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9
ENSG00000249859	PVT1	-1.58440074650798	0.00125266300918043	LPS_vs_Control	HSALNG0068477	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4281,hsa-miR-4279,hsa-miR-4434,hsa-miR-4492,hsa-miR-4505,hsa-miR-4526,hsa-miR-4535,hsa-miR-1587,hsa-miR-4690-3p,hsa-miR-4691-3p,hsa-miR-3064-5p,hsa-miR-4749-3p,hsa-miR-4436b-3p,hsa-miR-6069,hsa-miR-6757-5p,hsa-miR-6858-3p,hsa-miR-6883-5p	Allergic sensitization measurement,Allergic sensitization measurement; Allergic rhinitis,Inhalant adrenergic use measurement; Tonsillectomy risk measurement,Ovarian serous carcinoma; Ovarian carcinoma,Body height,Platelet count,Platelet crit,Cognitive decline measurement,Lung carcinoma,Susceptibility to scarlet fever measurement,Waist-hip ratio,Psychosis,Calcium measurement,Hematocrit,Left ventricular systolic function measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Reticulocyte measurement; Mean corpuscular hemoglobin concentration,Hemoglobin measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Mean corpuscular volume,Eosinophil count; Lymphocyte count; Basophil count,Neutrophil count,Reticulocyte count,Eosinophil count; Lymphocyte count; Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil count; Non-melanoma skin carcinoma; Eosinophil percentage of granulocytes,Leukocyte count; Platelet-to-lymphocyte ratio; Lymphocyte count; Myeloid white cell count,Gut microbiome measurement,Leukocyte count; Thyroid preparation use measurement,Eosinophil count; Basophil count,Neutrophil percentage of leukocytes; Eosinophil percentage of leukocytes,Phosphatidylcholine 40:6 measurement,Bell's palsy; Mean corpuscular hemoglobin concentration,Hematocrit; Hemoglobin measurement; Blood protein measurement; Serum non-albumin protein measurement,Total blood protein measurement,Mean corpuscular hemoglobin concentration,Chronic kidney disease,Hodgkins lymphoma,Neoplasm of mature b-cells; Central nervous system non-hodgkin lymphoma,Diffuse large b-cell lymphoma; Non-hodgkins lymphoma; Lymphoma,Serum non-albumin protein measurement,Facial morphology measurement,Reticulocyte measurement,Sporadic amyotrophic lateral sclerosis,C-reactive protein measurement,Colorectal cancer,Tonsillectomy risk measurement,Autoimmune thyroid disease,Birth weight; Lung adenocarcinoma; Primary biliary cirrhosis,Erythrocyte count,Systemic lupus erythematosus,Bmi-adjusted waist circumference,Breast carcinoma,Renal transplant outcome measurement; Donor genotype effect measurement; Apol1 risk genotype carrier status,Major depressive disorder; Major depressive episode,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Hypothyroidism,-	MYC
ENSG00000290793	ENSG00000290793	-1.92491076829361	0.00125266300918043	LPS_vs_Control	NA	NA	NA	NA	NA	AMZ2
ENSG00000216895	RBM33-DT	-1.70260364281793	0.00128886339096933	LPS_vs_Control	HSALNG0062595	anti_sense	Q75	hsa-miR-486-3p,hsa-miR-619-5p,hsa-miR-4723-3p	Self reported educational attainment,-	NA
ENSG00000290842	CROCCP3	-1.96325178494524	0.00144909419482712	LPS_vs_Control	HSALNG0001179	integenic	Not conserved			SPATA21
ENSG00000274370	ENSG00000274370	-1.91116919537085	0.00146408775514935	LPS_vs_Control	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p		METRNL
ENSG00000232229	LINC00865	-2.79083411755784	0.00151804333539586	LPS_vs_Control	HSALNG0079601	integenic	Not conserved	hsa-miR-4534	Colorectal cancer,Self reported educational attainment,-	KIF20B
ENSG00000272434	ENSG00000272434	-4.4864604873927	0.00154585744479413	LPS_vs_Control	HSALNG0025904	anti_sense	Q90		-	NDUFAF3
ENSG00000260077	ENSG00000260077	-1.70378704795684	0.00157174793608692	LPS_vs_Control	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1
ENSG00000290928	ENSG00000290928	-1.47112360529726	0.0016018421838692	LPS_vs_Control	HSALNG0115658	integenic	Not conserved			ATAD5
ENSG00000269044	ENSG00000269044	-1.37735527918139	0.00160859133160327	LPS_vs_Control	HSALNG0124458	sense	Not conserved	hsa-miR-665		SMIM7
ENSG00000261136	ENSG00000261136	-2.62303020593466	0.00163216297361177	LPS_vs_Control	HSALNG0105179	anti_sense	Not conserved			EIF2AK4
ENSG00000255521	CD44-DT	3.0455445028818	0.00163548402586042	LPS_vs_Control	HSALNG0083606	anti_sense	Q50		Response to vitamin,-	SLC1A2
ENSG00000183242	WT1-AS	4.41860252269197	0.00167972821908815	LPS_vs_Control	HSALNG0083478	integenic	Q90		-	EIF3M
ENSG00000240498	CDKN2B-AS1	1.78524263496151	0.00172035386799876	LPS_vs_Control	HSALNG0070400	integenic	Not conserved		Eosinophil count,Colorectal cancer,Coronary artery disease; Parental longevity,-	MTAP
ENSG00000248275	TRIM52-AS1	-1.43715890763556	0.0018005029527081	LPS_vs_Control	HSALNG0047244	anti_sense	Q50	hsa-miR-596,hsa-miR-619-5p,hsa-miR-4486,hsa-miR-4710,hsa-miR-5004-5p,hsa-miR-6085,hsa-miR-6129	-	TRIM41
ENSG00000271789	ENSG00000271789	-2.96752031337493	0.00183545346905957	LPS_vs_Control	HSALNG0052772	sense	Not conserved			MFSD4B
ENSG00000224846	NQO2-AS1	5.35946065901019	0.00183909822195051	LPS_vs_Control	HSALNG0047545	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-4519,hsa-miR-4640-3p,hsa-miR-6085,hsa-miR-7108-3p	Urinary metabolite measurement,Protein measurement,Blood protein measurement,-	SERPINB6
ENSG00000290854	ENSG00000290854	-1.64464578137058	0.0018642027425869	LPS_vs_Control	NA	NA	NA	NA	NA	CDK11A
ENSG00000290999	ENSG00000290999	2.93806189817283	0.00187254932873077	LPS_vs_Control	NA	NA	NA	NA	NA	SEC22B
ENSG00000245105	A2M-AS1	-2.95631356006498	0.00188110419895162	LPS_vs_Control	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1
ENSG00000234362	LINC01914	4.46214946641177	0.00193913353304329	LPS_vs_Control	HSALNG0014404	integenic	Q75	hsa-miR-622	Chronotype measurement,Fasting blood glucose measurement,Gastric carcinoma,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement,Intelligence,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Eye colour measurement,Lifestyle measurement,Triacylglycerol 48:0 measurement,Mathematical ability,Unipolar depression,Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Rheumatoid arthritis,Hair colour measurement; Heel bone mineral density,Electrocardiography,Breast carcinoma,Fev/fec ratio; Response to bronchodilator,Conduct disorder; Parental emotion expression measurmement,Cingulate cortex measurement; Amyloid-beta measurement,Response to vaccine,-	COX7A2L
ENSG00000232803	SLCO4A1-AS1	4.35594067142308	0.00193913353304329	LPS_vs_Control	HSALNG0146997	anti_sense	Q75	hsa-miR-5196-5p	Human papilloma virus infection; Oral cavity cancer,-	TCFL5
ENSG00000230918	DPP4-DT	3.21412364823061	0.00200218576500795	LPS_vs_Control	HSALNG0020015	anti_sense	Q75	hsa-miR-6124	-	SLC4A10
ENSG00000272476	ENSG00000272476	2.06544810155247	0.00200812709852215	LPS_vs_Control	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1
ENSG00000261512	ENSG00000261512	2.05671676839722	0.00204526897890846	LPS_vs_Control	NA	NA	NA	NA	NA	SHCBP1
ENSG00000269303	GRAMD1A-AS1	4.24380404583176	0.00205215587057119	LPS_vs_Control	HSALNG0125556	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6791-3p	Triacylglycerol 54:4 measurement	ZNF792
ENSG00000163081	CCDC140	4.31886025628792	0.00205295126997269	LPS_vs_Control	NA	NA	NA	NA	NA	SGPP2
ENSG00000268912	ENSG00000268912	-2.25290428849035	0.00215173201310746	LPS_vs_Control	HSALNG0127967	integenic	Not conserved			ZNF132
ENSG00000247679	ENSG00000247679	-2.15857193764972	0.00215331001619459	LPS_vs_Control	HSALNG0046959	integenic	Not conserved		Mathematical ability,-	B4GALT7
ENSG00000289009	ENSG00000289009	1.80154374914701	0.00219473033941096	LPS_vs_Control	HSALNG0133576	anti_sense	Not conserved		High density lipoprotein cholesterol measurement,Serum gamma-glutamyl transferase measurement	SLX9
ENSG00000253738	OTUD6B-AS1	-1.14619308858149	0.00219473033941096	LPS_vs_Control	HSALNG0066885	anti_sense	Q50		-	PIP4P2
ENSG00000273680	ENSG00000273680	-3.2429126702668	0.00220811451593221	LPS_vs_Control	HSALNG0090093	anti_sense	Not conserved			ERGIC2
ENSG00000253210	DENND3-AS1	1.80991189685569	0.0022607945474425	LPS_vs_Control	HSALNG0069052	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3155b,hsa-miR-4492,hsa-miR-4508,hsa-miR-6730-5p,hsa-miR-6797-5p,hsa-miR-6809-3p	-	SLC45A4
ENSG00000251615	ENSG00000251615	1.72609856679684	0.00228994718824488	LPS_vs_Control	NA	NA	NA	NA	NA	ACOX3
ENSG00000234199	LINC01191	2.27316427616076	0.00232220908452427	LPS_vs_Control	HSALNG0018115	integenic	Not conserved			ACTR3
ENSG00000214900	LINC01588	2.16223918314937	0.0023912698512179	LPS_vs_Control	HSALNG0101158	integenic	Q50			VCPKMT
ENSG00000259953	LINC02977	-1.0644025031387	0.00241216432905327	LPS_vs_Control	HSALNG0073741	integenic	Not conserved	hsa-miR-619-5p	Physical activity	SUSD1
ENSG00000237576	LINC01888	2.6723171890515	0.00243324946592287	LPS_vs_Control	HSALNG0015714	integenic	Not conserved		Rr interval	ARHGAP25
ENSG00000251136	RIPK2-DT	1.56852424257833	0.00245523834273163	LPS_vs_Control	HSALNG0066822	integenic	Q50		Human papilloma virus infection; Oropharynx cancer,-	NBN
ENSG00000250734	ENSG00000250734	2.72057828749218	0.00245757661754185	LPS_vs_Control	HSALNG0142346	anti_sense	Q90	hsa-miR-4472,hsa-miR-3960,hsa-miR-6803-5p,hsa-miR-8072	Headache,-	CELF3
ENSG00000287170	ENSG00000287170	-4.38933256328718	0.00249102215725151	LPS_vs_Control	HSALNG0145803	anti_sense	Not conserved	hsa-miR-6857-5p	-	EPS8L1
ENSG00000224086	PPM1F-AS1	-3.02010526012449	0.00251520275963819	LPS_vs_Control	HSALNG0134272	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6808-5p	Attention deficit hyperactivity disorder,Age at menopause,Macrophage inflammatory protein 1b measurement,-	PPIL2
ENSG00000274929	ENSG00000274929	-2.8594999158024	0.00251873466292558	LPS_vs_Control	HSALNG0096999	anti_sense,sense	Not conserved			RCBTB2
ENSG00000262050	ENSG00000262050	-3.65085126953743	0.00253162013916488	LPS_vs_Control	HSALNG0113932	anti_sense	Q50	hsa-miR-619-5p	-	PAFAH1B1
ENSG00000263327	TAPT1-AS1	-2.57771311551806	0.00255874503980834	LPS_vs_Control	HSALNG0033093	anti_sense	Q75	hsa-miR-4310,hsa-miR-6882-5p	Self reported educational attainment,Intelligence,Intelligence; Mathematical ability,Verbal-numerical reasoning measurement,Cognitive function measurement,Systemic juvenile idiopathic arthritis,Temporal horn of lateral ventricle volume measurement,Duchenne muscular dystrophy; Disease progression measurement,-	CD38
ENSG00000273387	ENSG00000273387	-2.94450354103694	0.00258709453643011	LPS_vs_Control	HSALNG0134940	anti_sense	Q75	hsa-miR-762,hsa-miR-4447,hsa-miR-4505,hsa-miR-6735-5p	Fev/fec ratio,-	SELENOM
ENSG00000232680	ENSG00000232680	3.30759849546829	0.00258888504023196	LPS_vs_Control	HSALNG0125614	integenic	Not conserved			KRTDAP
ENSG00000267254	ZNF790-AS1	-1.76559016939109	0.00258888504023196	LPS_vs_Control	HSALNG0125793	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	ZNF345
ENSG00000276317	ENSG00000276317	2.65914569315003	0.00260313849722351	LPS_vs_Control	HSALNG0131550	anti_sense	Not conserved	hsa-miR-940,hsa-miR-4492,hsa-miR-6752-3p,hsa-miR-6810-5p,hsa-miR-6810-3p,hsa-miR-7160-3p	Hemoglobin a1 measurement	GATA5
ENSG00000291129	PPIEL	-1.3004613570538	0.00260582685802478	LPS_vs_Control	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4
ENSG00000270120	ENSG00000270120	1.91389221556382	0.00261561422371332	LPS_vs_Control	HSALNG0111360	sense	Q50			NOD2
ENSG00000291003	ENSG00000291003	-1.30096845625583	0.00261681192067039	LPS_vs_Control	HSALNG0104483	integenic	Not conserved			GOLGA6L22
ENSG00000203327	ENSG00000203327	-3.47386174001954	0.00263560786540767	LPS_vs_Control	HSALNG0014994	sense	Not conserved	hsa-miR-6089		CLHC1
ENSG00000267272	LINC01140	4.35663354790984	0.00267089936028336	LPS_vs_Control	HSALNG0004949	sense	Q90		Smoking behavior,Cortical surface area measurement,-	NA
ENSG00000249042	FAM151B-DT	-2.23917965205446	0.00283480803705793	LPS_vs_Control	HSALNG0042987	anti_sense	Q90	hsa-miR-619-5p	Psoriasis,-	ANKRD34B
ENSG00000228203	GRASLND	4.32625305550509	0.00289609306078047	LPS_vs_Control	HSALNG0012734	anti_sense	Q50	hsa-miR-4710		CMPK2
ENSG00000232931	LINC00342	-1.21851601748101	0.00290182135360981	LPS_vs_Control	HSALNG0146543	integenic	Not conserved			ANKRD36C
ENSG00000213468	FIRRE	2.20953969741545	0.00301727386550222	LPS_vs_Control	HSALNG0140173	integenic	Not conserved	hsa-miR-6089		IGSF1
ENSG00000237753	SLC20A1-DT	-2.07473481164803	0.003035098075972	LPS_vs_Control	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L
ENSG00000291156	ENSG00000291156	1.37738213772509	0.00304726783596781	LPS_vs_Control	HSALNG0000078	integenic	Not conserved		-	AGRN
ENSG00000259321	ENSG00000259321	2.31567375506263	0.00308074374400388	LPS_vs_Control	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1
ENSG00000215765	ENSG00000215765	4.61770925267089	0.00308526966888577	LPS_vs_Control	HSALNG0127569	sense	Not conserved		Blood protein measurement,Monocyte percentage of leukocytes,-	KIR2DL1
ENSG00000245213	GALNT7-DT	-2.13044378765525	0.00310280979831376	LPS_vs_Control	HSALNG0038578	integenic	Not conserved			HMGB2
ENSG00000267416	HEATR6-DT	1.96629439531894	0.00311319683918019	LPS_vs_Control	HSALNG0117818	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6779-3p	-	CA4
ENSG00000234506	LINC01506	2.55537216306257	0.00317414655809025	LPS_vs_Control	HSALNG0071693	integenic	Not conserved	hsa-miR-5787		TMEM252
ENSG00000291072	CROCCP2	-1.17789879781235	0.00323392691855283	LPS_vs_Control	HSALNG0001201	integenic	Not conserved			NBPF1
ENSG00000290989	ENSG00000290989	-1.80440175814595	0.00330753152586002	LPS_vs_Control	HSALNG0010926	integenic	Not conserved		-	FBXO28
ENSG00000277089	CCL3-AS1	3.03857249721644	0.0033379010008093	LPS_vs_Control	HSALNG0116003	anti_sense,sense	Q75	hsa-miR-604,hsa-miR-4726-5p,hsa-miR-6077,hsa-miR-6089,hsa-miR-6743-5p	Blood protein measurement,C-c motif chemokine 3 measurement	CCL18
ENSG00000289378	ENSG00000289378	-3.7822575185806	0.00334574017384689	LPS_vs_Control	HSALNG0125414	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-1285-3p,hsa-miR-3178,hsa-miR-4508	-	SLC7A10
ENSG00000258559	ENSG00000258559	-1.6430829217057	0.00334647678382672	LPS_vs_Control	HSALNG0102422	sense	Not conserved	hsa-miR-604,hsa-miR-619-5p	-	ABCD4
ENSG00000269815	ENSG00000269815	-2.46537777260987	0.00349965887210616	LPS_vs_Control	HSALNG0124499	sense,intronic_antisense	Not conserved			ABHD8
ENSG00000273084	ENSG00000273084	-2.63874127195123	0.00350303490136047	LPS_vs_Control	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000287335	ENSG00000287335	3.85404516586013	0.00351375232397413	LPS_vs_Control	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3
ENSG00000289614	ENSG00000289614	2.86364239777916	0.00361654724396118	LPS_vs_Control	NA	NA	NA	NA	NA	NBPF9
ENSG00000246263	UBR5-DT	-1.81858373690343	0.00362155278200273	LPS_vs_Control	HSALNG0067415	anti_sense	Q90	hsa-miR-8485	-	ODF1
ENSG00000215256	DHRS4-AS1	-1.1139937394296	0.00365986557043877	LPS_vs_Control	HSALNG0100084	integenic	Q50	hsa-miR-8089	-	NRL
ENSG00000242086	MUC20-OT1	-1.19635647542676	0.00366126322024734	LPS_vs_Control	HSALNG0031831	sense	Q50	hsa-miR-29a-3p,hsa-miR-30b-3p,hsa-miR-339-5p,hsa-miR-619-5p,hsa-miR-1301-3p,hsa-miR-762,hsa-miR-1237-5p,hsa-miR-3180-3p,hsa-miR-3187-5p,hsa-miR-3180,hsa-miR-4447,hsa-miR-4722-5p,hsa-miR-4755-3p,hsa-miR-6089,hsa-miR-6769a-3p	Protein measurement,-	MUC20
ENSG00000230185	HSDL2-AS1	3.98643275992448	0.00378167351592066	LPS_vs_Control	HSALNG0073771	anti_sense	Q75	hsa-miR-4279,hsa-miR-4741,hsa-miR-6089	Epstein-barr virus infection,Chronotype measurement,Fev/fec ratio; Response to bronchodilator,Hip bone mineral density; Hip bone size,-	PTBP3
ENSG00000246100	LINC00900	-1.1910777894151	0.00379898262537304	LPS_vs_Control	HSALNG0087365	integenic	Q75	hsa-miR-665,hsa-miR-4281,hsa-miR-1268b,hsa-miR-3960		CADM1
ENSG00000223745	CCDC18-AS1	-1.1733050358695	0.00389266099443439	LPS_vs_Control	HSALNG0005250	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4768-3p	Triglyceride measurement,Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes,Self reported educational attainment,Testosterone measurement,Mathematical ability,-	TMED5
ENSG00000291186	ENSG00000291186	-1.66348856173366	0.00394018431600222	LPS_vs_Control	NA	NA	NA	NA	NA	DEFB108B
ENSG00000261351	ENSG00000261351	-2.73007366895933	0.00409384055927237	LPS_vs_Control	HSALNG0106698	anti_sense,sense	Q75		-	SNAPC5
ENSG00000278112	ENSG00000278112	-4.74857182521963	0.00411140164561137	LPS_vs_Control	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p		RILPL1
ENSG00000253522	MIR3142HG	1.31090760973257	0.00414221829368199	LPS_vs_Control	HSALNG0046249	integenic	Not conserved			PTTG1
ENSG00000206344	HCG27	2.03487989578101	0.00417236182791329	LPS_vs_Control	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19
ENSG00000233461	ENSG00000233461	1.97280944996063	0.00419771902053014	LPS_vs_Control	HSALNG0011452	anti_sense,sense	Q90	hsa-miR-619-5p	Pantothenic acid mesurement,-	NA
ENSG00000253669	GASAL1	-2.74676887699787	0.00421108424899829	LPS_vs_Control	HSALNG0067472	anti_sense	Q50		Alkaline phosphatase measurement,Leukocyte count,Eosinophil count; Neutrophil count; Basophil count; Granulocyte count,Bmi-adjusted waist circumference,-	ATP6V1C1
ENSG00000259062	ACTN1-DT	3.85525997223019	0.00422425964444115	LPS_vs_Control	HSALNG0102131	anti_sense	Q75	hsa-miR-4726-3p	Mean platelet volume; Platelet count,Reticulocyte count,-	EXD2
ENSG00000103472	RRN3P2	-2.49687040235358	0.00423830207401021	LPS_vs_Control	HSALNG0110562	integenic	Not conserved			LAT
ENSG00000260917	ENSG00000260917	-1.21416684114497	0.00424932205526293	LPS_vs_Control	HSALNG0080703	integenic	Not conserved		-	VTI1A
ENSG00000287265	ENSG00000287265	2.06482812889048	0.00435159944675046	LPS_vs_Control	HSALNG0047279	integenic	Not conserved			EXOC2
ENSG00000223855	PDGFA-DT	2.53787246853511	0.00438785915900826	LPS_vs_Control	HSALNG0055544	anti_sense	Q90	hsa-miR-4508,hsa-miR-6789-3p	Balding measurement,Alopecia,-	DNAAF5
ENSG00000271830	ENSG00000271830	4.57247055595441	0.00450501115504489	LPS_vs_Control	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA
ENSG00000188185	LINC00265	-1.63070199175222	0.00455508614898758	LPS_vs_Control	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA
ENSG00000283265	ENSG00000283265	5.27594994470998	0.00459420982928524	LPS_vs_Control	HSALNG0053773	integenic	Q50	hsa-miR-3665	Hodgkins lymphoma,C-reactive protein measurement; Inflammatory bowel disease; Ulcerative colitis; Systemic lupus erythematosus; Primary biliary cirrhosis; Rheumatoid arthritis,Rheumatoid arthritis,Diffuse plaque measurement,Rheumatoid arthritis; Inflammatory bowel disease; Celiac disease,Oral ulcer; Tonsillectomy risk measurement; Celiac disease; Autoimmune disease; Rheumatoid arthritis,C-reactive protein measurement,Empathy measurement,Psoriasis,Breast milk measurement,Leukocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,-	TNFAIP3
ENSG00000258867	HISLA	-2.17211844501997	0.00459930231612143	LPS_vs_Control	HSALNG0103023	integenic	Q50	hsa-miR-211-3p,hsa-miR-6763-5p,hsa-miR-6867-3p	Takayasu arteritis,Susceptibility to hepatitis b infection measurement,Congenital left-sided heart lesions,Serum igg measurement; Response to dietary antigen,Response to nitrofurantoin; Drug-induced liver injury,Bipolar disorder,-	GPR65
ENSG00000258634	ENSG00000258634	-1.20133538883566	0.00460797081198711	LPS_vs_Control	HSALNG0005948	anti_sense,sense	Q90		Cortical surface area measurement,-	STRIP1
ENSG00000234261	ENSG00000234261	3.01663844477531	0.00465322323264957	LPS_vs_Control	HSALNG0048264	integenic	Not conserved		Total blood protein measurement,Mean corpuscular hemoglobin,Mean corpuscular volume,Mean reticulocyte volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Mean reticulocyte volume; Erythrocyte count,Erythrocyte count,Red blood cell density measurement,Nucleus accumbens volume,Protein measurement,-	DTNBP1
ENSG00000255240	ENSG00000255240	-2.94005847164008	0.00490243903970182	LPS_vs_Control	HSALNG0084381	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-8485	Body height,Mathematical ability,Sex hormone-binding globulin measurement,-	GLYATL2
ENSG00000236591	UST-AS2	4.25142238238517	0.00491886658783192	LPS_vs_Control	HSALNG0054229	anti_sense	Not conserved	hsa-miR-4284,hsa-miR-4292,hsa-miR-8485		ZC3H12D
ENSG00000275719	ENSG00000275719	-4.1882853789286	0.00515031182606156	LPS_vs_Control	HSALNG0126719	anti_sense	Not conserved		-	FKRP
ENSG00000272341	ENSG00000272341	-2.17322826288048	0.00518765956612463	LPS_vs_Control	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1
ENSG00000289145	ENSG00000289145	-1.92401175734133	0.00521804804111477	LPS_vs_Control	NA	NA	NA	NA	NA	ZDHHC2
ENSG00000225434	LINC01504	-1.55687116208779	0.00524057408548399	LPS_vs_Control	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA
ENSG00000272462	LINC02980	-1.63928324660114	0.00526549969991344	LPS_vs_Control	HSALNG0048722	anti_sense,sense	Not conserved	hsa-miR-383-3p,hsa-miR-3178,hsa-miR-6089	Iron biomarker measurement,Glomerular filtration rate; Lung carcinoma; Upper aerodigestive tract neoplasm,Calcium measurement,Mean corpuscular volume,High density lipoprotein cholesterol measurement; Alcohol consumption measurement; Alcohol drinking,Bmi-adjusted hip circumference,Mean corpuscular hemoglobin concentration,Intelligence,Venous thromboembolism,Liver iron measurement,Glomerular filtration rate,Mean reticulocyte volume,Red blood cell distribution width; Hemoglobin a1 measurement; Mean corpuscular hemoglobin; Hematocrit; Hemoglobin measurement; Liver iron measurement; Mean corpuscular volume,Hemoglobin measurement; Red blood cell distribution width,Serum hepcidin measurement; Transferrin measurement; Ferritin measurement; Erythrocyte count; Osteoarthritis, hip; Serum alanine aminotransferase measurement; Bilirubin measurement; Iron biomarker measurement; Total cholesterol measurement; Platelet count; Mean corpuscular volume; Total iron binding capacity; Mean corpuscular hemoglobin; Hepcidin:ferritin ratio; Alcohol drinking; Hba1c measurement; Liver disease biomarker; Serum iron measurement; Reticulocyte count; Hemoglobin measurement; Reticulocyte measurement; Aspartate aminotransferase measurement; Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Low density lipoprotein cholesterol measurement; Hematocrit; Transferrin saturation measurement; Liver fat measurement,Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Mean corpuscular hemoglobin; Mean arterial pressure; Hematocrit; Hemoglobin measurement; Mean corpuscular volume; Erythrocyte count,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Neutrophil count; Bmi-adjusted hip circumference; Monocyte count,Serum alanine aminotransferase measurement; Osteoarthritis, hip; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Platelet count; Reticulocyte count; Hematocrit; Reticulocyte measurement; Physical activity,Heel bone mineral density,Autism spectrum disorder,Hemoglobin measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin concentration; Mean arterial pressure; Hba1c measurement; Hemoglobin measurement; Mean corpuscular volume,C-reactive protein measurement; Diuretic use measurement; Platelet component distribution width; Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Reticulocyte measurement; Red blood cell distribution width; Mean corpuscular hemoglobin; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Hematocrit; Reticulocyte count; Hemoglobin measurement; Liver iron measurement; Mean corpuscular volume; Alcohol consumption measurement; Urate measurement,Refractive error,Bmi-adjusted waist circumference,Wellbeing measurement,Bmi-adjusted waist-hip ratio,Mean corpuscular volume; Platelet crit,Body height,Erythrocyte count,Protein measurement; Bilirubin measurement,Bmi-adjusted waist circumference; Skin and soft tissue staphylococcus aureus infection; Osteoarthritis, hip; Hemoglobin measurement,Unipolar depression,Reticulocyte count; Platelet crit; Platelet count; Erythrocyte count,Brain volume measurement,Pulse pressure measurement; Squamous cell lung carcinoma; Lung carcinoma; Upper aerodigestive tract neoplasm,Cocaine dependence; Triglyceride measurement,Risk-taking behaviour,Neuroticism measurement,Red blood cell distribution width,Intelligence; Prostate carcinoma,Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,Neutrophil count; Smoking status measurement; Susceptibility to childhood ear infection measurement; Monocyte count,Bmi-adjusted hip circumference; Parental longevity; Body mass index,Self reported educational attainment; Lifestyle measurement; Bmi-adjusted waist circumference; Testosterone measurement; Brain volume measurement; Bmi-adjusted hip circumference,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Body fat percentage,Diet measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement; Breast carcinoma,Lymphocyte count; Neutrophil count; Mathematical ability,Unipolar depression; Anti-varicella zoster virus igg measurement,Bmi-adjusted waist circumference; Birth weight; Bmi-adjusted hip circumference; Urate measurement,Parental longevity,Cigarettes per day measurement; Body height,Bmi-adjusted hip circumference; Body weight,Hip circumference; Bmi-adjusted waist circumference; Waist circumference; Physical activity measurement; Bmi-adjusted hip circumference; Body height; Diet measurement; Parental longevity,Gout,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body height; Diet measurement,Intelligence; Guilt measurement,Mosquito bite reaction size measurement,Platelet-to-lymphocyte ratio,Body height; Physical activity measurement,Body fat distribution,Interleukin 10 measurement,Linoleic acid measurement,Immunosuppressant use measurement,Bmi-adjusted hip circumference; Smoking behaviour measurement,Parental genotype effect measurement; Birth weight,Total iron binding capacity,Transferrin saturation measurement; Serum iron measurement,Ferritin measurement,Worry measurement,Varicose veins; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking behavior; Platelet-to-lymphocyte ratio,Bipolar i disorder,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Mean arterial pressure; Alcohol drinking,Heel bone mineral density; Eczema; Allergic rhinitis,-,Anxiety,Serum iga measurement,Mean corpuscular hemoglobin,Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Hypertension; Mean corpuscular hemoglobin; Transferrin saturation measurement; Systolic blood pressure; Mean arterial pressure; Hba1c measurement; Ferritin measurement; Hematocrit; Platelet count; Smoking status measurement; Serum iron measurement; Reticulocyte count; Hemoglobin measurement; Agents acting on the renin-angiotensin system use measurement; Reticulocyte measurement,Intelligence; Depressive symptom measurement; Systolic blood pressure; Wellbeing measurement; Cognitive function measurement; Neuroticism measurement; Risky sexual behaviour measurement,Monocyte percentage of leukocytes	TRIM38
ENSG00000279277	ENSG00000279277	1.69564676112317	0.00528388321772001	LPS_vs_Control	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47
ENSG00000265666	RARA-AS1	-2.56914088576364	0.00537991890711615	LPS_vs_Control	HSALNG0116345	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-6809-3p,hsa-miR-6861-3p	-	GJD3
ENSG00000243960	ENSG00000243960	-3.82831836641007	0.00555570164087161	LPS_vs_Control	HSALNG0006050	sense	Q90	hsa-miR-3620-5p	-	WDR77
ENSG00000226816	ENSG00000226816	-2.74100335452122	0.00558759142964694	LPS_vs_Control	HSALNG0056646	integenic	Not conserved			NUP42
ENSG00000285761	ENSG00000285761	2.81260649646756	0.00559776567510998	LPS_vs_Control	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F
ENSG00000289507	ENSG00000289507	-3.09232444536548	0.00561787823961144	LPS_vs_Control	NA	NA	NA	NA	NA	KLHL18
ENSG00000267009	ENSG00000267009	-2.76531519868963	0.00575127099996054	LPS_vs_Control	HSALNG0118368	anti_sense,sense	Q90		Glomerular filtration rate; Creatinine measurement; Alkaline phosphatase measurement,Glomerular filtration rate,Unipolar depression,Reticulocyte measurement,Red blood cell distribution width,Mean corpuscular hemoglobin,Vitamin d measurement,Glucose measurement,Mean corpuscular hemoglobin concentration,Bilirubin measurement,Creatinine measurement,High density lipoprotein cholesterol measurement,Alkaline phosphatase measurement,Reticulocyte count; Vitamin d measurement; Reticulocyte measurement,Reticulocyte count,Reticulocyte count; Reticulocyte measurement,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Coronary artery disease,Sugar consumption measurement,Comparative body size at age 10, self-reported,-,Mean corpuscular hemoglobin concentration; Red blood cell distribution width	PRKAR1A
ENSG00000227398	KIF9-AS1	-2.0108263925882	0.00575967699913844	LPS_vs_Control	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485		KLHL18
ENSG00000248476	BACH1-IT1	2.10196227676386	0.00580612375596607	LPS_vs_Control	HSALNG0132543	sense	Q75		Red blood cell distribution width	BACH1
ENSG00000227502	MROCKI	1.50093855958252	0.00580612375596607	LPS_vs_Control	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505		HDAC2
ENSG00000286375	ENSG00000286375	4.13458375261611	0.00593779846097527	LPS_vs_Control	HSALNG0073114	anti_sense	Q50		Response to bisphosphonate; Atypical femoral fracture,Abnormality of refraction,-	TSTD2
ENSG00000261526	ENSG00000261526	-1.7445360138401	0.00594712893777026	LPS_vs_Control	HSALNG0123094	integenic	Not conserved			ABHD17A
ENSG00000272582	ENSG00000272582	2.59753876970888	0.00600587099362168	LPS_vs_Control	HSALNG0135368	anti_sense	Q75		-	POLR2F
ENSG00000278464	ENSG00000278464	4.46639324808657	0.00601128494931721	LPS_vs_Control	HSALNG0120842	anti_sense	Q90	hsa-miR-4271,hsa-miR-4463,hsa-miR-6089,hsa-miR-6132,hsa-miR-6763-5p	-	ZSCAN30
ENSG00000286977	ENSG00000286977	-2.73707793064065	0.00609542103547569	LPS_vs_Control	HSALNG0138195	integenic	Not conserved	hsa-miR-4710		FAAH2
ENSG00000237036	ZEB1-AS1	-4.34343880078766	0.0062758947226136	LPS_vs_Control	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438
ENSG00000262370	ENSG00000262370	-1.21804566412284	0.00629046042239511	LPS_vs_Control	HSALNG0109115	anti_sense	Not conserved	hsa-miR-4329	Body height,-	ZSCAN10
ENSG00000290548	ENSG00000290548	-3.06924905992819	0.00633539819810129	LPS_vs_Control	HSALNG0041076	integenic	Not conserved			C1QTNF3-AMACR
ENSG00000273320	ENSG00000273320	2.38138649009042	0.00659522232886375	LPS_vs_Control	HSALNG0060372	anti_sense	Q75		-	CDHR3
ENSG00000236088	COX10-DT	-1.23724643296263	0.00667732332806469	LPS_vs_Control	HSALNG0114686	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6786-3p,hsa-miR-6871-5p,hsa-miR-8485	Age at onset,Conduct disorder,Serum igg glycosylation measurement,Systemic lupus erythematosus,Endometriosis,Adipic acid mesurement,Adolescent idiopathic scoliosis,Serum albumin measurement,Sex hormone-binding globulin measurement,Eyelid sagging measurement,Temperament and character inventory,Chronic obstructive pulmonary disease,Polychlorinated biphenyls measurement; Gestational serum measurement,Stressful life event measurement; Depressive symptom measurement,Childhood trauma measurement; Alcohol consumption measurement,Educational attainment,-	HS3ST3A1
ENSG00000290831	NSUN5P2	-2.8237669355531	0.00670080800528717	LPS_vs_Control	NA	NA	NA	NA	NA	TRIM74
ENSG00000284633	ENSG00000284633	2.56936040118955	0.00674685226221841	LPS_vs_Control	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1
ENSG00000248890	HHIP-AS1	3.84415348399106	0.00684772033029393	LPS_vs_Control	HSALNG0037609	anti_sense,sense	Q50	hsa-miR-4692,hsa-miR-6826-3p	Bmi-adjusted waist circumference; Body height; Physical activity measurement,Infant body height; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement; Body height; Smoking behavior,Body height; Birth weight,Body fat distribution,Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Femoral neck size; Hip bone size,Susceptibility to chronic sinus infection measurement,Mean corpuscular volume,Bmi-adjusted hip circumference,-	NA
ENSG00000206567	ENSG00000206567	-2.84668267329244	0.00692862720049755	LPS_vs_Control	HSALNG0024081	sense	Not conserved	hsa-miR-3620-5p,hsa-miR-3650,hsa-miR-4472,hsa-miR-4486,hsa-miR-4505,hsa-miR-1587,hsa-miR-4747-3p,hsa-miR-6089		EMC3
ENSG00000260257	ENSG00000260257	-1.13563374401665	0.00699933527553802	LPS_vs_Control	HSALNG0129600	integenic	Not conserved		Attention deficit hyperactivity disorder,-	EFCAB8
ENSG00000271216	LINC01050	2.18147084833521	0.00718317072494772	LPS_vs_Control	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1
ENSG00000253477	ENSG00000253477	4.37258655747793	0.0074165469653418	LPS_vs_Control	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA
ENSG00000255142	ENSG00000255142	-3.48981627880204	0.00752359458208652	LPS_vs_Control	HSALNG0082025	integenic	Q75	hsa-miR-4472		PANO1
ENSG00000230479	ENSG00000230479	-1.41736449781141	0.00753883360798252	LPS_vs_Control	HSALNG0132951	integenic	Not conserved			CHAF1B
ENSG00000289586	ENSG00000289586	-2.01994841526409	0.00768225120727864	LPS_vs_Control	HSALNG0035338	integenic	Q50			SOWAHB
ENSG00000231407	GORAB-AS1	3.06197725372113	0.00778665459904922	LPS_vs_Control	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3
ENSG00000291203	ENSG00000291203	-1.30717977573328	0.00791650772052531	LPS_vs_Control	HSALNG0148177	anti_sense	Not conserved			USP53
ENSG00000223446	ENSG00000223446	3.68228860858003	0.00801713542029483	LPS_vs_Control	HSALNG0072817	integenic	Q50	hsa-miR-326,hsa-miR-619-5p,hsa-miR-4507,hsa-miR-5585-3p,hsa-miR-6132,hsa-miR-6764-5p,hsa-miR-6799-5p,hsa-miR-7112-5p	Body height,Adolescent idiopathic scoliosis	NINJ1
ENSG00000203739	PRDX6-AS1	-2.24445009232573	0.00802988551727811	LPS_vs_Control	HSALNG0008523	anti_sense	Q50		-	SLC9C2
ENSG00000225377	NRSN2-AS1	1.34216618682684	0.00803827923175266	LPS_vs_Control	HSALNG0128021	integenic	Not conserved			C20orf96
ENSG00000289061	ENSG00000289061	3.0215911019607	0.00808551302083055	LPS_vs_Control	NA	NA	NA	NA	NA	LPIN2
ENSG00000260306	ENSG00000260306	-2.11546202976665	0.00810416913623097	LPS_vs_Control	HSALNG0110138	integenic	Not conserved		-	NPIPB4
ENSG00000290720	ZNF542P	-1.20278680226211	0.00817098719497148	LPS_vs_Control	HSALNG0127752	anti_sense	Not conserved	hsa-miR-939-3p		ZNF583
ENSG00000227189	ENSG00000227189	-4.11915246358484	0.00817338994122052	LPS_vs_Control	NA	NA	NA	NA	NA	FGFRL1
ENSG00000287665	ENSG00000287665	2.11767079374242	0.00819519764105533	LPS_vs_Control	HSALNG0149593	sense	Not conserved			FOXK1
ENSG00000223692	DIP2A-IT1	-3.91881199841199	0.00824503642661224	LPS_vs_Control	HSALNG0133742	sense	Q50		S100 calcium-binding protein b measurement	DIP2A
ENSG00000288833	ENSG00000288833	1.99047628470018	0.00825795935606377	LPS_vs_Control	HSALNG0086779	integenic	Q90			TMEM123
ENSG00000291149	ENSG00000291149	2.53036717494928	0.00826684774078972	LPS_vs_Control	HSALNG0061972	anti_sense,sense	Not conserved	hsa-miR-6779-5p	-	CTAGE6
ENSG00000254231	WWP1-AS1	-2.7519574194704	0.00826963011087313	LPS_vs_Control	HSALNG0066736	anti_sense	Not conserved		Protein measurement,-	SLC7A13
ENSG00000273076	ENSG00000273076	2.98826657019874	0.00843412251382833	LPS_vs_Control	HSALNG0135443	anti_sense	Not conserved	hsa-miR-6779-5p		GTPBP1
ENSG00000263072	ZNF213-AS1	-1.21766447136143	0.00847729784276642	LPS_vs_Control	HSALNG0109122	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-513a-5p,hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-4508,hsa-miR-6089,hsa-miR-6769b-3p	Hydroxy-leucine measurement,Cognitive function measurement,-	ZSCAN10
ENSG00000258384	RCCD1-AS1	-4.27513075081069	0.00860834260880513	LPS_vs_Control	HSALNG0108180	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6836-5p	-	PRC1
ENSG00000229922	LINC02865	3.84200938413222	0.00863215474642669	LPS_vs_Control	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3
ENSG00000233705	SLC26A4-AS1	4.13439696776249	0.00868761495198326	LPS_vs_Control	HSALNG0060441	anti_sense	Q50	hsa-miR-4268,hsa-miR-4486,hsa-miR-5587-3p	3-hydroxy-1-methylpropylmercapturic acid measurement,-	COG5
ENSG00000289485	ENSG00000289485	3.85844691521698	0.0087215419526866	LPS_vs_Control	HSALNG0116006	anti_sense	Not conserved		C-c motif chemokine 3 measurement,Blood protein measurement,Clopidogrel metabolite measurement,Visual perception measurement,Protein measurement,Refractive error; Ccl4 measurement; Blood protein measurement; Age at onset; Myopia	TBC1D3B
ENSG00000230533	LINC03004	4.56986752335597	0.00883764529461915	LPS_vs_Control	HSALNG0053783	integenic	Q75	hsa-miR-619-5p		TNFAIP3
ENSG00000215244	LINC02649	1.59510251616385	0.0088408333232972	LPS_vs_Control	HSALNG0142500	integenic	Not conserved		Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3
ENSG00000204685	STARD7-AS1	-1.39682065326409	0.00901766678879288	LPS_vs_Control	HSALNG0017031	integenic	Not conserved	hsa-miR-676-3p		CIAO1
ENSG00000271631	ENSG00000271631	-2.94131122385804	0.0090446832316221	LPS_vs_Control	HSALNG0073796	intronic_antisense	Not conserved			SNX30
ENSG00000223511	LINC02968	2.80339552238507	0.00905007657583315	LPS_vs_Control	HSALNG0151032	integenic	Not conserved	hsa-miR-512-5p		ASMT
ENSG00000224699	LAMTOR5-AS1	-2.00265789819774	0.00906598175123682	LPS_vs_Control	HSALNG0005977	anti_sense	Q75		-	RBM15
ENSG00000286681	ENSG00000286681	-1.91301260308145	0.0091591152544233	LPS_vs_Control	HSALNG0069476	integenic	Not conserved			COMMD5
ENSG00000229931	ATXN1-AS1	-1.89305326591364	0.00919421347258705	LPS_vs_Control	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1
ENSG00000225032	ENSG00000225032	1.93071469991393	0.00927823206271159	LPS_vs_Control	HSALNG0074542	anti_sense	Q50	hsa-miR-6089	-	FPGS
ENSG00000271327	ENSG00000271327	-3.41611487497198	0.0092824977573894	LPS_vs_Control	HSALNG0092942	integenic	Not conserved			TMTC3
ENSG00000288663	ENSG00000288663	-1.89824706452455	0.0093465880693083	LPS_vs_Control	NA	NA	NA	NA	NA	MYG1
ENSG00000179406	LINC00174	-1.28982238261315	0.00943688600087767	LPS_vs_Control	HSALNG0058597	integenic	Not conserved			GUSB
ENSG00000289574	ENSG00000289574	2.17503882286504	0.00948398236565445	LPS_vs_Control	HSALNG0030964	sense	Q75	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	-	MFN1
ENSG00000257277	ENSG00000257277	3.32451178617182	0.00954616763825954	LPS_vs_Control	HSALNG0019322	anti_sense	Q50		Self reported educational attainment	GTDC1
ENSG00000233429	HOTAIRM1	-1.65564000267053	0.0096447642402299	LPS_vs_Control	HSALNG0056850	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-3960	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Tonsillectomy risk measurement,-	EVX1
ENSG00000284719	ENSG00000284719	-2.57622467394341	0.00975673920720616	LPS_vs_Control	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE
ENSG00000272205	POU2F1-DT	-2.99983003146573	0.00994476575796584	LPS_vs_Control	HSALNG0008218	integenic	Q50	hsa-miR-1237-5p		GPA33
ENSG00000272953	ENSG00000272953	-4.01860040851771	0.0100726655700194	LPS_vs_Control	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000236871	LINC00106	-1.77856186492848	0.0101899053115876	LPS_vs_Control	HSALNG0136360	integenic	Not conserved	hsa-miR-1227-5p,hsa-miR-3178,hsa-miR-6089,hsa-miR-6816-5p,hsa-miR-8485		IL3RA
ENSG00000206337	HCP5	-1.16664825213589	0.0103015224123995	LPS_vs_Control	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB
ENSG00000256751	PLBD1-AS1	-1.21954534001143	0.0103290126870167	LPS_vs_Control	HSALNG0089514	anti_sense	Q75	hsa-miR-7706	-	ATF7IP
ENSG00000290021	ENSG00000290021	1.7656994714901	0.0103632267324884	LPS_vs_Control	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6
ENSG00000230530	LIMD1-AS1	-2.09430483059064	0.0104767494277767	LPS_vs_Control	HSALNG0025628	anti_sense	Q50		-	SLC6A20
ENSG00000249740	OSMR-DT	3.8503973835506	0.0104849946771505	LPS_vs_Control	HSALNG0041294	anti_sense	Not conserved	hsa-miR-6873-3p	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Bmi-adjusted waist circumference,Reticulocyte count,Hemoglobin measurement,Colorectal adenoma,Retinal vasculature measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Response to selective serotonin reuptake inhibitor,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hematocrit,Erythrocyte count,Heart rate variability measurement; Response to antipsychotic drug,-	LIFR
ENSG00000272356	ENSG00000272356	-1.86681095756113	0.0105927798867675	LPS_vs_Control	HSALNG0149229	anti_sense,sense	Q90			MFSD4B
ENSG00000244041	LINC01011	-1.51280954560716	0.0106010958744401	LPS_vs_Control	HSALNG0047546	sense	Not conserved		Urinary metabolite measurement,Protein measurement,-	NQO2
ENSG00000272247	ENSG00000272247	-3.93931210993406	0.0106348563670804	LPS_vs_Control	HSALNG0030170	intronic_antisense	Not conserved		Periodontitis,-	RARRES1
ENSG00000227748	ENSG00000227748	4.75911856867108	0.0106794187288949	LPS_vs_Control	HSALNG0054151	integenic	Q50		-	ADGB
ENSG00000236453	ENSG00000236453	4.06097670367975	0.0108017130094076	LPS_vs_Control	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11
ENSG00000229873	OGFR-AS1	1.91660847826394	0.0108490543990147	LPS_vs_Control	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5
ENSG00000269019	HOMER3-AS1	-1.45423176137105	0.0109369082828351	LPS_vs_Control	HSALNG0124679	anti_sense	Q50			DDX49
ENSG00000260361	ENSG00000260361	2.25850964430658	0.0109764464752888	LPS_vs_Control	HSALNG0108254	sense	Q90	hsa-miR-6089		FAM174B
ENSG00000286118	ENSG00000286118	-4.03471552402261	0.0111092427370982	LPS_vs_Control	HSALNG0151085	anti_sense	Not conserved	hsa-miR-619-5p		FAM156B
ENSG00000247317	LY6E-DT	4.42456359772521	0.0111803616575285	LPS_vs_Control	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S
ENSG00000258376	PAPLN-AS1	-1.32320265817457	0.0112671198378369	LPS_vs_Control	HSALNG0102336	anti_sense	Not conserved		Red blood cell distribution width,Sapho syndrome,-	NUMB
ENSG00000269906	ENSG00000269906	2.28544824313956	0.011374166763954901	LPS_vs_Control	HSALNG0101196	sense	Q50			SAV1
ENSG00000269934	ENSG00000269934	-1.59849740231026	0.0115384957709254	LPS_vs_Control	HSALNG0011224	anti_sense	Not conserved		-	TRIM11
ENSG00000237372	ENSG00000237372	3.37881056380405	0.0116828669783269	LPS_vs_Control	HSALNG0072619	integenic	Not conserved			GADD45G
ENSG00000238197	PAXBP1-AS1	-1.29894806770394	0.0118487469109657	LPS_vs_Control	HSALNG0132711	anti_sense	Q90	hsa-miR-500b-3p	-	EVA1C
ENSG00000257964	ENSG00000257964	3.02724374665059	0.0120039230173022	LPS_vs_Control	HSALNG0090959	anti_sense	Q50			FAM186B
ENSG00000243701	DUBR	1.41356214176194	0.012038017210538	LPS_vs_Control	HSALNG0027862	integenic	Q50			CCDC54
ENSG00000233621	ZC3H12A-DT	1.3823968120178	0.0121427322371825	LPS_vs_Control	HSALNG0002623	integenic	Not conserved			MEAF6
ENSG00000224536	CSRP1-AS1	-2.76834466595161	0.0122067091939332	LPS_vs_Control	HSALNG0009660	integenic	Not conserved	hsa-miR-619-5p		NAV1
ENSG00000285448	ENSG00000285448	2.84043533216435	0.0122105438332587	LPS_vs_Control	HSALNG0098910	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4722-5p,hsa-miR-6089	Tyrosine measurement,-	GPR183
ENSG00000236901	MIR600HG	-1.99035514088317	0.01246798072296	LPS_vs_Control	HSALNG0074272	sense	Not conserved		-	STRBP
ENSG00000214783	POLR2J4	-2.11716666516652	0.0124713701279876	LPS_vs_Control	HSALNG0057608	anti_sense	Not conserved			URGCP
ENSG00000224066	ENSG00000224066	-2.19577867232287	0.0126333158662745	LPS_vs_Control	HSALNG0002297	anti_sense	Q75	hsa-miR-361-3p	-	TMEM234
ENSG00000245556	SCAMP1-AS1	1.06343361957215	0.0127013281451593	LPS_vs_Control	HSALNG0042878	integenic	Q50	hsa-miR-619-5p		AP3B1
ENSG00000227917	ENSG00000227917	3.84142027194623	0.0128027430228464	LPS_vs_Control	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4
ENSG00000291147	ENSG00000291147	-2.31843151287774	0.0128988736610636	LPS_vs_Control	HSALNG0146386	integenic	Not conserved	hsa-miR-4463	Vitamin b12 measurement	RTP5
ENSG00000260260	SNHG19	-1.67967574078457	0.0133226430037796	LPS_vs_Control	HSALNG0108990	anti_sense	Q50		-	PKD1
ENSG00000225329	LHFPL3-AS2	3.51671922631723	0.0136218172020852	LPS_vs_Control	HSALNG0060286	anti_sense	Q90			SRPK2
ENSG00000223923	TNS1-AS1	4.00561607615505	0.0136445444569054	LPS_vs_Control	HSALNG0022218	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-4265,hsa-miR-6873-3p	Cognitive decline measurement,-	RUFY4
ENSG00000254827	SLC22A18AS	-2.23197561010064	0.0136516685698541	LPS_vs_Control	NA	NA	NA	NA	NA	CDKN1C
ENSG00000261416	CORO1A-AS1	-1.83621278894577	0.0138274214871667	LPS_vs_Control	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B
ENSG00000250714	TNFRSF10A-DT	2.38974580972674	0.0140330573033637	LPS_vs_Control	HSALNG0063969	integenic	Not conserved	hsa-miR-619-5p	Wet macular degeneration; Atrophic macular degeneration; Central serous retinopathy; Tnf-related apoptosis-inducing ligand measurement; Age-related macular degeneration,Protein measurement	TNFRSF10A
ENSG00000274029	ENSG00000274029	1.79968818517242	0.0140523037892174	LPS_vs_Control	HSALNG0094571	integenic	Not conserved			P2RX7
ENSG00000290796	ENSG00000290796	-1.70014522914011	0.0140619414474429	LPS_vs_Control	HSALNG0134568	sense	Not conserved	hsa-miR-328-3p		LHFPL7
ENSG00000273356	LINC02019	-2.20416633398205	0.014134223921716	LPS_vs_Control	HSALNG0026057	integenic	Q90		-	DOCK3
ENSG00000267549	ZSCAN5A-AS1	-3.00656389732091	0.0141629468680899	LPS_vs_Control	HSALNG0127749	anti_sense	Not conserved		-	EDDM13
ENSG00000267278	MAP3K14-AS1	2.39070555594611	0.014310383528147	LPS_vs_Control	HSALNG0116845	anti_sense	Q50	hsa-miR-4316,hsa-miR-7160-3p	Atopic asthma,Protein measurement,Respiratory system disease,Leukocyte count; Myeloid white cell count,Lymphocyte count,Platelet crit,-	FMNL1
ENSG00000258183	LINC02392	4.08567984108055	0.0143153412751899	LPS_vs_Control	HSALNG0092974	integenic	Not conserved	hsa-miR-6756-5p,hsa-miR-6803-5p	Interleukin 2 receptor antagonist measurement,Heel bone mineral density,Family history of lung cancer; Lung adenocarcinoma,-	TMTC3
ENSG00000260293	ENSG00000260293	-2.34862581950514	0.0144974093876191	LPS_vs_Control	HSALNG0144648	sense	Q75			TBC1D24
ENSG00000287494	ENSG00000287494	-2.07636036220649	0.0145440488408548	LPS_vs_Control	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1
ENSG00000271380	ENSG00000271380	-1.96570132964287	0.014581378153418499	LPS_vs_Control	HSALNG0007446	anti_sense	Not conserved	hsa-miR-6754-5p	Inflammatory bowel disease,-	CKS1B
ENSG00000273145	ENSG00000273145	-2.45524634767398	0.014695208925094	LPS_vs_Control	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA
ENSG00000232648	ING2-DT	-1.97524075535601	0.0147129993139389	LPS_vs_Control	HSALNG0038941	integenic	Q50	hsa-miR-4492,hsa-miR-4508	-	RWDD4
ENSG00000253217	ENSG00000253217	3.85132421510995	0.0147791925256412	LPS_vs_Control	HSALNG0067281	anti_sense	Q75		Unipolar depression,Lymphocyte count,-	SPAG1
ENSG00000273729	ENSG00000273729	-1.50831347658836	0.0148230232569484	LPS_vs_Control	HSALNG0102621	anti_sense	Q50	hsa-miR-615-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4467,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-6795-3p,hsa-miR-6838-5p	Response to anticonvulsant,Smoking status measurement; Smoking behaviour measurement,Triglyceride measurement,Feeling nervous measurement,Sleep quality; Mathematical ability,C-reactive protein measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Fev/fec ratio; Systolic blood pressure,Serum alanine aminotransferase measurement,Body weight,Serum albumin measurement,Body mass index,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-,Body mass index; Aspartate aminotransferase measurement	CIPC
ENSG00000219665	ZNF433-AS1	-1.30198082366976	0.0148710126877832	LPS_vs_Control	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA
ENSG00000287883	ENSG00000287883	-2.41315864383653	0.0149338994998894	LPS_vs_Control	HSALNG0055491	anti_sense	Q50	hsa-miR-564,hsa-miR-619-5p,hsa-miR-4279,hsa-miR-4283,hsa-miR-4467,hsa-miR-4492,hsa-miR-6089,hsa-miR-7150	Heel bone mineral density,Non-word reading,Response to opioid,Glioma,-	PDGFA
ENSG00000280832	GSEC	2.00525539261251	0.0151743950668923	LPS_vs_Control	HSALNG0088026	anti_sense	Q50		Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3
ENSG00000285906	ENSG00000285906	1.16514853958649	0.0152684023238838	LPS_vs_Control	HSALNG0024144	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1233-5p,hsa-miR-1303,hsa-miR-4266,hsa-miR-6089	Bmi-adjusted hip circumference,Blood urea nitrogen measurement,Appendicular lean mass,Pulse pressure measurement; Diastolic blood pressure; Systolic blood pressure,Lean body mass; Bone measurement; Fat body mass	VGLL4
ENSG00000257354	MIRLET7IHG	1.08803326190635	0.0155161643698056	LPS_vs_Control	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2
ENSG00000236618	PITPNA-AS1	-2.17049135982795	0.015591703230227	LPS_vs_Control	HSALNG0113813	anti_sense	Q75	hsa-miR-3960,hsa-miR-4725-5p,hsa-miR-8072	-	WDR81
ENSG00000228109	MELTF-AS1	-2.15867095167154	0.0156489998934394	LPS_vs_Control	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2
ENSG00000283674	ENSG00000283674	-2.3450518116948	0.0157102136687263	LPS_vs_Control	HSALNG0063498	integenic	Not conserved	hsa-miR-1304-3p,hsa-miR-6803-5p	-	FAM86B2
ENSG00000261888	ENSG00000261888	-1.55539229168154	0.0157153600792138	LPS_vs_Control	HSALNG0145190	integenic	Not conserved		Hematocrit	METRNL
ENSG00000288908	ENSG00000288908	1.55852367604288	0.0157387740389591	LPS_vs_Control	HSALNG0137831	anti_sense	Q75			PQBP1
ENSG00000228544	CCDC183-AS1	-1.49094513649913	0.0158676588735161	LPS_vs_Control	HSALNG0075303	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-1587	-	LCN15
ENSG00000290858	ENSG00000290858	-3.79845741319542	0.0160092238635699	LPS_vs_Control	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM
ENSG00000273129	PACERR	1.86595727166505	0.0160266177681741	LPS_vs_Control	HSALNG0009103	integenic	Not conserved	hsa-miR-3960	-	PLA2G4A
ENSG00000233817	ENSG00000233817	3.70545614410319	0.0162785075943051	LPS_vs_Control	HSALNG0073854	integenic	Not conserved	hsa-miR-505-5p	Heel bone mineral density,Hair colour measurement,-	RGS3
ENSG00000237605	DYRK3-AS1	3.41192065689939	0.0163082944194852	LPS_vs_Control	HSALNG0010037	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-1224-3p,hsa-miR-4297,hsa-miR-4492,hsa-miR-4749-3p,hsa-miR-6763-5p	-	EIF2D
ENSG00000267064	UXT-AS1	1.30792860305614	0.0164981782175437	LPS_vs_Control	HSALNG0137730	anti_sense	Q75			TIMP1
ENSG00000267325	LINC01415	3.95981955946926	0.0167466534568326	LPS_vs_Control	HSALNG0121699	sense	Q50	hsa-miR-3960,hsa-miR-8072	Corneal hysteresis; Body mass index; Intraocular pressure measurement; Body height; Urinary albumin to creatinine ratio; Corneal resistance factor; Uric acid measurement; Urate measurement,Household income,Age at first sexual intercourse measurement,Social interaction measurement; Loneliness measurement,Grip strength measurement; Loneliness measurement,Leukocyte count; Household income; Feeling ""fed-up"" measurement; Mood instability measurement,Fuchs endothelial corneal dystrophy; Potassium measurement; Worry measurement; Urinary albumin to creatinine ratio; Sodium measurement; Gait measurement; Albuminuria,Wellbeing measurement; Sitting height ratio,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Irritability measurement,Risk-taking behaviour; Risky sexual behaviour measurement,Risky sexual behaviour measurement,Chronotype measurement,Heel bone mineral density,Waist-hip ratio,Mood disorder; Unipolar depression,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	TCF4
ENSG00000289121	ENSG00000289121	3.71497042079929	0.0168021574267061	LPS_vs_Control	HSALNG0007891	anti_sense	Q90		Monocyte percentage of leukocytes; Monocyte count,-	KLHDC9
ENSG00000291060	ENSG00000291060	1.52994027962461	0.017194232385594	LPS_vs_Control	HSALNG0110201	sense	Not conserved		-	NPIPB5
ENSG00000264895	ENSG00000264895	-4.27469601715859	0.0176252095527585	LPS_vs_Control	HSALNG0145324	intronic_sense	Not conserved			MBTD1
ENSG00000241163	LINC00877	1.21490327828831	0.017874520018317	LPS_vs_Control	HSALNG0026804	integenic	Not conserved		Protein measurement	RYBP
ENSG00000227017	ENSG00000227017	2.90985732931651	0.0179116549084523	LPS_vs_Control	HSALNG0056985	integenic	Q50		-	FKBP14
ENSG00000291286	ENSG00000291286	4.39321924770938	0.0179509921685132	LPS_vs_Control	HSALNG0055149	sense	Not conserved			CCR6
ENSG00000254054	ENSG00000254054	-4.27334373270735	0.0180672899466705	LPS_vs_Control	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p		PCM1
ENSG00000269473	ZNF132-DT	-3.6557321230776	0.0180748006413424	LPS_vs_Control	HSALNG0127971	integenic	Not conserved	hsa-miR-6837-5p	Platelet count,Platelet crit,-	ZNF324B
ENSG00000291207	ENSG00000291207	-1.13789023242525	0.0180900707323527	LPS_vs_Control	HSALNG0057744	integenic	Not conserved		-	CCDC201
ENSG00000244055	ENSG00000244055	-1.21480072426575	0.0181342924938008	LPS_vs_Control	HSALNG0149731	anti_sense	Not conserved		Body height	GATAD1
ENSG00000274292	ENSG00000274292	1.94084332721575	0.0184021902273	LPS_vs_Control	HSALNG0094607	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1287-5p,hsa-miR-4472	-	SETD1B
ENSG00000286153	ENSG00000286153	2.11726888481988	0.0185380797942825	LPS_vs_Control	HSALNG0132875	anti_sense	Not conserved		Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6
ENSG00000287382	ENSG00000287382	2.00232718103924	0.0185410581539533	LPS_vs_Control	HSALNG0034557	anti_sense	Q50	hsa-miR-6829-3p	-	NMU
ENSG00000235314	LINC00957	-1.73042425426052	0.0186424684964604	LPS_vs_Control	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL
ENSG00000286507	ENSG00000286507	-3.94823686836031	0.0186580751791429	LPS_vs_Control	HSALNG0056826	integenic	Q75	hsa-miR-6735-5p	Triiodothyronine measurement,Disease free survival; Overall survival,Erosive tooth wear measurement,Unipolar depression,-	SKAP2
ENSG00000213600	ENSG00000213600	-1.99476445872004	0.0186756294236038	LPS_vs_Control	HSALNG0026005	intronic_sense	Not conserved	hsa-miR-4508		GNAI2
ENSG00000287623	ENSG00000287623	3.20206092922839	0.0186959767920047	LPS_vs_Control	HSALNG0147456	anti_sense	Q75		Self reported educational attainment	THUMPD3
ENSG00000284977	ENSG00000284977	1.51163174509201	0.0190166910898987	LPS_vs_Control	HSALNG0074045	sense	Q50	hsa-miR-8485	Ischemic stroke,Pepsinogen i/ii ratio,Susceptibility to strep throat measurement,Low density lipoprotein cholesterol measurement,Body mass index,Response to antipsychotic drug,Behavioural disinhibition measurement,Self reported educational attainment,-	NA
ENSG00000203644	ENSG00000203644	-1.19584821298065	0.0190494545991441	LPS_vs_Control	HSALNG0147928	sense	Not conserved			TMCC1
ENSG00000224721	FLVCR2-AS1	3.68090570958293	0.019093472603978	LPS_vs_Control	HSALNG0102528	anti_sense	Not conserved			ERG28
ENSG00000251417	ENSG00000251417	-2.81649265768255	0.0192262658943081	LPS_vs_Control	HSALNG0144730	integenic	Not conserved	hsa-miR-1273h-5p	Intelligence; Physical activity measurement; Body mass index,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Hip circumference; Caudate nucleus volume,Handedness,Intelligence; Vital capacity,-	ATXN2L
ENSG00000236432	MFF-DT	-1.91911923419556	0.0192893698041852	LPS_vs_Control	HSALNG0022730	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-5699-3p,hsa-miR-6089	Refractive error,Abnormality of refraction,Glucose metabolism decline measurement,Diabetic nephropathy; Albuminuria,Central corneal thickness; Resting heart rate; Intraocular pressure measurement,Hematuria,Intraocular pressure measurement,Hematocrit,Mhpg measurement; 5-hiaa measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-,Central corneal thickness; Corneal topography,Hematocrit; Central corneal thickness,Erythrocyte count	TM4SF20
ENSG00000226091	LINC00937	2.26157448116207	0.0193370139708591	LPS_vs_Control	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1
ENSG00000272568	CPVL-AS2	3.51279186961188	0.0193449300715426	LPS_vs_Control	HSALNG0056940	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-6089	Lobe attachment,Response to irinotecan,Neuropsychological test,-	CHN2
ENSG00000249628	LINC00942	-2.52956085709584	0.019387281468616	LPS_vs_Control	HSALNG0088539	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-4673,hsa-miR-6803-5p		ERC1
ENSG00000203364	ENSG00000203364	3.79744550918085	0.0196309616754361	LPS_vs_Control	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19
ENSG00000177133	PRDM16-DT	2.98509601834247	0.0198961039982785	LPS_vs_Control	HSALNG0000303	anti_sense	Q50	hsa-miR-612,hsa-miR-1180-5p,hsa-miR-663b,hsa-miR-1207-3p,hsa-miR-4472,hsa-miR-3960,hsa-miR-4638-5p,hsa-miR-4710,hsa-miR-6787-5p,hsa-miR-6894-3p,hsa-miR-8072	Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Bmi-adjusted waist circumference,Platelet crit; Monocyte count,Platelet crit,Monocyte count,Myocardial infarction,-	TTC34
ENSG00000290091	ENSG00000290091	-2.5328807537919	0.0199768353855748	LPS_vs_Control	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4
ENSG00000247081	BAALC-AS1	3.70038644873733	0.0200765937166006	LPS_vs_Control	HSALNG0067506	integenic	Q50			SLC25A32
ENSG00000288851	ENSG00000288851	3.70522464888085	0.0209773298450627	LPS_vs_Control	HSALNG0048627	integenic	Q90	hsa-miR-4281,hsa-miR-4447,hsa-miR-4467,hsa-miR-4492		ACOT13
ENSG00000269951	ENSG00000269951	-2.27813487991087	0.020982403522531	LPS_vs_Control	HSALNG0107375	sense	Q75			TSPAN3
ENSG00000227896	WAPL-DT	-1.90724281707936	0.0211245585767688	LPS_vs_Control	HSALNG0079399	anti_sense	Q90	hsa-miR-4660,hsa-miR-4687-3p,hsa-miR-6089,hsa-miR-6779-5p	Parental longevity,-	OPN4
ENSG00000271856	LINC01215	2.67385198595357	0.0214114413133814	LPS_vs_Control	HSALNG0027888	integenic	Q50			HHLA2
ENSG00000260475	SLC25A28-DT	2.71842193316563	0.0214707413631968	LPS_vs_Control	HSALNG0080059	anti_sense	Q50	hsa-miR-10392-3p	Serum alanine aminotransferase measurement,Diverticular disease,-	ENTPD7
ENSG00000246363	LINC02458	2.68688234120522	0.0217647960509102	LPS_vs_Control	HSALNG0092935	integenic	Not conserved			DUSP6
ENSG00000291188	ENSG00000291188	-2.14765685185112	0.0218785274221268	LPS_vs_Control	HSALNG0110573	integenic	Not conserved			LAT
ENSG00000214870	LINC02981	-1.74474603686866	0.0219934104833765	LPS_vs_Control	HSALNG0056819	integenic	Not conserved			SNX10
ENSG00000289421	ENSG00000289421	-3.54466500970614	0.0222676664068309	LPS_vs_Control	HSALNG0147211	anti_sense	Not conserved		-	C21orf58
ENSG00000259895	TEDC2-AS1	-2.90690286107049	0.0222806404020349	LPS_vs_Control	HSALNG0109012	anti_sense	Q50	hsa-miR-6840-3p	-	CEMP1
ENSG00000226696	LENG8-AS1	-1.45383606832745	0.022299168514348	LPS_vs_Control	HSALNG0127531	anti_sense	Not conserved	hsa-miR-5007-5p	-	LENG9
ENSG00000241769	EOLA1-DT	-2.38777487726792	0.0224477193704031	LPS_vs_Control	HSALNG0140599	anti_sense,sense	Not conserved	hsa-miR-4257		NA
ENSG00000272338	ENSG00000272338	-3.69159585772598	0.0224898544383093	LPS_vs_Control	HSALNG0064463	integenic	Not conserved			FUT10
ENSG00000274833	ENSG00000274833	3.71400362626276	0.0225482772500455	LPS_vs_Control	HSALNG0119253	integenic	Q50	hsa-miR-1296-3p,hsa-miR-4508,hsa-miR-7106-5p	Dental caries; Bmi-adjusted hip circumference; Dentures	BAHCC1
ENSG00000291075	ENSG00000291075	-1.15854314208535	0.0226240843380218	LPS_vs_Control	HSALNG0071578	integenic	Not conserved			SPATA31A6
ENSG00000285410	GABPB1-IT1	-1.17908201556624	0.0226544668231161	LPS_vs_Control	HSALNG0105871	anti_sense,sense	Q90	hsa-miR-5585-3p	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,Mean reticulocyte volume,Mean arterial pressure,Systolic blood pressure; Heel bone mineral density,Leukocyte count,Hypertension,Electrocardiography,Granulocyte percentage of myeloid white cells,Intelligence,Eosinophil count,Lymphocyte count,Qt interval,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Lean body mass,Self reported educational attainment,Pulse pressure measurement,Serum alanine aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Pulse pressure measurement; Systolic blood pressure,Aspartate aminotransferase measurement,Coronary artery disease,Uric acid measurement,Urate measurement,Monocyte count,Chronic obstructive pulmonary disease,Hematocrit,Calcium measurement,Fibrinogen measurement,Late-onset alzheimers disease,Lymphocyte count; Myeloid white cell count; Leukocyte count; Calcium measurement; Monocyte count,Sex hormone-binding globulin measurement; Blood phosphate measurement; Serum gamma-glutamyl transferase measurement; Calcium measurement; High density lipoprotein cholesterol measurement,Estradiol measurement,Osteoarthritis, knee,Osteoarthritis, knee; Osteoarthritis, hip, osteoarthritis, knee,Monocyte percentage of leukocytes,-,Neutrophil count; Myeloid white cell count; Leukocyte count; Eosinophil count; Granulocyte count,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Blood protein measurement; Triglyceride measurement; Serum non-albumin protein measurement; Aspartate aminotransferase measurement,Ankylosing spondylitis; Aspartate aminotransferase to alanine aminotransferase ratio; Total cholesterol measurement,Household income	GABPB1
ENSG00000271646	IRF2-DT	1.48362613619541	0.0228115383747403	LPS_vs_Control	HSALNG0039019	integenic	Q75	hsa-miR-4466,hsa-miR-6749-3p	-	PRIMPOL
ENSG00000290994	FAM86C2P	-3.72757039646714	0.0228686448231306	LPS_vs_Control	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2
ENSG00000232973	CYP1B1-AS1	1.10849817611965	0.0229062747823248	LPS_vs_Control	HSALNG0014289	anti_sense	Q75	hsa-miR-4313,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6775-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6829-3p,hsa-miR-6872-3p	Suntan,Nevus count; Cutaneous melanoma,Cytokine measurement,Ischemic stroke; Coronary artery disease,Body height,Breast carcinoma,Non-melanoma skin carcinoma,Environmental tobacco smoke exposure measurement; Age at onset,Viral load; Hiv infection; Cd4-positive t-lymphocyte count; Disease progression measurement,-	RMDN2
ENSG00000271122	HERPUD2-AS1	-1.2069869836742	0.0229362203799178	LPS_vs_Control	HSALNG0057228	anti_sense	Q50		-	SEPTIN7
ENSG00000259004	LINC02285	-2.15844666476244	0.023126462908521	LPS_vs_Control	HSALNG0144163	integenic	Not conserved	hsa-miR-4313	Protein measurement	DLK1
ENSG00000234546	LNCTAM34A	-1.6803520714837	0.023141408165736	LPS_vs_Control	HSALNG0000685	integenic	Q50	hsa-miR-1249-5p,hsa-miR-6769b-5p,hsa-miR-7113-3p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Lean body mass	H6PD
ENSG00000214894	LINC00243	3.49916147615669	0.0231480234419385	LPS_vs_Control	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3
ENSG00000261488	TBILA	3.51207364066557	0.0238206935810074	LPS_vs_Control	HSALNG0028028	integenic	Not conserved			C3orf52
ENSG00000272768	ENSG00000272768	1.42978297079795	0.0239075170372683	LPS_vs_Control	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA
ENSG00000288559	ENSG00000288559	-1.60176205859492	0.0240614460711813	LPS_vs_Control	HSALNG0142811	integenic	Not conserved	hsa-miR-4481		DNAJC9
ENSG00000288742	ENSG00000288742	-1.77621677291691	0.0242747141274847	LPS_vs_Control	HSALNG0127521	integenic	Not conserved			LAIR1
ENSG00000235843	ENSG00000235843	3.7210771476317	0.0244295185987338	LPS_vs_Control	HSALNG0076814	sense	Not conserved			PDSS1
ENSG00000233178	ENSG00000233178	-2.90748769605249	0.0246890297517642	LPS_vs_Control	HSALNG0071684	anti_sense	Q90		-	TMEM252
ENSG00000270175	ENSG00000270175	-2.22399471191355	0.0255890333343733	LPS_vs_Control	HSALNG0091285	anti_sense	Q75		-	MAP3K12
ENSG00000233806	LINC01237	2.66000170769143	0.025611873112422	LPS_vs_Control	HSALNG0023737	anti_sense	Not conserved	hsa-miR-891a-3p,hsa-miR-937-5p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6085,hsa-miR-6748-3p,hsa-miR-6792-3p,hsa-miR-6883-5p,hsa-miR-6889-3p,hsa-miR-7108-5p	Caudal anterior cingulate cortex volume measurement,Brain aneurysm,Eczema,Ovarian carcinoma,High density lipoprotein cholesterol measurement,Age at onset; Refractive error; Myopia,-	RTP5
ENSG00000255310	ENSG00000255310	-1.82612032513339	0.0257390908586729	LPS_vs_Control	HSALNG0063412	sense	Q50	hsa-miR-370-3p	-	XKR6
ENSG00000291263	SMG1P7	-2.10136608006466	0.0258952694428393	LPS_vs_Control	NA	NA	NA	NA	NA	EXOSC6
ENSG00000273175	ENSG00000273175	2.47330715490711	0.0262038075083382	LPS_vs_Control	HSALNG0012114	integenic	Not conserved			COX20
ENSG00000291135	FCGR1BP	-1.45088539979978	0.0267742605004019	LPS_vs_Control	NA	NA	NA	NA	NA	SRGAP2C
ENSG00000272990	ENSG00000272990	-2.72123678963122	0.0271841726331934	LPS_vs_Control	HSALNG0030055	anti_sense	Q75		-	SSR3
ENSG00000276900	ENSG00000276900	-2.14600482809341	0.0273685463800851	LPS_vs_Control	HSALNG0143376	anti_sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	ETFBKMT
ENSG00000203395	ENSG00000203395	3.14225547888711	0.0273846613734484	LPS_vs_Control	HSALNG0015689	anti_sense	Q50	hsa-miR-1268b		CNRIP1
ENSG00000279873	LINC01126	-3.66642484476183	0.0273940669753504	LPS_vs_Control	HSALNG0014530	anti_sense	Q75	hsa-miR-663a,hsa-miR-4685-3p,hsa-miR-4749-3p,hsa-miR-6819-3p,hsa-miR-8485,hsa-miR-10392-3p	Neutrophil count; Intraocular pressure measurement; Creatinine measurement; Appendicular lean mass; Bmi-adjusted waist-hip ratio; Reticulocyte measurement,Bmi-adjusted waist-hip ratio; Myocardial infarction,-	PLEKHH2
ENSG00000227531	ENSG00000227531	4.12444990716274	0.0275348410050033	LPS_vs_Control	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2
ENSG00000245552	LNCRNA-IUR	1.6866646395369	0.0276680242345248	LPS_vs_Control	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1
ENSG00000259768	ZFHX3-AS1	-1.31967444136193	0.0277811154941082	LPS_vs_Control	HSALNG0112595	anti_sense	Not conserved			DHX38
ENSG00000289038	ENSG00000289038	2.78431620107036	0.0279234407444334	LPS_vs_Control	HSALNG0138354	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3960		OPHN1
ENSG00000250988	SNHG21	-3.53683010152651	0.0280935008273156	LPS_vs_Control	HSALNG0107711	anti_sense	Q75	hsa-miR-1268b,hsa-miR-6089	Bmi-adjusted hip circumference,-	WHAMM
ENSG00000205300	ENSG00000205300	2.63903935719065	0.0282916703259398	LPS_vs_Control	HSALNG0128297	integenic	Q50	hsa-miR-6769b-5p	Vital capacity,Platelet-derived growth factor bb measurement,-	RNF24
ENSG00000232677	LINC00665	-2.02448063003561	0.0286404485486719	LPS_vs_Control	HSALNG0125745	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1233-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6089,hsa-miR-6090,hsa-miR-6795-5p,hsa-miR-6813-5p	Monocyte count	ZFP14
ENSG00000269826	ENSG00000269826	3.72473464816183	0.0287471781414615	LPS_vs_Control	HSALNG0113288	integenic	Q75		Response to statin,-	FOXF1
ENSG00000256973	ENSG00000256973	-1.84866053375921	0.029077740034686	LPS_vs_Control	HSALNG0143593	sense	Q75			C2CD5
ENSG00000288596	C8orf44	-1.15156418980502	0.0293168961652871	LPS_vs_Control	HSALNG0065908	sense	Not conserved			C8orf44-SGK3
ENSG00000227082	LINC02798	1.8063541893121	0.029376706591347	LPS_vs_Control	HSALNG0006555	integenic	Not conserved	hsa-miR-548c-5p,hsa-miR-548d-5p,hsa-miR-548w,hsa-miR-548o-5p,hsa-miR-548ad-5p,hsa-miR-548ae-5p,hsa-miR-548ak,hsa-miR-548am-5p,hsa-miR-548ar-5p,hsa-miR-548au-5p,hsa-miR-548ay-5p		SRGAP2C
ENSG00000286940	MICB-DT	1.36067095555281	0.0294634017806097	LPS_vs_Control	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B
ENSG00000291178	ENSG00000291178	-1.13568447003092	0.0294746765736035	LPS_vs_Control	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimerâ€™s disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1
ENSG00000277007	ENSG00000277007	-3.41130439832218	0.0296179143062031	LPS_vs_Control	HSALNG0010635	sense	Q75		Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1
ENSG00000289135	ENSG00000289135	-2.27787021415889	0.0298986974535421	LPS_vs_Control	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23
ENSG00000231672	DIRC3	1.53026595032997	0.0300432831740277	LPS_vs_Control	HSALNG0022200	integenic	Not conserved			TNS1
ENSG00000289372	ENSG00000289372	3.49028646308708	0.030064483442539	LPS_vs_Control	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC
ENSG00000272335	ENSG00000272335	-1.40254390903632	0.0302443697358852	LPS_vs_Control	HSALNG0041565	integenic	Not conserved		-	MRPS30
ENSG00000258810	ENSG00000258810	-1.66818224696328	0.0304559255497826	LPS_vs_Control	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p		RNASE6
ENSG00000227036	LINC00511	2.07849387506164	0.0305077606897787	LPS_vs_Control	HSALNG0118552	integenic	Not conserved	hsa-miR-4800-3p		SLC39A11
ENSG00000268205	ENSG00000268205	1.16826144564716	0.0306434005510502	LPS_vs_Control	HSALNG0127823	integenic	Not conserved			ZNF460
ENSG00000258791	LINC00520	2.14332111351253	0.030998817766301	LPS_vs_Control	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2
ENSG00000224478	ENSG00000224478	3.86653878036409	0.031218463366382	LPS_vs_Control	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1
ENSG00000233922	LINC01694	-2.28222463352483	0.0312606540163237	LPS_vs_Control	HSALNG0133661	integenic	Q75	hsa-miR-6763-5p	Covid-19,Myopia,Self reported educational attainment,-	PCBP3
ENSG00000260911	ENSG00000260911	-1.765344770297	0.0312953771815147	LPS_vs_Control	HSALNG0110810	integenic	Not conserved			STX4
ENSG00000223653	BCL10-AS1	1.54550895685134	0.0315827997860025	LPS_vs_Control	HSALNG0004865	anti_sense	Q50		Protein measurement	CCN1
ENSG00000229331	GK-IT1	2.33656405621028	0.031791870090771	LPS_vs_Control	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p		GK
ENSG00000224616	RTCA-AS1	-1.55849647195193	0.0318077212703813	LPS_vs_Control	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT
ENSG00000261189	DSP-AS1	3.51317967158471	0.0324490209582483	LPS_vs_Control	HSALNG0047891	anti_sense	Q90	hsa-miR-6508-3p,hsa-miR-6769b-5p	-	CAGE1
ENSG00000235652	EPM2A-DT	-1.40296958648616	0.0332577234172646	LPS_vs_Control	HSALNG0054132	anti_sense	Not conserved	hsa-miR-6089	Heel bone mineral density	GRM1
ENSG00000273262	ENSG00000273262	-3.61565375512795	0.0336310132118557	LPS_vs_Control	HSALNG0080298	anti_sense	Q75	hsa-miR-4292	-	MFSD13A
ENSG00000213994	ENSG00000213994	3.31769283246009	0.0336403011885911	LPS_vs_Control	HSALNG0075928	anti_sense	Not conserved	hsa-miR-4279,hsa-miR-6860	Interleukin 2 receptor antagonist measurement,Cumulative dose response to bevacizumab,-	IL2RA
ENSG00000234694	CDC20-DT	-3.95131718007689	0.0338273360158607	LPS_vs_Control	HSALNG0003089	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-6798-5p,hsa-miR-6845-5p,hsa-miR-10392-3p	Platelet count,-	ELOVL1
ENSG00000266947	ENSG00000266947	1.73749603610071	0.0338454560846623	LPS_vs_Control	HSALNG0115929	integenic	Not conserved	hsa-miR-619-5p	-	SLC35G3
ENSG00000261123	ENSG00000261123	-2.71732704043619	0.0340372528467104	LPS_vs_Control	HSALNG0108978	sense	Not conserved	hsa-miR-4270,hsa-miR-4519,hsa-miR-7155-5p	Heel bone mineral density,Grip strength measurement,Unipolar depression,Myeloid white cell count; Monocyte count,-	PKD1
ENSG00000291171	ENSG00000291171	-1.06380843697348	0.034190416322865	LPS_vs_Control	NA	NA	NA	NA	NA	EP400
ENSG00000267058	ENSG00000267058	-3.66516607072396	0.0342033896936029	LPS_vs_Control	HSALNG0126395	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4515,hsa-miR-8485	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,-	ZNF404
ENSG00000287932	ENSG00000287932	-3.38401586829739	0.0343030463876662	LPS_vs_Control	HSALNG0059552	sense	Q75		-	CDK6
ENSG00000196668	LINC00173	3.54699753504572	0.0343802570794769	LPS_vs_Control	HSALNG0094327	integenic	Q75	hsa-miR-4297,hsa-miR-7109-5p	-	MAP1LC3B2
ENSG00000262061	RPH3AL-AS1	1.75852384667028	0.0344117145000772	LPS_vs_Control	HSALNG0113717	anti_sense	Q75	hsa-miR-631,hsa-miR-632,hsa-miR-1226-3p,hsa-miR-4516		C17orf97
ENSG00000260517	ENSG00000260517	-2.25618630850196	0.0345150475990349	LPS_vs_Control	HSALNG0110566	integenic	Not conserved		Lymphocyte count,-	LAT
ENSG00000255946	ENSG00000255946	-3.41116219993269	0.0346415703137409	LPS_vs_Control	HSALNG0094544	integenic	Not conserved		Serum metabolite measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,Serum metabolite measurement; Smoking behavior,Reticulocyte count; Serum metabolite measurement; Reticulocyte measurement,Total blood protein measurement,Leukocyte count,Myeloid white cell count,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome	SPPL3
ENSG00000260454	LINC02957	4.13627521174964	0.03476049153659	LPS_vs_Control	HSALNG0072697	integenic	Not conserved	hsa-miR-619-5p		SYK
ENSG00000233885	YEATS2-AS1	-3.7002206987412	0.0348083245376658	LPS_vs_Control	HSALNG0031185	anti_sense	Q50		-	NA
ENSG00000224950	ENSG00000224950	-1.09763810400628	0.0348515020101956	LPS_vs_Control	HSALNG0006329	sense	Q50	hsa-miR-619-5p,hsa-miR-670-5p,hsa-miR-920,hsa-miR-3160-5p,hsa-miR-4286,hsa-miR-4447,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6776-5p	Covid-19,Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Primary biliary cirrhosis,Response to sulfasalazine; Drug-induced agranulocytosis,Stressful life event measurement; Depressive symptom measurement,-	CD58
ENSG00000232940	HCG25	-1.62726246403299	0.035043616214893	LPS_vs_Control	HSALNG0049506	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7113-3p	-	RPS18
ENSG00000268573	ENSG00000268573	-1.29472214879214	0.035565539041959	LPS_vs_Control	NA	NA	NA	NA	NA	ZSCAN30
ENSG00000279342	ENSG00000279342	-1.32853846747559	0.035565539041959	LPS_vs_Control	HSALNG0087913	sense	Q50			MSANTD2
ENSG00000258768	ENSG00000258768	-2.51820319556777	0.0357450398562127	LPS_vs_Control	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5
ENSG00000288818	ENSG00000288818	2.11677647710645	0.036697389458621	LPS_vs_Control	HSALNG0065278	anti_sense	Q50		Leptin measurement,Mitochondrial dna measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Quality of life during menstruation measurement; Dysmenorrheic pain measurement,-	NPBWR1
ENSG00000289390	ENSG00000289390	2.70392144763828	0.036969177257285	LPS_vs_Control	HSALNG0047002	integenic	Not conserved	hsa-miR-5010-5p,hsa-miR-6798-5p		PHYKPL
ENSG00000276278	ENSG00000276278	-1.98038597058948	0.037156736188801	LPS_vs_Control	HSALNG0107800	anti_sense	Q50		-	WDR73
ENSG00000272692	ENSG00000272692	-3.51411087202728	0.0372219658415725	LPS_vs_Control	HSALNG0078964	integenic	Q50	hsa-miR-30b-3p,hsa-miR-1228-5p,hsa-miR-4447	-	LRMDA
ENSG00000263069	RNF213-AS1	-2.15484815788486	0.0374860874125643	LPS_vs_Control	HSALNG0119191	anti_sense	Q50		-	NPTX1
ENSG00000227477	STK4-DT	-3.77915946279246	0.0375284694922978	LPS_vs_Control	HSALNG0130354	anti_sense	Q50		Mean platelet volume,-	TOMM34
ENSG00000245904	BTG1-DT	1.65126989015785	0.0375557769538454	LPS_vs_Control	HSALNG0143464	integenic	Not conserved	hsa-miR-7703	Eosinophil count; Eosinophil percentage of leukocytes,Covid-19,-	PLEKHG7
ENSG00000287463	ENSG00000287463	-4.02118711411717	0.0377476641361438	LPS_vs_Control	HSALNG0019032	anti_sense	Not conserved	hsa-miR-4270,hsa-miR-4290	Gut microbiome measurement,-	ACMSD
ENSG00000224738	ENSG00000224738	-1.98361967761352	0.0377476641361438	LPS_vs_Control	HSALNG0117749	intronic_antisense	Q75			PRR11
ENSG00000215769	ARHGAP27P1-BPTFP1-KPNA2P3	-1.14891301010361	0.0378739815416838	LPS_vs_Control	HSALNG0118135	integenic	Not conserved	hsa-miR-5088-3p,hsa-miR-7108-3p,hsa-miR-10392-3p	-	LRRC37A3
ENSG00000291236	ENSG00000291236	1.91256240801268	0.0380388245997376	LPS_vs_Control	NA	NA	NA	NA	NA	TNS1
ENSG00000267108	ENSG00000267108	-2.53526616534088	0.0380851251245259	LPS_vs_Control	HSALNG0120110	anti_sense	Q75		-	PRELID3A
ENSG00000231064	THBS3-AS1	3.90464989741763	0.0382360108191661	LPS_vs_Control	HSALNG0007477	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6769b-5p	Gastric carcinoma,Treatment-resistant hypertension,Carpal tunnel syndrome,Occipital lobe volume measurement; Calcium measurement; Heel bone mineral density,Hemoglobin a1 measurement; Mean corpuscular hemoglobin concentration,Cancer antigen 15.3 measurement; Fev/fec ratio,Glomerular filtration rate; Bmi-adjusted waist circumference; Cancer antigen 15.3 measurement; Creatinine measurement; Cortical thickness,-	MTX1
ENSG00000228741	SPATA13	3.3300722531812	0.0384689361879356	LPS_vs_Control	HSALNG0095761	sense	Not conserved	hsa-miR-874-3p		SPATA13
ENSG00000269973	ENSG00000269973	1.13439903110226	0.0384786332171294	LPS_vs_Control	HSALNG0012933	sense	Not conserved		-	TAF1B
ENSG00000226012	ENSG00000226012	3.58847836927065	0.0385167521363041	LPS_vs_Control	HSALNG0133051	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-6089,hsa-miR-7703	Bmi-adjusted hip circumference,-	KCNJ6
ENSG00000232194	ENSG00000232194	3.01366452083336	0.0387229768596684	LPS_vs_Control	HSALNG0008257	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6891-5p,hsa-miR-10392-3p	-	MPZL1
ENSG00000245688	ENSG00000245688	-3.02291495670636	0.0388131628390675	LPS_vs_Control	HSALNG0047024	sense	Not conserved			COL23A1
ENSG00000184441	ENSG00000184441	-1.03946530560891	0.0388976299558	LPS_vs_Control	HSALNG0133526	anti_sense	Not conserved	hsa-miR-4447,hsa-miR-4472,hsa-miR-4781-5p,hsa-miR-6748-3p	-	PFKL
ENSG00000267365	KCNJ2-AS1	1.58063434853528	0.0389040425573875	LPS_vs_Control	HSALNG0118455	anti_sense	Q50		Body weight,-	ABCA5
ENSG00000285331	ENSG00000285331	-1.38913900757259	0.0391872891928146	LPS_vs_Control	HSALNG0106164	sense	Not conserved			NA
ENSG00000231999	LRRC8C-DT	-1.29738646791396	0.039225293132902	LPS_vs_Control	HSALNG0005078	integenic	Q75			GBP5
ENSG00000255284	GATD1-DT	-1.34799101017805	0.0397989374236793	LPS_vs_Control	HSALNG0082025	integenic	Q75	hsa-miR-4472		PANO1
ENSG00000243224	TWF2-DT	-2.62695790731801	0.0399109705214541	LPS_vs_Control	HSALNG0026122	integenic	Not conserved	hsa-miR-92a-2-5p,hsa-miR-3176	-	PPM1M
ENSG00000290762	ENSG00000290762	-1.77550548343671	0.040388390943773	LPS_vs_Control	HSALNG0031865	integenic	Not conserved	hsa-miR-6736-3p	-	TNK2
ENSG00000255182	ENSG00000255182	-1.48719352459091	0.0408855072882026	LPS_vs_Control	HSALNG0069435	anti_sense	Q75	hsa-miR-892b,hsa-miR-4488	-	RECQL4
ENSG00000269609	C10orf95-AS1	-1.13322718406524	0.0416474984840574	LPS_vs_Control	HSALNG0080293	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-920,hsa-miR-1233-5p,hsa-miR-4297,hsa-miR-4516,hsa-miR-4534,hsa-miR-6089	Autism spectrum disorder symptom,Intelligence,Body mass index,Parental genotype effect measurement; Birth weight,-	MFSD13A
ENSG00000291064	RPL23AP7	-1.24773632073987	0.0418134735006853	LPS_vs_Control	HSALNG0136334	anti_sense	Not conserved	hsa-miR-4469		ACR
ENSG00000237940	LINC01238	2.87500155386096	0.0424210333606595	LPS_vs_Control	HSALNG0023737	anti_sense	Not conserved	hsa-miR-891a-3p,hsa-miR-937-5p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6085,hsa-miR-6748-3p,hsa-miR-6792-3p,hsa-miR-6883-5p,hsa-miR-6889-3p,hsa-miR-7108-5p	Caudal anterior cingulate cortex volume measurement,Brain aneurysm,Eczema,Ovarian carcinoma,High density lipoprotein cholesterol measurement,Age at onset; Refractive error; Myopia,-	RTP5
ENSG00000270277	ENSG00000270277	-2.01746697980738	0.043041284813895	LPS_vs_Control	HSALNG0020716	anti_sense	Q90		Atrial fibrillation,-	PLEKHA3
ENSG00000272501	ENSG00000272501	1.40142440879977	0.0432073984543747	LPS_vs_Control	HSALNG0049245	anti_sense,sense	Q75	hsa-miR-556-3p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-1199-5p,hsa-miR-6803-5p	Membranous glomerulonephritis,Crohn's disease; Toxic epidermal necrolysis; Stevens-johnson syndrome,Hiv-1 infection; Neutrophil count; Basophil count,Body height; Multiple myeloma,Age at diagnosis,Neutrophil count; Bmi-adjusted waist-hip ratio,Cleft lip; Bmi-adjusted waist-hip ratio; Cleft palate,Aging,Psoriatic arthritis,Susceptibility to cold sores measurement,Bmi-adjusted hip circumference,Hemoglobin measurement,Psoriasis,Bmi-adjusted waist-hip ratio,Parental longevity,Von willebrand factor measurement,Lung carcinoma,Tonsillectomy risk measurement,Monocyte count,Monocyte percentage of leukocytes,Mean platelet volume,Reticulocyte measurement,Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Platelet crit; Monocyte count,Lymphocyte count,Bmi-adjusted waist circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,Takayasu arteritis,Serum ige measurement,High density lipoprotein cholesterol measurement,Cancer,Response to vaccine,Susceptibility to plantar warts measurement,Eosinophil count,Sarcoidosis,Basophil count,Reticulocyte count,C-reactive protein measurement,Cervical carcinoma,Platelet-to-lymphocyte ratio; Lymphocyte count; Neutrophil count; Monocyte count,Drugs used in diabetes use measurement,Ulcerative colitis,Bmi-adjusted hip circumference; Basal cell carcinoma,Susceptibility to childhood ear infection measurement,Leukocyte count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Platelet count,Eosinophil percentage of leukocytes,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Basophil count; Bmi-adjusted hip circumference; Leukocyte count; Bmi-adjusted waist-hip ratio; Eosinophil count; Granulocyte count,Chronic hepatitis b virus infection; Hepatitis b virus infection,Chronic hepatitis b virus infection,Serum metabolite measurement,Neutrophil-to-lymphocyte ratio; Lymphocyte percentage of leukocytes,Prostate carcinoma,Viral subtype carrier status,Mean corpuscular volume,Leukocyte count; Myeloid white cell count; Anti-anoctamin 2 antibody measurement; Monocyte count,Mean corpuscular hemoglobin,Waist-hip ratio,Triglyceride measurement; Bmi-adjusted hip circumference,Leukocyte count; Neutrophil count; Lymphocyte count; Myeloid white cell count,Bmi-adjusted waist-hip ratio; Cytokine measurement,Irritable bowel syndrome; Bmi-adjusted waist-hip ratio,Dna methylation,Protein measurement,Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Skin pigmentation measurement,Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Varicose veins,Granulocyte percentage of myeloid white cells,Erythrocyte count,Mean reticulocyte volume,Vitiligo,Monoclonal gammopathy; Multiple myeloma,Mean corpuscular hemoglobin concentration; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Leukocyte count; Body height,Cd4:cd8 lymphocyte ratio; Cd8-positive t-lymphocyte count,Leprosy,Eczema,Bmi-adjusted waist-hip ratio; Gastric carcinoma,Systemic lupus erythematosus,Granzyme a measurement,Leukocyte count; Reticulocyte count,Neutrophil count,Interleukin 18 measurement,Aids; Psoriasis; Cutaneous psoriasis measurement,Triglyceride measurement; Body height; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Nasopharyngeal neoplasm,Atopic eczema,Psoriasis; Psoriasis vulgaris,Crohn's disease,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Body height; Blood protein measurement; Triglyceride measurement,Hypertension,Autoimmune disease,Mean corpuscular volume; Bmi-adjusted waist-hip ratio,Stomach polyp,Sex hormone-binding globulin measurement,Oral ulcer,Major depressive disorder; Major depressive episode,Unipolar depression,Mhc class i polypeptide-related sequence a measurement,Myeloid white cell count,Body weight; Bmi-adjusted hip circumference; Perceived unattractiveness to mosquitos measurement,Body height,Maximum cigarettes per day measurement,Lymphocyte percentage of leukocytes,Myelodysplastic syndrome,Appendicular lean mass,Angiopoietin-1 receptor measurement,Vasodilators used in cardiac diseases use measurement,Intelligence; Unipolar depression,Severe aplastic anemia,Non-melanoma skin carcinoma,Systemic lupus erythematosus; Bmi-adjusted waist-hip ratio,Post-traumatic stress disorder,Triglyceride measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Alpha-2-macroglobulin receptor-associated protein measurement,Psoriasis vulgaris,Facial morphology measurement,Feeling miserable measurement,Psoriasis; Membranous glomerulonephritis,Response to interferon beta; Mean corpuscular hemoglobin concentration; Human papilloma virus infection; Anti-drug antibody measurement; Hiv-1 infection; Oral cavity cancer; Beta-2 microglobulin measurement,Hiv viral set point measurement,Diffuse large b-cell lymphoma; Visual perception measurement,Immunoglobulin isotype switching measurement; Bmi-adjusted hip circumference; Rheumatic heart disease,Atopic asthma,Apolipoprotein a 1 measurement; Autism spectrum disorder; Feeling nervous measurement,Allergic rhinitis; Nasal cavity polyp; Adult onset asthma,Serum albumin measurement,Angina pectoris; Liver neoplasm,Seasonal allergic rhinitis; Platelet count,Neutrophil count; Basophil count,Bmi-adjusted waist circumference; Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Hypothyroidism; Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Self reported educational attainment; Metabolic syndrome; Bmi-adjusted hip circumference; Mathematical ability; Triglyceride measurement,Mean reticulocyte volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Cannabis use; Bmi-adjusted waist-hip ratio; Age at onset,Cirrhosis of liver,Chronic hepatitis c virus infection,Pneumonia,Cognitive function measurement; Mathematical ability,Iga glomerulonephritis; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Myocardial infarction,17-hydroxyprogesterone measurement,Gastroesophageal reflux disease,Glomerular filtration rate,Keratinocyte carcinoma,Body fat percentage,Proliferative diabetic retinopathy; Skin neoplasm,Frontal fibrosing alopecia,Ankylosing spondylitis,Cx3cl1 measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Monocyte count,Susceptibility to mumps measurement,Susceptibility to chickenpox measurement,Autism spectrum disorder; Small cell lung carcinoma,Mean corpuscular volume; Bmi-adjusted hip circumference; Erythrocyte count,Triglyceride measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Eosinophil percentage of granulocytes,Susceptibility to strep throat measurement,Mosquito bite reaction itch intensity measurement,Colorectal cancer; Colorectal adenoma; Mean platelet volume,Neutrophil percentage of leukocytes,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Red blood cell density measurement,Platelet component distribution width,Behcet's syndrome,Mean platelet volume; Bipolar disorder; Eosinophil percentage of leukocytes,Hiv-1 infection; Anxiety measurement,Trichloroethylene-induced hypersensitivity,Marginal zone b-cell lymphoma,Diastolic blood pressure; Systolic blood pressure,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Atopic asthma,Squamous cell lung carcinoma,Bmi-adjusted hip circumference; White matter integrity; Bmi-adjusted waist-hip ratio,Anterior uveitis,Neutrophil count; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Basophil count; Bmi-adjusted waist-hip ratio,Tropical spastic paraparesis,Neutrophil-to-lymphocyte ratio; Monocyte count,Eosinophil count; Lymphocyte count; Bmi-adjusted hip circumference,Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Gastroesophageal reflux disease; Bmi-adjusted waist circumference; Oral ulcer; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Aspirin use measurement,Oral ulcer; Bmi-adjusted hip circumference; Aspirin use measurement; Calcium channel blocker use measurement; Antithrombotic agent use measurement,Systolic blood pressure,Iritis,Pulse pressure measurement; Systolic blood pressure,Blood protein measurement; Heel bone mineral density,Viral load,Self reported educational attainment; Cognitive function measurement,Mathematical ability,Antithrombotic agent use measurement,Bmi-adjusted waist circumference; Mhc class i polypeptide-related sequence a measurement,Platelet crit,Hematocrit,Sjogren syndrome,Neutrophil percentage of granulocytes,Eosinophil count; Basophil count,Basophil percentage of granulocytes,Body height; Cerebrospinal fluid biomarker measurement,Graves disease; Thyrotoxic periodic paralysis,Body height; Bmi-adjusted hip circumference; Low density lipoprotein cholesterol measurement,Allergic sensitization measurement,Rheumatoid arthritis,Chronic obstructive pulmonary disease; Rosacea severity measurement,Surfactant protein d measurement; Blood protein measurement; Chronic obstructive pulmonary disease; Adult onset asthma,Gastric carcinoma,Autoimmune disease; Bmi-adjusted hip circumference,Anterior uveitis; Ankylosing spondylitis,Hemoglobin a1 measurement,Eosinophil count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Response to sulfasalazine; Bmi-adjusted waist-hip ratio; Drug-induced agranulocytosis,Anti-anoctamin 2 antibody measurement,Autism spectrum disorder; Bmi-adjusted hip circumference,Sclerosing cholangitis,Hepatocellular carcinoma,Hiv-1 infection,Beta-2 microglobulin measurement,Autoimmune thyroid disease,Female reproductive system disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Conotruncal heart malformations; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum iga measurement,Uveitis,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Body weight,Response to antineoplastic agent,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Susceptibility to mononucleosis measurement,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Glucose measurement,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Mhc class i polypeptide-related sequence b measurement,Alcohol use disorder measurement,Testosterone measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Mathematical ability,Lobe attachment; Lymphocyte count,Atopic eczema; Susceptibility to strep throat measurement,Comparative body size at age 10, self-reported,Response to thioamide; Drug-induced agranulocytosis,Surfactant protein d measurement; Chronic obstructive pulmonary disease,Mean platelet volume; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Basophil count; Leukocyte count; Platelet count; Monocyte count; Eosinophil count; Mean corpuscular volume; Erythrocyte count,Toxic epidermal necrolysis; Response to reverse transcriptase inhibitor; Stevens-johnson syndrome,Triglyceride measurement; C-reactive protein measurement,Response to rhododendrol; Vitiligo,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Eczema; Allergic rhinitis,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Cervical intraepithelial neoplasia grade 2/3; Cervical carcinoma,Response to anti-thyroid drug; Drug-induced agranulocytosis,Hypersensitivity reaction disease; Response to reverse transcriptase inhibitor,Response to drug; Drug-induced agranulocytosis,Human papilloma virus infection; Oropharynx cancer,Puberty; Height growth measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Hiv-1 infection; Crohn's disease; Inflammatory bowel disease,Handedness,Lupus nephritis; Blood protein measurement,Leukocyte count; Lymphocyte count,Glucose metabolism decline measurement; Cingulate cortex measurement,Igg galactosylation measurement,Mean platelet volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Reticulocyte count; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Human herpesvirus 6 seropositivity; Neutrophil count; Bmi-adjusted waist-hip ratio,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Platelet-to-lymphocyte ratio,Autism spectrum disorder; Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Angiopoietin-1 receptor measurement; Platelet count; Platelet crit,Bmi-adjusted hip circumference; Basophil count,Drug-induced agranulocytosis; Response to clozapine,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Basal cell carcinoma,Low density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Age at onset,Susceptibility to pneumonia measurement,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio,-	POU5F1
ENSG00000290110	ENSG00000290110	-3.23846570699612	0.0432726387469448	LPS_vs_Control	NA	NA	NA	NA	NA	TCF7L1
ENSG00000262712	ENSG00000262712	-2.40244760263102	0.0433932689264521	LPS_vs_Control	NA	NA	NA	NA	NA	PAM16
ENSG00000250133	HOXC-AS2	3.54436625456891	0.0433932689264521	LPS_vs_Control	HSALNG0091321	anti_sense,intronic_antisense	Q90		Leukocyte count; Bmi-adjusted waist-hip ratio; Waist-hip ratio; Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Platelet crit,Vital capacity,-	SMUG1
ENSG00000234142	LINC01675	3.48768429074714	0.0434635414934291	LPS_vs_Control	HSALNG0008185	integenic	Q75		-	FAM78B
ENSG00000231154	MORF4L2-AS1	-3.78381607293132	0.0437716229268275	LPS_vs_Control	HSALNG0139326	anti_sense	Q50			TMEM31
ENSG00000254860	TMEM9B-AS1	-1.43130834577117	0.0438346056746657	LPS_vs_Control	HSALNG0082585	anti_sense	Q75	hsa-miR-6808-5p	-	AKIP1
ENSG00000278921	EPB41L4A-DT	3.52484517250441	0.0438835989766638	LPS_vs_Control	HSALNG0141607	integenic	Q75		-	APC
ENSG00000289357	ENSG00000289357	-3.24759846351438	0.0441141288838496	LPS_vs_Control	NA	NA	NA	NA	NA	CDCA2
ENSG00000288827	ENSG00000288827	-1.74168457266081	0.0441317832370088	LPS_vs_Control	NA	NA	NA	NA	NA	DHX34
ENSG00000291224	ENSG00000291224	-1.32418963218457	0.0441563079665559	LPS_vs_Control	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2
ENSG00000261067	ENSG00000261067	-1.80013055347571	0.045008111185035	LPS_vs_Control	HSALNG0110553	sense	Not conserved			LAT
ENSG00000271964	ENSG00000271964	-3.23656460671966	0.0450292491899704	LPS_vs_Control	HSALNG0024477	anti_sense,sense	Not conserved	hsa-miR-6763-5p		OXNAD1
ENSG00000229921	KIF25-AS1	3.702078548105	0.0453472915652643	LPS_vs_Control	HSALNG0055219	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-3652,hsa-miR-6089,hsa-miR-6826-3p	5-hiaa measurement,Nicotine dependence symptom count,Heel bone mineral density,-	FRMD1
ENSG00000262227	ENSG00000262227	-1.976014359591	0.0457111257051214	LPS_vs_Control	HSALNG0114081	anti_sense	Q90	hsa-miR-4730,hsa-miR-6877-3p	-	KIF1C
ENSG00000255750	ENSG00000255750	2.98149419780151	0.0457176617030562	LPS_vs_Control	HSALNG0089971	anti_sense,sense	Q50		Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hair morphology measurement,Leukocyte count; Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Cup-to-disc ratio measurement,Balding measurement,Thrombin-antithrombin complex measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Alopecia; Androgenetic alopecia; Heel bone mineral density,Alopecia; Androgenetic alopecia; Balding measurement,Alopecia,Endometrial carcinoma,Mammographic density measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement,Systolic blood pressure,High density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference,Lymphocyte count,Bmi-adjusted waist circumference; Waist-hip ratio; Body fat percentage; Physical activity measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement; Renal cell carcinoma,Heel bone mineral density,Serum alanine aminotransferase measurement; Waist-hip ratio,Sex hormone-binding globulin measurement; Heel bone mineral density; Bmi-adjusted hip circumference; Physical activity measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Triglyceride measurement,Sex hormone-binding globulin measurement,Body height,Cardiovascular disease,Alkaline phosphatase measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Triglyceride measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Sex interaction measurement; Waist-hip ratio; Physical activity measurement; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Physical activity measurement,Serum alanine aminotransferase measurement,Waist-hip ratio; Alkaline phosphatase measurement,Dense area measurement; Mammographic density measurement,Response to oxcarbazepine; Oxcarbazepine-induced hyponatremia; Carbamazepine-induced hyponatremia; Response to carbamazepine,-,Cognitive impairment measurement	ITPR2
ENSG00000272221	ENSG00000272221	1.42924284718472	0.0458291056347701	LPS_vs_Control	HSALNG0049245	anti_sense,sense	Q75	hsa-miR-556-3p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-1199-5p,hsa-miR-6803-5p	Membranous glomerulonephritis,Crohn's disease; Toxic epidermal necrolysis; Stevens-johnson syndrome,Hiv-1 infection; Neutrophil count; Basophil count,Body height; Multiple myeloma,Age at diagnosis,Neutrophil count; Bmi-adjusted waist-hip ratio,Cleft lip; Bmi-adjusted waist-hip ratio; Cleft palate,Aging,Psoriatic arthritis,Susceptibility to cold sores measurement,Bmi-adjusted hip circumference,Hemoglobin measurement,Psoriasis,Bmi-adjusted waist-hip ratio,Parental longevity,Von willebrand factor measurement,Lung carcinoma,Tonsillectomy risk measurement,Monocyte count,Monocyte percentage of leukocytes,Mean platelet volume,Reticulocyte measurement,Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Platelet crit; Monocyte count,Lymphocyte count,Bmi-adjusted waist circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,Takayasu arteritis,Serum ige measurement,High density lipoprotein cholesterol measurement,Cancer,Response to vaccine,Susceptibility to plantar warts measurement,Eosinophil count,Sarcoidosis,Basophil count,Reticulocyte count,C-reactive protein measurement,Cervical carcinoma,Platelet-to-lymphocyte ratio; Lymphocyte count; Neutrophil count; Monocyte count,Drugs used in diabetes use measurement,Ulcerative colitis,Bmi-adjusted hip circumference; Basal cell carcinoma,Susceptibility to childhood ear infection measurement,Leukocyte count,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Platelet count,Eosinophil percentage of leukocytes,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Basophil count; Bmi-adjusted hip circumference; Leukocyte count; Bmi-adjusted waist-hip ratio; Eosinophil count; Granulocyte count,Chronic hepatitis b virus infection; Hepatitis b virus infection,Chronic hepatitis b virus infection,Serum metabolite measurement,Neutrophil-to-lymphocyte ratio; Lymphocyte percentage of leukocytes,Prostate carcinoma,Viral subtype carrier status,Mean corpuscular volume,Leukocyte count; Myeloid white cell count; Anti-anoctamin 2 antibody measurement; Monocyte count,Mean corpuscular hemoglobin,Waist-hip ratio,Triglyceride measurement; Bmi-adjusted hip circumference,Leukocyte count; Neutrophil count; Lymphocyte count; Myeloid white cell count,Bmi-adjusted waist-hip ratio; Cytokine measurement,Irritable bowel syndrome; Bmi-adjusted waist-hip ratio,Dna methylation,Protein measurement,Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Skin pigmentation measurement,Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Varicose veins,Granulocyte percentage of myeloid white cells,Erythrocyte count,Mean reticulocyte volume,Vitiligo,Monoclonal gammopathy; Multiple myeloma,Mean corpuscular hemoglobin concentration; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Leukocyte count; Body height,Cd4:cd8 lymphocyte ratio; Cd8-positive t-lymphocyte count,Leprosy,Eczema,Bmi-adjusted waist-hip ratio; Gastric carcinoma,Systemic lupus erythematosus,Granzyme a measurement,Leukocyte count; Reticulocyte count,Neutrophil count,Interleukin 18 measurement,Aids; Psoriasis; Cutaneous psoriasis measurement,Triglyceride measurement; Body height; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Nasopharyngeal neoplasm,Atopic eczema,Psoriasis; Psoriasis vulgaris,Crohn's disease,Eosinophil count; Basophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Body height; Blood protein measurement; Triglyceride measurement,Hypertension,Autoimmune disease,Mean corpuscular volume; Bmi-adjusted waist-hip ratio,Stomach polyp,Sex hormone-binding globulin measurement,Oral ulcer,Major depressive disorder; Major depressive episode,Unipolar depression,Mhc class i polypeptide-related sequence a measurement,Myeloid white cell count,Body weight; Bmi-adjusted hip circumference; Perceived unattractiveness to mosquitos measurement,Body height,Maximum cigarettes per day measurement,Lymphocyte percentage of leukocytes,Myelodysplastic syndrome,Appendicular lean mass,Angiopoietin-1 receptor measurement,Vasodilators used in cardiac diseases use measurement,Intelligence; Unipolar depression,Severe aplastic anemia,Non-melanoma skin carcinoma,Systemic lupus erythematosus; Bmi-adjusted waist-hip ratio,Post-traumatic stress disorder,Triglyceride measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Alpha-2-macroglobulin receptor-associated protein measurement,Psoriasis vulgaris,Facial morphology measurement,Feeling miserable measurement,Psoriasis; Membranous glomerulonephritis,Response to interferon beta; Mean corpuscular hemoglobin concentration; Human papilloma virus infection; Anti-drug antibody measurement; Hiv-1 infection; Oral cavity cancer; Beta-2 microglobulin measurement,Hiv viral set point measurement,Diffuse large b-cell lymphoma; Visual perception measurement,Immunoglobulin isotype switching measurement; Bmi-adjusted hip circumference; Rheumatic heart disease,Atopic asthma,Apolipoprotein a 1 measurement; Autism spectrum disorder; Feeling nervous measurement,Allergic rhinitis; Nasal cavity polyp; Adult onset asthma,Serum albumin measurement,Angina pectoris; Liver neoplasm,Seasonal allergic rhinitis; Platelet count,Neutrophil count; Basophil count,Bmi-adjusted waist circumference; Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Hypothyroidism; Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Self reported educational attainment; Metabolic syndrome; Bmi-adjusted hip circumference; Mathematical ability; Triglyceride measurement,Mean reticulocyte volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Cannabis use; Bmi-adjusted waist-hip ratio; Age at onset,Cirrhosis of liver,Chronic hepatitis c virus infection,Pneumonia,Cognitive function measurement; Mathematical ability,Iga glomerulonephritis; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Myocardial infarction,17-hydroxyprogesterone measurement,Gastroesophageal reflux disease,Glomerular filtration rate,Keratinocyte carcinoma,Body fat percentage,Proliferative diabetic retinopathy; Skin neoplasm,Frontal fibrosing alopecia,Ankylosing spondylitis,Cx3cl1 measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Monocyte count,Susceptibility to mumps measurement,Susceptibility to chickenpox measurement,Autism spectrum disorder; Small cell lung carcinoma,Mean corpuscular volume; Bmi-adjusted hip circumference; Erythrocyte count,Triglyceride measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Eosinophil percentage of granulocytes,Susceptibility to strep throat measurement,Mosquito bite reaction itch intensity measurement,Colorectal cancer; Colorectal adenoma; Mean platelet volume,Neutrophil percentage of leukocytes,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Red blood cell density measurement,Platelet component distribution width,Behcet's syndrome,Mean platelet volume; Bipolar disorder; Eosinophil percentage of leukocytes,Hiv-1 infection; Anxiety measurement,Trichloroethylene-induced hypersensitivity,Marginal zone b-cell lymphoma,Diastolic blood pressure; Systolic blood pressure,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Atopic asthma,Squamous cell lung carcinoma,Bmi-adjusted hip circumference; White matter integrity; Bmi-adjusted waist-hip ratio,Anterior uveitis,Neutrophil count; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Basophil count; Bmi-adjusted waist-hip ratio,Tropical spastic paraparesis,Neutrophil-to-lymphocyte ratio; Monocyte count,Eosinophil count; Lymphocyte count; Bmi-adjusted hip circumference,Neutrophil percentage of leukocytes; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Gastroesophageal reflux disease; Bmi-adjusted waist circumference; Oral ulcer; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Aspirin use measurement,Oral ulcer; Bmi-adjusted hip circumference; Aspirin use measurement; Calcium channel blocker use measurement; Antithrombotic agent use measurement,Systolic blood pressure,Iritis,Pulse pressure measurement; Systolic blood pressure,Blood protein measurement; Heel bone mineral density,Viral load,Self reported educational attainment; Cognitive function measurement,Mathematical ability,Antithrombotic agent use measurement,Bmi-adjusted waist circumference; Mhc class i polypeptide-related sequence a measurement,Platelet crit,Hematocrit,Sjogren syndrome,Neutrophil percentage of granulocytes,Eosinophil count; Basophil count,Basophil percentage of granulocytes,Body height; Cerebrospinal fluid biomarker measurement,Graves disease; Thyrotoxic periodic paralysis,Body height; Bmi-adjusted hip circumference; Low density lipoprotein cholesterol measurement,Allergic sensitization measurement,Rheumatoid arthritis,Chronic obstructive pulmonary disease; Rosacea severity measurement,Surfactant protein d measurement; Blood protein measurement; Chronic obstructive pulmonary disease; Adult onset asthma,Gastric carcinoma,Autoimmune disease; Bmi-adjusted hip circumference,Anterior uveitis; Ankylosing spondylitis,Hemoglobin a1 measurement,Eosinophil count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Response to sulfasalazine; Bmi-adjusted waist-hip ratio; Drug-induced agranulocytosis,Anti-anoctamin 2 antibody measurement,Autism spectrum disorder; Bmi-adjusted hip circumference,Sclerosing cholangitis,Hepatocellular carcinoma,Hiv-1 infection,Beta-2 microglobulin measurement,Autoimmune thyroid disease,Female reproductive system disease,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Conotruncal heart malformations; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum iga measurement,Uveitis,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Body weight,Response to antineoplastic agent,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Susceptibility to mononucleosis measurement,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Glucose measurement,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Mhc class i polypeptide-related sequence b measurement,Alcohol use disorder measurement,Testosterone measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Mathematical ability,Lobe attachment; Lymphocyte count,Atopic eczema; Susceptibility to strep throat measurement,Comparative body size at age 10, self-reported,Response to thioamide; Drug-induced agranulocytosis,Surfactant protein d measurement; Chronic obstructive pulmonary disease,Mean platelet volume; Neutrophil count; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Basophil count; Leukocyte count; Platelet count; Monocyte count; Eosinophil count; Mean corpuscular volume; Erythrocyte count,Toxic epidermal necrolysis; Response to reverse transcriptase inhibitor; Stevens-johnson syndrome,Triglyceride measurement; C-reactive protein measurement,Response to rhododendrol; Vitiligo,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Eczema; Allergic rhinitis,Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Estrogen-receptor negative breast cancer,Cervical intraepithelial neoplasia grade 2/3; Cervical carcinoma,Response to anti-thyroid drug; Drug-induced agranulocytosis,Hypersensitivity reaction disease; Response to reverse transcriptase inhibitor,Response to drug; Drug-induced agranulocytosis,Human papilloma virus infection; Oropharynx cancer,Puberty; Height growth measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Hiv-1 infection; Crohn's disease; Inflammatory bowel disease,Handedness,Lupus nephritis; Blood protein measurement,Leukocyte count; Lymphocyte count,Glucose metabolism decline measurement; Cingulate cortex measurement,Igg galactosylation measurement,Mean platelet volume; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Reticulocyte count; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Human herpesvirus 6 seropositivity; Neutrophil count; Bmi-adjusted waist-hip ratio,Lymphocyte count; Neutrophil count; Bmi-adjusted waist circumference; Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Platelet-to-lymphocyte ratio,Autism spectrum disorder; Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Angiopoietin-1 receptor measurement; Platelet count; Platelet crit,Bmi-adjusted hip circumference; Basophil count,Drug-induced agranulocytosis; Response to clozapine,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Basal cell carcinoma,Low density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement,Age at onset,Susceptibility to pneumonia measurement,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio,-	HLA-B
ENSG00000285108	ENSG00000285108	3.88059345979601	0.0461413269423549	LPS_vs_Control	HSALNG0068596	integenic	Q50		Beta-aminoisobutyric acid measurement,High density lipoprotein cholesterol measurement; Balding measurement,Skin aging measurement,Eosinophil count; Eosinophil percentage of leukocytes,Bmi-adjusted waist circumference; Body height; Osteoarthritis, hip,Body height; Heel bone mineral density,Heel bone mineral density,Back pain,Body height,Bmi-adjusted waist circumference,Hemorrhoid,Body weight,Bmi-adjusted hip circumference,Body height; Bmi-adjusted hip circumference; Infant body height,Body fat distribution,Total hip arthroplasty,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Lean body mass,Sciatica; Lumbar disc herniation; Ldh-related sciatica symptom severity measurement,-	GSDMC
ENSG00000273151	ENSG00000273151	-1.55245252131703	0.0467421911194562	LPS_vs_Control	NA	NA	NA	NA	NA	ADAP1
ENSG00000273216	ENSG00000273216	-2.11282304702566	0.0474891506059638	LPS_vs_Control	HSALNG0134823	sense	Not conserved	hsa-miR-4447		RASL10A
ENSG00000260249	ENSG00000260249	3.93845369080707	0.0475087035922678	LPS_vs_Control	HSALNG0111357	anti_sense	Not conserved	hsa-miR-6860	Heel bone mineral density	NKD1
ENSG00000228649	SNHG26	-1.27774342722592	0.047662831538243	LPS_vs_Control	HSALNG0056623	integenic	Q75	hsa-miR-483-3p,hsa-miR-4320	Alkaline phosphatase measurement,-	IL6
ENSG00000290387	SORD2P	3.90311725932338	0.0479493221857965	LPS_vs_Control	HSALNG0144510	integenic	Not conserved		Adolescent idiopathic scoliosis	PATL2
ENSG00000237781	ADAMTSL4-AS2	1.24178834680453	0.0479801045491879	LPS_vs_Control	HSALNG0007049	anti_sense	Q50	hsa-miR-607,hsa-miR-619-5p,hsa-miR-8485	Prostate carcinoma,Body height,-	MCL1
ENSG00000236017	ASMTL-AS1	-1.18004086237008	0.0480456853531063	LPS_vs_Control	HSALNG0151029	anti_sense	Not conserved			IL3RA
ENSG00000261335	ENSG00000261335	-4.00363360648675	0.0482245408392915	LPS_vs_Control	HSALNG0118865	anti_sense	Not conserved			METTL23
ENSG00000256582	LINC02390	3.80311636676016	0.0484782620220067	LPS_vs_Control	HSALNG0089168	integenic	Not conserved		Sleep duration; High density lipoprotein cholesterol measurement	CLEC2D
ENSG00000285492	ENSG00000285492	2.27537457988048	0.0486385732116796	LPS_vs_Control	HSALNG0054723	sense	Q90	hsa-miR-7160-3p	Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Myeloid white cell count; Neutrophil count; Basophil count,Psoriasis vulgaris,Rheumatoid arthritis; Celiac disease,Eosinophil percentage of leukocytes,-	TAGAP
ENSG00000273007	ENSG00000273007	-3.65494989478736	0.0486385732116796	LPS_vs_Control	HSALNG0036873	anti_sense,sense	Q50		-	NUDT6
ENSG00000289439	ENSG00000289439	-2.170987497253	0.048676397548001	LPS_vs_Control	HSALNG0012076	integenic	Q90	hsa-miR-4650-5p,hsa-miR-6089	Unipolar depression,Brain volume measurement,Self reported educational attainment,Cognitive function measurement; Mathematical ability,Response to alcohol,Monocyte count,-	ADSS2
ENSG00000288971	ENSG00000288971	2.69550951159469	0.0488263479541257	LPS_vs_Control	NA	NA	NA	NA	NA	BMAL2
ENSG00000228013	IL6R-AS1	2.11653510297808	0.0489006403934717	LPS_vs_Control	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE
ENSG00000291055	ENSG00000291055	-1.77368538893199	0.0491002438630191	LPS_vs_Control	HSALNG0039572	integenic	Not conserved		Lung adenocarcinoma,-	LPCAT1
ENSG00000275888	ENSG00000275888	-2.79311634639588	0.0497894631139986	LPS_vs_Control	HSALNG0145184	anti_sense,sense	Q90	hsa-miR-7113-3p	-	SLC16A3
